View Filing Data

Print Document View Excel Document

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Dec. 31, 2012	Jan. 31, 2013	Jun. 30, 2012
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	FY
Trading Symbol	UHS
Entity Registrant Name	UNIVERSAL HEALTH SERVICES INC
Entity Central Index Key	0000352915
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 3,820,000,000
Class A
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		6,625,708
Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		90,407,949
Class C
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		664,000
Class D
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		31,942

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Net revenues before provision for doubtful accounts	$ 7,688,071	$ 7,356,798	$ 5,429,233
Less: Provision for doubtful accounts	726,671	596,576	529,086
Net revenues	6,961,400	6,760,222	4,900,147
Operating charges:
Salaries, wages and benefits	3,440,917	3,326,378	2,363,383
Other operating expenses	1,376,122	1,353,693	968,612
Supplies expense	799,621	805,489	716,925
Depreciation and amortization	302,426	287,211	216,930
Lease and rental expense	94,885	90,323	75,363
Transaction costs	5,716	0	53,220
Electronic health records incentive income	(30,038)	0	0
Costs related to extinguishment of debt	29,170	0	0
Operating expenses	6,018,819	5,863,094	4,394,433
Income from operations	942,581	897,128	505,714
Interest expense, net	178,918	200,792	77,617
Income before income taxes	763,663	696,336	428,097
Provision for income taxes	274,616	247,466	152,302
Net income	489,047	448,870	275,795
Less: Net income attributable to noncontrolling interests	45,601	50,703	45,612
Net income attributable to UHS	$ 443,446	$ 398,167	$ 230,183
Basic earnings per share attributable to UHS	$ 4.57	$ 4.09	$ 2.37
Diluted earnings per share attributable to UHS	$ 4.53	$ 4.04	$ 2.34
Weighted average number of common shares-basic	96,821	97,199	96,786
Add: Other share equivalents	890	1,338	1,187
Weighted average number of common shares and equivalents-diluted	97,711	98,537	97,973

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Net income	$ 147,660	$ 81,373	$ 117,444	$ 142,570	$ 108,007	$ 94,842	$ 116,034	$ 129,987	$ 489,047	$ 448,870	$ 275,795
Other comprehensive income (loss):
Unrealized derivative gains (losses) on cash flow hedges									6,677	(37,477)	1,396
Amortization of terminated hedge									(336)	(336)	(336)
Minimum Pension Liability									4,986	(12,397)	743
Other comprehensive income (loss) before tax									11,327	(50,210)	1,803
Income tax (benefit) expense related to items of other comprehensive income									4,306	(19,174)	689
Total other comprehensive income (loss), net of tax									7,021	(31,036)	1,114
Comprehensive income									496,068	417,834	276,909
Less: Comprehensive income attributable to noncontrolling interests									45,601	50,703	45,612
Comprehensive income attributable to UHS									$ 450,467	$ 367,131	$ 231,297

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 23,471	$ 41,229
Accounts receivable, net	1,067,197	969,802
Supplies	99,000	96,775
Deferred income taxes	104,461	108,324
Other current assets	87,936	99,859
Assets of facilities held for sale	25,431	48,916
Total current assets	1,407,496	1,364,905
Property and Equipment
Land	387,248	377,984
Buildings and improvements	3,366,146	3,244,117
Equipment	1,344,643	1,256,165
Property under capital lease	27,836	37,037
Property Equipment Gross	5,125,873	4,915,303
Accumulated depreciation	(1,986,110)	(1,818,180)
Property and equipment excluding construction in progress net	3,139,763	3,097,123
Construction-in-progress	242,472	190,857
Property Equipment, net	3,382,235	3,287,980
Other assets:
Goodwill	3,036,765	2,627,602
Deferred charges	75,888	111,780
Other	298,459	272,978
Other Assets, Noncurrent, Total	3,411,112	3,012,360
Total assets	8,200,843	7,665,245
Current liabilities:
Current maturities of long-term debt	2,589	2,479
Accounts payable	247,033	228,043
Liabilities of facilities held for sale	850	2,329
Accrued liabilities
Compensation and related benefits	259,646	233,583
Interest	10,774	10,622
Taxes other than income	49,829	45,359
Other	322,275	314,518
Current federal and state income taxes	1,062	0
Total current liabilities	894,058	836,933
Other noncurrent liabilities	395,355	401,908
Long-term debt	3,727,431	3,651,428
Deferred income taxes	183,747	209,592
Commitments and contingencies (Note 8)
Reedemable noncontrolling interest	234,303	218,266
Equity:
Cumulative dividends	(205,910)	(147,515)
Retained earnings	2,962,433	2,494,076
Accumulated other comprehensive loss	(44,154)	(51,175)
Universal Health Services, Inc. common stockholders' equity	2,713,345	2,296,352
Noncontrolling interest	52,604	50,766
Total Equity	2,765,949	2,347,118
Liabilities and Equity, Total	8,200,843	7,665,245
Class A
Equity:
Common Stock	66	66
Class B
Equity:
Common Stock	903	893
Class C
Equity:
Common Stock	7	7
Class D
Equity:
Common Stock	$ 0	$ 0

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2012	Dec. 31, 2011
Class A
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	12,000,000	12,000,000
Common Stock, shares issued	6,625,708	6,625,708
Common Stock, shares outstanding	6,625,708	6,625,708
Class B
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	150,000,000	150,000,000
Common Stock, shares issued	90,269,397	89,286,305
Common Stock, shares outstanding	90,269,397	89,286,305
Class C
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	1,200,000	1,200,000
Common Stock, shares issued	664,000	664,000
Common Stock, shares outstanding	664,000	664,000
Class D
Common Stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	5,000,000	5,000,000
Common Stock, shares issued	31,948	33,164
Common Stock, shares outstanding	31,948	33,164

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Class A Common	Class B Common	Class C Common	Class D Common	Capital in Excess of Par Value	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Balance (Redeemable Interest) at Dec. 31, 2009	$ 197,152
Balance (Cumulative Dividends) at Dec. 31, 2009	(108,627)
Balance (UHS Common Stockholders' Equity) at Dec. 31, 2009	1,751,071
Balance at Dec. 31, 2009	1,792,394	$ 67	$ 896	$ 7	$ 0	$ 0	$ 1,879,981	$ (21,253)	$ 41,323
Common Stock
Issued/(converted) including tax benefits from exercise of stock options \| UHS Common Stockholders' Equity	10,894
Issued/(converted) including tax benefits from exercise of stock options	10,894		4				10,890
Repurchased \| UHS Common Stockholders' Equity	(11,528)
Repurchased	(11,528)		(3)				(11,525)
Restricted share-based compensation expense \| UHS Common Stockholders' Equity	3,139
Restricted share-based compensation expense	3,139						3,139
Dividends paid \| Cumulative Dividends	(19,422)
Dividends paid \| UHS Common Stockholders' Equity	(19,422)
Dividends paid	(19,422)
Stock option expense \| UHS Common Stockholders' Equity	13,321
Stock option expense	13,321						13,321
Distributions to noncontrolling interests \| Redeemable Interest	(23,777)
Distributions to noncontrolling interests	(8,662)								(8,662)
Capital contributions from noncontrolling interests \| Redeemable Interest
Capital contributions from noncontrolling interests \| Cumulative Dividends
Capital contributions from noncontrolling interests \| UHS Common Stockholders' Equity
Capital contributions from noncontrolling interests
Purchase of minority ownership interests in majority owned businesses	600								600
Other \| Redeemable Interest	4,512
Comprehensive income:
Net income \| Redeemable Interest	33,874
Net income \| UHS Common Stockholders' Equity	230,183
Net income	241,921						230,183		11,738
Amortization of terminated hedge (net of income tax effect of $120 in 2012, $120 in 2011 and $120 in 2010) \| UHS Common Stockholders' Equity	(216)
Amortization of terminated hedge (net of income tax effect of $120 in 2012, $120 in 2011 and $120 in 2010)	(216)							(216)
Unrealized derivative losses on cash flow hedges (net of income tax effect of $2,528 in 2012, $14363 in 2011 and $528 in 2010) \| UHS Common Stockholders' Equity	868
Unrealized derivative losses on cash flow hedges (net of income tax effect of $2,528 in 2012, $14363 in 2011 and $528 in 2010)	868							868
Minimum pension liability (net of income tax effect of $1,898 in 2012, $4,691 in 2011 and $281 in 2010) \| UHS Common Stockholders' Equity	462
Minimum pension liability (net of income tax effect of $1,898 in 2012, $4,691 in 2011 and $281 in 2010)	462							462
Comprehensive income \| Redeemable Interest	33,874
Comprehensive income \| UHS Common Stockholders' Equity	231,297
Comprehensive income	276,909						230,183	1,114	11,738
Balance (Redeemable Interest) at Dec. 31, 2010	211,761
Balance (Cumulative Dividends) at Dec. 31, 2010	(128,049)
Balance (UHS Common Stockholders' Equity) at Dec. 31, 2010	1,978,772
Balance at Dec. 31, 2010	2,023,771	67	897	7	0	0	2,125,989	(20,139)	44,999
Common Stock
Issued/(converted) including tax benefits from exercise of stock options \| UHS Common Stockholders' Equity	12,633
Issued/(converted) including tax benefits from exercise of stock options	12,633	(1)	12				12,622
Repurchased \| UHS Common Stockholders' Equity	(60,482)
Repurchased	(60,482)		(16)				(60,466)
Restricted share-based compensation expense \| UHS Common Stockholders' Equity	1,957
Restricted share-based compensation expense	1,957						1,957
Dividends paid \| Cumulative Dividends	(19,466)
Dividends paid \| UHS Common Stockholders' Equity	(19,466)
Dividends paid	(19,466)
Stock option expense \| UHS Common Stockholders' Equity	15,807
Stock option expense	15,807						15,807
Distributions to noncontrolling interests \| Redeemable Interest	(31,016)
Distributions to noncontrolling interests	(7,416)								(7,416)
Comprehensive income:
Net income \| Redeemable Interest	37,521
Net income \| UHS Common Stockholders' Equity	398,167
Net income	411,350						398,167		13,183
Amortization of terminated hedge (net of income tax effect of $120 in 2012, $120 in 2011 and $120 in 2010) \| UHS Common Stockholders' Equity	(216)
Amortization of terminated hedge (net of income tax effect of $120 in 2012, $120 in 2011 and $120 in 2010)	(216)							(216)
Unrealized derivative losses on cash flow hedges (net of income tax effect of $2,528 in 2012, $14363 in 2011 and $528 in 2010) \| UHS Common Stockholders' Equity	(23,114)
Unrealized derivative losses on cash flow hedges (net of income tax effect of $2,528 in 2012, $14363 in 2011 and $528 in 2010)	(23,114)							(23,114)
Minimum pension liability (net of income tax effect of $1,898 in 2012, $4,691 in 2011 and $281 in 2010) \| UHS Common Stockholders' Equity	(7,706)
Minimum pension liability (net of income tax effect of $1,898 in 2012, $4,691 in 2011 and $281 in 2010)	(7,706)							(7,706)
Comprehensive income \| Redeemable Interest	37,521
Comprehensive income \| UHS Common Stockholders' Equity	367,131
Comprehensive income	417,834						398,167	(31,036)	13,183
Balance (Redeemable Interest) at Dec. 31, 2011	218,266
Balance (Cumulative Dividends) at Dec. 31, 2011	(147,515)
Balance (UHS Common Stockholders' Equity) at Dec. 31, 2011	2,296,352
Balance at Dec. 31, 2011	2,347,118	66	893	7	0	0	2,494,076	(51,175)	50,766
Common Stock
Issued/(converted) including tax benefits from exercise of stock options \| UHS Common Stockholders' Equity	21,684
Issued/(converted) including tax benefits from exercise of stock options	21,684		14				21,670
Repurchased \| UHS Common Stockholders' Equity	(19,154)
Repurchased	(19,154)		(4)				(19,150)
Restricted share-based compensation expense \| UHS Common Stockholders' Equity	2,308
Restricted share-based compensation expense	2,308						2,308
Dividends paid \| Cumulative Dividends	(58,395)
Dividends paid \| UHS Common Stockholders' Equity	(58,395)
Dividends paid	(58,395)
Stock option expense \| UHS Common Stockholders' Equity	20,083
Stock option expense	20,083						20,083
Distributions to noncontrolling interests \| Redeemable Interest	(18,961)
Distributions to noncontrolling interests	(7,933)								(7,933)
Purchase of minority ownership interests in majority owned businesses	(832)								(832)
Comprehensive income:
Net income \| Redeemable Interest	34,998
Net income \| UHS Common Stockholders' Equity	443,446
Net income	454,049						443,446		10,603
Amortization of terminated hedge (net of income tax effect of $120 in 2012, $120 in 2011 and $120 in 2010) \| UHS Common Stockholders' Equity	(216)
Amortization of terminated hedge (net of income tax effect of $120 in 2012, $120 in 2011 and $120 in 2010)	(216)							(216)
Unrealized derivative losses on cash flow hedges (net of income tax effect of $2,528 in 2012, $14363 in 2011 and $528 in 2010) \| UHS Common Stockholders' Equity	4,149
Unrealized derivative losses on cash flow hedges (net of income tax effect of $2,528 in 2012, $14363 in 2011 and $528 in 2010)	4,149							4,149
Minimum pension liability (net of income tax effect of $1,898 in 2012, $4,691 in 2011 and $281 in 2010) \| UHS Common Stockholders' Equity	3,088
Minimum pension liability (net of income tax effect of $1,898 in 2012, $4,691 in 2011 and $281 in 2010)	3,088							3,088
Comprehensive income \| Redeemable Interest	34,998
Comprehensive income \| UHS Common Stockholders' Equity	450,467
Comprehensive income	496,068						443,446	7,021	10,603
Balance (Redeemable Interest) at Dec. 31, 2012	234,303
Balance (Cumulative Dividends) at Dec. 31, 2012	(205,910)
Balance (UHS Common Stockholders' Equity) at Dec. 31, 2012	2,713,345
Balance at Dec. 31, 2012	$ 2,765,949	$ 66	$ 903	$ 7	$ 0	$ 0	$ 2,962,433	$ (44,154)	$ 52,604

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Amortization of terminated hedge, income tax effect	$ 120	$ 120	$ 120
Unrealized derivative losses on cash flow hedges, income tax effect	2,528	14,363	528
Minimum pension liability, income tax effect	$ 1,898	$ 4,691	$ 281

- Definition

Tax effect of the income statement impact of the reclassification adjustment of accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges realized in net income. Also includes reclassification adjustments of an entity's share of an equity investee's deferred hedging gain (loss) realized in net income.

+ References + Details

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Cash Flows from Operating Activities:
Net income	$ 489,047	$ 448,870	$ 275,795
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation & amortization	308,690	295,861	223,997
Gains on sales of assets and businesses, net of losses	(27,085)	(452)	(1,993)
Stock based compensation expense	22,518	18,225	16,799
Costs related to extinguishment of debt	29,170	0	0
Changes in assets & liabilities, net of effects from acquisitions and dispositions:
Accounts receivable	(71,068)	(134,838)	22,726
Accrued interest	152	(3,577)	8,408
Accrued and deferred income taxes	10,374	85,792	132
Other working capital accounts	28,554	(28,382)	(26,437)
Other assets and deferred charges	30,976	37,160	11,539
Other	6,367	(1,387)	812
Accrued insurance expense, net of commercial premiums paid	62,660	83,612	19,739
Payments made in settlement of self-insurance claims	(75,084)	(82,633)	(50,173)
Net cash provided by operating activities	815,271	718,251	501,344
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(363,192)	(285,682)	(239,274)
Acquisition of property and businesses	(527,847)	(29,466)	(1,958,298)
Proceeds received from sales of assets and businesses	149,311	67,592	21,460
Costs incurred for purchase and implementation of electronic health records application	(54,362)	(38,249)	(17,971)
Return of deposit on terminated purchase agreement	6,500	0	0
Net cash provided by (used in) investing activities	(789,590)	(285,805)	(2,194,083)
Cash Flows from Financing Activities:
Reduction of long-term debt	(849,647)	(381,517)	(1,392,086)
Additional borrowings	913,500	98,100	3,266,146
Financing costs	(8,283)	(23,608)	(101,815)
Repurchase of common shares	(19,154)	(60,482)	(11,528)
Dividends paid	(58,395)	(19,466)	(19,422)
Issuance of common stock	5,435	4,779	3,594
Profit distributions to noncontrolling interests	(26,895)	(38,497)	(32,456)
Proceeds from sale of noncontrolling interests in majority owned business	0	0	600
Net cash (used in) provided by financing activities	(43,439)	(420,691)	1,713,033
(Decrease) increase in cash and cash equivalents	(17,758)	11,755	20,294
Cash and cash equivalents, beginning of period	41,229	29,474	9,180
Cash and cash equivalents, end of period	23,471	41,229	29,474
Supplemental Disclosures of Cash Flow Information:
Interest paid	157,415	176,328	76,900
Income taxes paid, net of refunds	$ 264,824	$ 163,029	$ 152,088

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2012

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

1) BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Services provided by our hospitals, all of which are operated by subsidiaries of ours include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. We, through our subsidiaries, provide capital resources as well as a variety of management services to our facilities, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations.

The more significant accounting policies follow:

A) Principles of Consolidation: The consolidated financial statements include the accounts of our majority-owned subsidiaries and partnerships controlled by us or our subsidiaries as the managing general partner. All significant intercompany accounts and transactions have been eliminated.

B) Revenue Recognition: We record revenues and related receivables for health care services at the time the services are provided. Medicare and Medicaid revenues represented 39% of our net patient revenues during 2012, 41% during 2011 and 42% during 2010. Revenues from managed care entities, including health maintenance organizations and managed Medicare and Medicaid programs accounted for 49% of our net patient revenues during 2012, 47% during 2011 and 51% during 2010.

We report net patient service revenue at the estimated net realizable amounts from patients and third-party payors and others for services rendered. We have agreements with third-party payors that provide for payments to us at amounts different from our established rates. Payment arrangements include prospectively determined rates per discharge, reimbursed costs, discounted charges and per diem payments. Estimates of contractual allowances under managed care plans are based upon the payment terms specified in the related contractual agreements. We closely monitor our historical collection rates, as well as changes in applicable laws, rules and regulations and contract terms, to assure that provisions are made using the most accurate information available. However, due to the complexities involved in these estimations, actual payments from payors may be different from the amounts we estimate and record.

We estimate our Medicare and Medicaid revenues using the latest available financial information, patient utilization data, government provided data and in accordance with applicable Medicare and Medicaid payment rules and regulations. The laws and regulations governing the Medicare and Medicaid programs are extremely complex and subject to interpretation and as a result, there is at least a reasonable possibility that recorded estimates will change by material amounts in the near term. Certain types of payments by the Medicare program and state Medicaid programs (e.g. Medicare Disproportionate Share Hospital, Medicare Allowable Bad Debts and Inpatient Psychiatric Services) are subject to retroactive adjustment in future periods as a result of administrative review and audit and our estimates may vary from the final settlements. Such amounts are included in accounts receivable, net, on our Consolidated Balance Sheets. The funding of both federal Medicare and state Medicaid programs are subject to legislative and regulatory changes. As such, we cannot provide any assurance that future legislation and regulations, if enacted, will not have a material impact on our future Medicare and Medicaid reimbursements. Adjustments related to the final settlement of these retrospectively determined amounts did not materially impact our results in 2012, 2011 or 2010.

We provide care to patients who meet certain financial or economic criteria without charge or at amounts substantially less than our established rates. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in net revenues or in accounts receivable, net. See additional disclosure below in Charity Care and Uninsured Discounts for our estimated uncompensated care provided and estimated cost of providing uncompensated care.

C) Provision for Doubtful Accounts: Collection of receivables from third-party payers and patients is our primary source of cash and is critical to our operating performance. Our primary collection risks relate to uninsured patients and the portion of the bill which is the patient’s responsibility, primarily co-payments and deductibles. We estimate our provisions for doubtful accounts based on general factors such as payer mix, the agings of the receivables and historical collection experience. We routinely review accounts receivable balances in conjunction with these factors and other economic conditions which might ultimately affect the collectability of the patient accounts and make adjustments to our allowances as warranted. At our acute care hospitals, third party liability accounts are pursued until all payment and adjustments are posted to the patient account. For those accounts with a patient balance after third party liability is finalized or accounts for uninsured patients, the patient receives statements and collection letters. Patients that express an inability to pay are reviewed for potential sources of financial assistance including our charity care policy. If the patient is deemed unwilling to pay, the account is written-off as bad debt and transferred to an outside collection agency for additional collection effort.

Uninsured patients that do not qualify as charity patients are extended an uninsured discount of a minimum of 30% of total charges. Our hospitals establish a partial reserve for self-pay accounts in the allowance for doubtful accounts for both unbilled balances and those that have been billed and are under 90 days old. All self-pay accounts are fully reserved at 90 days from the date of discharge. Third party liability accounts are fully reserved in the allowance for doubtful accounts when the balance ages past 180 days from the date of discharge. Potential charity accounts are fully reserved when it is determined the patient may be unable to pay.

As of December 31, 2012, our accounts receivable includes $70 million due from Illinois ($54 million as of December 31, 2011), the collection of which has been delayed due to budgetary and funding pressures experienced by the state. Although as of December 31, 2012 approximately $51 million of the receivables due from Illinois have been outstanding in excess of 60 days ($41 million as of December 31, 2011), and a large portion will likely remain outstanding for the foreseeable future, we expect to eventually collect all amounts due to us and therefore no related reserves have been established in our consolidated financial statements. However, we can provide no assurance that we will eventually collect all amounts due to us from Illinois. Failure to ultimately collect all outstanding amounts due from Illinois would have an adverse impact on our future consolidated results of operations and cash flows.

On a consolidated basis, we monitor our total self-pay receivables to ensure that the total allowance for doubtful accounts provides adequate coverage based on historical collection experience. Our accounts receivable are recorded net of allowance for doubtful accounts of $311 million and $253 million at December 31, 2012 and 2011, respectively.

D) Concentration of Revenues: Our five majority owned acute care hospitals in the Las Vegas, Nevada market contributed, on a combined basis, 14% in 2012, 15% in 2011 and 20% in 2010, of our consolidated net revenues. On a combined basis, our facilities in the McAllen/Edinburg, Texas market (consisting of three acute care facilities, a children’s hospital and a behavioral health facility) contributed 4% in 2012, 5% in 2011 and 6% in 2010, of our consolidated net revenues.

E) Charity Care and Uninsured Discounts: A significant portion of the patients treated throughout our portfolio of acute care hospitals are uninsured patients which, in part, has resulted from an increase in the number of patients who are employed but do not have health insurance or who have policies with relatively high deductibles. Patients treated at our hospitals for non-elective services, who have gross income less than 400% of the federal poverty guidelines, are deemed eligible for charity care. The federal poverty guidelines are established by the federal government and are based on income and family size. Because we do not pursue collection of amounts that qualify as charity care, they are not reported in our net revenues or in our accounts receivable, net. We also provide discounts to uninsured patients (included in “uninsured discounts” amounts below) who do not qualify for Medicaid or charity care. Because we do not pursue collection of amounts classified as uninsured discounts, they are not reported in our net revenues or in our accounts receivable, net. In implementing the discount policy, we first attempt to qualify uninsured patients for governmental programs, charity care or any other discount program. If an uninsured patient does not qualify for these programs, the uninsured discount is applied.

Uncompensated care:

The following table shows the amounts recorded at our acute care hospitals for charity care and uninsured discounts, based on charges at established rates, for the years ended December 31, 2012, 2011 and 2010:


	(dollar amounts in thousands)
	2012					2011					2010
	Amount		%			Amount		%			Amount		%
Charity care	$	778,268		74	%	$	804,301		84	%	$	664,212		82	%
Uninsured discounts		267,304		26	%		151,447		16	%		142,467		18	%

Total uncompensated care	$	1,045,572		100	%	$	955,748		100	%	$	806,679		100	%

The estimated cost of providing uncompensated care:

The estimated cost of providing uncompensated care, as reflected below, were based on a calculation which multiplied the percentage of operating expenses for our acute care hospitals to gross charges for those hospitals by the above-mentioned total uncompensated care amounts. The percentage of cost to gross charges is calculated based on the total operating expenses for our acute care facilities divided by gross patient service revenue for those facilities. An increase in the level of uninsured patients to our facilities and the resulting adverse trends in the provision for doubtful accounts and uncompensated care provided could have a material unfavorable impact on our future operating results.


	(amounts in thousands)
	2012		2011		2010
Estimated cost of providing charity care	$	131,890	$	145,350	$	129,820
Estimated cost of providing uninsured discounts related care		45,299		27,363		27,845

Estimated cost of providing uncompensated care	$	177,189	$	172,713	$	157,665

F) Accounting for Medicare and Medicaid Electronic Health Records Incentive Payments: In July 2010, the Department of Health and Human Services published final regulations implementing the health information technology provisions of the American Recovery and Reinvestment Act. The regulation defines the “meaningful use” of Electronic Health Records (“EHR”) and established the requirements for the Medicare and Medicaid EHR payment incentive programs. The implementation period for these new Medicare and Medicaid incentive payments started in federal fiscal year 2011 and can end as late as 2016 for Medicare and 2021 for the state Medicaid programs. We recognize income related to Medicare and Medicaid incentive payments using a gain contingency model that is based upon when our eligible hospitals have demonstrated “meaningful use” of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.

Medicare EHR incentive payments: Federal regulations require that Medicare EHR incentive payments be computed based on the Medicare cost report that begins in the federal fiscal period in which a hospital meets the applicable “meaningful use” requirements. Since the annual Medicare cost report periods for each of our acute care hospitals ends on December 31^st, we will recognize Medicare EHR incentive income for each hospital during the fourth quarter of the year in which the facility meets the “meaningful use” criteria and during the fourth quarter of each applicable subsequent year.

Medicaid EHR incentive payments: Medicaid EHR incentive payments are determined based upon prior period cost report information available at the time our hospitals meet the “meaningful use” criteria. Therefore, the majority of the Medicaid EHR incentive income recognition occurs in the period in which the applicable hospitals are deemed to have met initial “meaningful use” criteria. Upon meeting subsequent fiscal year “meaningful use” criteria, our hospitals may become entitled to additional Medicaid EHR incentive payments which will be recognized as incentive income in future periods. Medicaid EHR incentive payments received prior to our hospitals meeting the “meaningful use” criteria are included in other current liabilities (as deferred EHR incentive income) in our consolidated balance sheet.

G) Cash and Cash Equivalents: We consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents.

H) Property and Equipment: Property and equipment are stated at cost. Expenditures for renewals and improvements are charged to the property accounts. Replacements, maintenance and repairs which do not improve or extend the life of the respective asset are expensed as incurred. We remove the cost and the related accumulated depreciation from the accounts for assets sold or retired and the resulting gains or losses are included in the results of operations. Construction-in-progress includes both construction projects and equipment not yet placed into service.

We capitalize interest expense on major construction projects while in progress. We capitalized interest on major construction projects and the development and implementation of electronic health records applications amounting to $5.7 million during 2012, $400,000 during 2011 and $7.6 million during 2010.

Depreciation is provided on the straight-line method over the estimated useful lives of buildings and improvements (twenty to forty years) and equipment (three to fifteen years). Depreciation expense (excluding discontinued operations) was $270.5 million during 2012, $262.1 million during 2011 and $197.3 million during 2010.

I) Long-Lived Assets: We review our long-lived assets, including amortizable intangible assets, for impairment whenever events or circumstances indicate that the carrying value of these assets may not be recoverable. The assessment of possible impairment is based on our ability to recover the carrying value of our asset based on our estimate of its undiscounted future cash flow. If the analysis indicates that the carrying value is not recoverable from future cash flows, the asset is written down to its estimated fair value and an impairment loss is recognized. Fair values are determined based on estimated future cash flows using appropriate discount rates.

J) Goodwill: Goodwill is reviewed for impairment at the reporting unit level on an annual basis or sooner if the indicators of impairment arise. Our judgments regarding the existence of impairment indicators are based on market conditions and operational performance of each reporting unit. We have designated September 1^st as our annual impairment assessment date and performed an impairment assessment as of September 1, 2012 which indicated no impairment of goodwill. There were also no goodwill impairments during 2011 or 2010. Future changes in the estimates used to conduct the impairment review, including profitability and market value projections, could indicate impairment in future periods potentially resulting in a write-off of a portion or all of our goodwill.

Changes in the carrying amount of goodwill for the two years ended December 31, 2012 were as follows (in thousands):


	Acute Care Services			Behavioral Health Services			Total Consolidated
Balance, January 1, 2011	$	389,484		$	2,200,430		$	2,589,914
Adjustments to goodwill (a)		—			37,688			37,688

Balance, January 1, 2012		389,484			2,238,118			2,627,602
Goodwill acquired during the period		11,110			434,551			445,661
Goodwill divested during the period		(17,450	)		(1,902	)		(19,352	)
Adjustments to goodwill (b)		(448	)		(16,698	)		(17,146	)

Balance, December 31, 2012	$	382,696		$	2,654,069		$	3,036,765

(a)	Consists of adjustments to prior year purchase price allocations.

(b)

The reduction to the Behavioral Health Services’ goodwill consists primarily of a reclassification to “assets of facilities held for sale” and represents the goodwill attributable to Peak Behavioral Health Services which we agreed to divest pursuant to our agreement with the Federal Trade Commission in connection with our acquisition of Ascend Health Corporation in October, 2012. Adjustments to prior year purchase price allocations for Acute Care and Behavioral Health Services are also included.

K) Other Assets: Other assets consist primarily of amounts related to: (i) intangible assets acquired in connection with our acquisition of Psychiatric Solutions, Inc. (“PSI”) in November, 2010 and Ascend Health Corporation in October, 2012, consisting of Medicare licenses, certificates of need and contracts to manage the operations of behavioral health services owned by third-parties (PSI only); (ii) prepaid fees for various software and other applications used by our hospitals; (iii) costs incurred in connection with the purchase and implementation of an electronic health records application for each of our acute care facilities; (iv) deposits; (v) investments in various businesses, including Universal Health Realty Income Trust; (vi) the invested assets related to a deferred compensation plan that is held by an independent trustee in a rabbi-trust and that has a related payable included in other noncurrent liabilities; (vii) the estimated future payments related to physician-related contractual commitments, as discussed below, and; (viii) other miscellaneous assets. As of December 31, 2012 and 2011, other intangible assets, net of accumulated amortization, were approximately $99 million and $97 million, respectively.

L) Physician Guarantees and Commitments: As of December 31, 2012 and 2011, our accrued liabilities-other, and our other assets included $3 million and $7 million, respectively, of estimated future payments related to physician-related contractual commitments. Pursuant to contractual guarantees outstanding as of December 31, 2012 that are applicable to future years, we have $3 million of potential future financial obligations, substantially all of which are potential obligations during 2013.

M) Self-Insured Risks: We provide for self-insured risks, primarily general and professional liability claims and workers’ compensation claims. Our estimated liability for self-insured professional and general liability claims is based on a number of factors including, among other things, the number of asserted claims and reported incidents, estimates of losses for these claims based on recent and historical settlement amounts, estimate of incurred but not reported claims based on historical experience, and estimates of amounts recoverable under our commercial insurance policies. All relevant information, including our own historical experience is used in estimating the expected amount of claims. While we continuously monitor these factors, our ultimate liability for professional and general liability claims could change materially from our current estimates due to inherent uncertainties involved in making this estimate. Our estimated self-insured reserves are reviewed and changed, if necessary, at each reporting date and changes are recognized currently as additional expense or as a reduction of expense. See Note 8 for discussion of adjustments to our prior year reserves for claims related to our self-insured general and professional liability and workers’ compensation liability.

In addition, we also maintain self-insured employee benefits programs for employee healthcare and dental claims. The ultimate costs related to these programs include expenses for claims incurred and paid in addition to an accrual for the estimated expenses incurred in connection with claims incurred but not yet reported.

N) Income Taxes: Deferred tax assets and liabilities are recognized for the amount of taxes payable or deductible in future years as a result of differences between the tax bases of assets and liabilities and their reported amounts in the financial statements. We believe that future income will enable us to realize our deferred tax assets net of recorded valuation allowances relating to state net operating loss carry-forwards.

We operate in multiple jurisdictions with varying tax laws. We are subject to audits by any of these taxing authorities. Our tax returns have been examined by the Internal Revenue Service (“IRS”) through the year ended December 31, 2006. We believe that adequate accruals have been provided for federal, foreign and state taxes.

See Note 6 for additional disclosure regarding income taxes.

O) Other Noncurrent Liabilities: Other noncurrent liabilities include the long-term portion of our professional and general liability, workers’ compensation reserves, pension and deferred compensation liabilities, liability incurred in connection with split-dollar life insurance agreements on the lives of our chief executive officer and his wife and interest rate swap liabilities.

P) Redeemable Noncontrolling Interests and Noncontrolling Interest: Outside owners hold noncontrolling, minority ownership interests of: (i) approximately 28% in our five acute care facilities located in Las Vegas, Nevada; (ii) 20% in an acute care facility located in Washington, D.C.; (iii) approximately 11% in an acute care facility located in Laredo, Texas, and; (iv) 20% in a behavioral health care facility located in Philadelphia, Pennsylvania, the majority ownership interest of which was acquired by us as result of our acquisition of PSI in November, 2010. The redeemable noncontrolling interest balances of $234 million and $218 million as of December 31, 2012 and 2011, respectively, and the noncontrolling interest balances of $53 million and $51 million as of December 31, 2012 and 2011, respectively, consist primarily of the third-party ownership interests in these hospitals.

In connection with the five acute care facilities located in Las Vegas, Nevada, the minority ownership interests of which are reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owners have certain “put rights”, that are currently exercisable, that if exercised, require us to purchase the minority member’s interests at fair market value. The put rights are exercisable upon the occurrence of: (i) certain specified financial conditions falling below established thresholds; (ii) breach of the management contract by the managing member (a subsidiary of ours), or; (iii) if the minority member’s ownership percentage is reduced to less than certain thresholds. In connection with the behavioral health care facility located in Philadelphia, Pennsylvania, the minority ownership interest of which is also reflected as redeemable noncontrolling interests on our Consolidated Balance Sheet, the outside owner has a “put option” to put its entire ownership interest to us at any time. If exercised, the put option requires us to purchase the minority member’s interest at fair market value. As of December 31, 2012, we believe the fair market value of the minority ownership interests in these facilities, pursuant to the terms of the put options, approximates the book value of the redeemable noncontrolling interests.

Q) Comprehensive Income and Accumulated Other Comprehensive Income: Comprehensive income or loss is comprised of net income, changes in unrealized gains or losses on derivative financial instruments and a pension liability.

The accumulated other comprehensive income (“AOCI”) component of stockholders’ equity includes: net unrealized gains and losses on effective cash flow hedges; and the net minimum pension liability of a non-contributory defined benefit pension plan which covers employees at one of our subsidiaries. See Note 10, “Pension Plan” for additional disclosure regarding the defined benefit pension plan.

The amounts recognized in AOCI for the two years ended December 31, 2012 were as follows (in thousands):


	Net Unrealized Gains (Losses) on Effective Cash Flow Hedges			Minimum Pension Liability			Total AOCI
Balance, January 1, 2011, net of income tax	$	(5,130	)	$	(15,009	)	$	(20,139	)
2011 activity:
Pre-tax amount		(37,813	)		(12,397	)		(50,210	)
Income tax effect		14,483			4,691			19,174

Change, net of income tax		(23,330	)		(7,706	)		(31,036	)

Balance, January 1, 2012, net of income tax		(28,460	)		(22,715	)		(51,175	)
2012 activity:
Pre-tax amount		6,341			4,986			11,327
Income tax effect		(2,408	)		(1,898	)		(4,306	)

Change, net of income tax		3,933			3,088			7,021

Balance, December 31, 2012, net of income tax	$	(24,527	)	$	(19,627	)	$	(44,154	)

R) Accounting for Derivative Financial Investments and Hedging Activities: We manage our ratio of fixed to floating rate debt with the objective of achieving a mix that management believes is appropriate. To manage this risk in a cost-effective manner, we, from time to time, enter into interest rate swap agreements in which we agree to exchange various combinations of fixed and/or variable interest rates based on agreed upon notional amounts.

We account for our derivative and hedging activities using the Financial Accounting Standard Board’s (“FASB”) guidance which requires all derivative instruments, including certain derivative instruments embedded in other contracts, to be carried at fair value on the balance sheet. For derivative transactions designated as hedges, we formally document all relationships between the hedging instrument and the related hedged item, as well as its risk-management objective and strategy for undertaking each hedge transaction.

Derivative instruments designated in a hedge relationship to mitigate exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Cash flow hedges are accounted for by recording the fair value of the derivative instrument on the balance sheet as either an asset or liability, with a corresponding amount recorded in accumulated other comprehensive income (“AOCI”) within stockholders’ equity. Amounts are reclassified from AOCI to the income statement in the period or periods the hedged transaction affects earnings. Changes in the fair value of our cash flow hedges are classified as operating on our cash flow statement.

We use interest rate derivatives in our cash flow hedge transactions. Such derivatives are designed to be highly effective in offsetting changes in the cash flows related to the hedged liability. For derivative instruments designated as cash flow hedges, the ineffective portion of the change in expected cash flows of the hedged item are recognized currently in the income statement.

Derivative instruments designated in a hedge relationship to mitigate exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Fair value hedges are accounted for by recording the changes in the fair value of both the derivative instrument and the hedged item in the income statement.

For hedge transactions that do not qualify for the short-cut method, at the hedge’s inception and on a regular basis thereafter, a formal assessment is performed to determine whether changes in the fair values or cash flows of the derivative instruments have been highly effective in offsetting changes in cash flows of the hedged items and whether they are expected to be highly effective in the future.

S) Stock-Based Compensation: At December 31, 2012, we have a number of stock-based employee compensation plans. Pursuant to the FASB’s guidance, we expense the grant-date fair value of stock options and other equity-based compensation pursuant to the straight-line method over the stated vesting period of the award using the Black-Scholes option-pricing model.

The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities. The applicable FASB guidance requires that cash flows resulting from tax deductions in excess of compensation cost recognized be classified as financing cash flows. During 2012, 2011 and 2010, there were no net excess tax benefits generated.

T) Earnings per Share: Basic earnings per share are based on the weighted average number of common shares outstanding during the year. Diluted earnings per share are based on the weighted average number of common shares outstanding during the year adjusted to give effect to common stock equivalents.

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:


	Twelve Months Ended December 31,
	2012			2011			2010
Basic and diluted:
Net Income	$	489,047		$	448,870		$	275,795
Less: Net income attributable to noncontrolling interest		(45,601	)		(50,703	)		(45,612	)
Less: Net income attributable to unvested restricted share grants		(497	)		(521	)		(918	)

Net income attributable to UHS—basic and diluted	$	442,949		$	397,646		$	229,265

Basic earnings per share attributable to UHS:
Weighted average number of common shares—basic		96,821			97,199			96,786

Total basic earnings per share	$	4.57		$	4.09		$	2.37

Diluted earnings per share attributable to UHS:
Weighted average number of common shares		96,821			97,199			96,786
Net effect of dilutive stock options and grants based on the treasury stock method		890			1,338			1,187

Weighted average number of common shares and equivalents—diluted		97,711			98,537			97,973

Total diluted earnings per share	$	4.53		$	4.04		$	2.34

The “Net effect of dilutive stock options and grants based on the treasury stock method”, for all years presented above, excludes certain outstanding stock options applicable to each year since the effect would have been anti-dilutive. The excluded weighted-average stock options totaled 2.0 million during 2012, 1.4 million during 2011and 1,000 during 2010.

U) Fair Value of Financial Instruments: The fair values of our registered debt and investments are based on quoted market prices. The fair values of other long-term debt, including capital lease obligations, are estimated by discounting cash flows using period-end interest rates and market conditions for instruments with similar maturities and credit quality. The carrying amounts reported in the balance sheet for cash, accounts receivable, accounts payable, and short-term borrowings approximates their fair values due to the short-term nature of these instruments. Accordingly, these items have been excluded from the fair value disclosures included elsewhere in these notes to consolidated financial statements.

V) Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

W) Mergers and Acquisitions: The acquisition method of accounting for business combinations requires that the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective fair values with limited exceptions. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Any excess of the purchase price (consideration transferred) over the estimated fair values of net assets acquired is recorded as goodwill. Transaction costs and costs to restructure the acquired company are expensed as incurred. The fair value of intangible assets, including Medicare Licenses, Certificates of Need, and certain contracts, is based on significant judgments made by our management, and accordingly, for significant items we typically obtain assistance from third party valuation specialists.

X) Accounting Standards:

Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities: During the first quarter of 2012, we adopted the Financial Accounting Standards Board’s Accounting Standards Update (“ASU”) No. 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,” which required certain health care entities to change the presentation in their statement of operations by reclassifying the provision for bad debts associated with patient service revenue from an operating expense to a deduction from patient service revenue (net of contractual allowances and discounts). As a result, the provision for doubtful accounts for our acute care and behavioral health care facilities is reflected as a deduction from net revenues in the accompanying consolidated statements of income for 2012, 2011 and 2010. The adoption of this standard had no impact on our financial position or overall results of operations.

Presentation of Comprehensive Income: In June 2011, the FASB amended its guidance governing the presentation of comprehensive income. The amended guidance eliminates the option to report other comprehensive income and its components in the statement of changes in equity. Under the new guidance, an entity can elect to present items of net income and other comprehensive income in one continuous statement referred to as the statement of comprehensive income or in two separate, but consecutive, statements. While the options for presenting other comprehensive income change under the guidance, other portions of the current guidance will not change. For public entities, these changes are effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of this standard did not have an impact on our consolidated financial position or results of operations.

ACQUISITIONS AND DIVESTITURES

12 Months Ended

Dec. 31, 2012

ACQUISITIONS AND DIVESTITURES

2) ACQUISITIONS AND DIVESTITURES

Year ended December 31, 2012:

2012 Acquisitions of Assets and Businesses:

During 2012, we spent $528 million to acquire the following assets and businesses:

•

spent $503 million to acquire 9 behavioral health care facilities from Ascend Health Corporation (“Ascend”) in October, 2012, and;

•

spent $25 million in connection with the acquisition of physician practices and various real property.

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their estimated fair values as follows:


	Amount (000s)
Working capital, net	$	21,000
Property, plant & equipment		60,000
Goodwill		446,000
Other assets		9,000
Income tax assets, net of deferred tax liabilities		(1,000	)
Other liabilities		(7,000	)

Cash paid in 2012 for acquisitions	$	528,000

Goodwill of the facilities acquired is computed, pursuant to the residual method, by deducting the fair value of the acquired assets and liabilities from the total purchase price. The factors that contribute to the recognition of goodwill, which may also influence the purchase price, include the following for each of the acquired facilities: (i) the historical cash flows and income levels; (ii) the reputations in their respective markets; (iii) the nature of the respective operations, and; (iv) the future cash flows and income growth projections.

Assuming the acquisition of Ascend occurred on January 1, 2011, our 2011 pro forma net revenues would have been approximately $6.90 billion and our pro forma net income attributable to UHS and pro forma net income attributable to UHS per diluted share would have been $401 million and $4.06 per diluted share, respectively. The 2011 pro forma net income attributable to UHS and pro forma net income attributable to UHS per diluted share include the after-tax impact of the transaction costs incurred by us in connection with the acquisition of Ascend amounting to $5 million or $.06 per diluted share.

Our 2012 pro forma net revenues would have been approximately $7.11 billion and our pro forma net income attributable to UHS and pro forma net income attributable to UHS per diluted share would have been $464 million and $4.74 per diluted share, respectively.

During the period of October 10, 2012 through December 31, 2012, the facilities acquired from Ascend generated $42 million of net revenues which are included in our consolidated net revenues for the year ended December 31, 2012. The aggregate effect of the earnings generated by these facilities since the date of acquisition, less the cost on the borrowings utilized to finance the acquisition, and less the above-mentioned transaction costs, was not material to our 2012 net income attributable to UHS and net income attributable to UHS per diluted share.

2012 Divestiture of Assets and Businesses:

During 2012, we received $149 million from the divestiture of assets and businesses, including the following:

•

received $93 million for the sale of Auburn Regional Medical Center (“Auburn”), a 159-bed acute care hospital located in Auburn, Washington (sold in October);

•

received $50 million for the sale of the Hospital San Juan Capestrano, a 108-bed acute care hospital located in Rio Piedras, Puerto Rico (sold in January pursuant to our below-mentioned agreement with the FTC in connection with our acquisition of PSI in November, 2010), and;

•

received an aggregate of $6 million for the sale of the real property of two non-operating behavioral health facilities and our majority ownership interest in an outpatient surgery center located in Puerto Rico.

In connection with the receipt of antitrust clearance from the Federal Trade Commission (“FTC”) in connection with our acquisition of Ascend Health Corporation in October of 2012, we agreed to certain conditions, including the divestiture, within approximately six months, of Peak Behavioral Health Services (“Peak”), a 104-bed behavioral health care facility located in Santa Teresa, New Mexico. The revenues of Peak were approximately $18 million and $14 million during 2012 and 2011, respectively.

In connection with the receipt of antitrust clearance from the FTC in connection with our acquisition of PSI in November, 2010, we agreed to divest three former PSI facilities as well as one of our legacy behavioral health facilities in Puerto Rico. Pursuant to the terms of our agreement with the FTC, we divested:

•

in July, 2011, the MeadowWood Behavioral Health System, a 58-bed facility located in New Castle, Delaware;

•

in December, 2011, the Montevista Hospital (101-bed) and Red Rock Hospital (21-bed), both of which are located in Las Vegas, Nevada, and;

•

in January, 2012, the Hospital San Juan Capestrano, a 108-bed facility located in Rio Piedras, Puerto Rico.

The operating results for Auburn, Peak and the three former PSI facilities located in Delaware and Nevada are reflected as discontinued operations during our period of ownership during each of the years presented herein. Since the aggregate income from discontinued operations before income tax expense for these facilities is not material to our consolidated financial statements, it is included as a reduction to other operating expenses. As reflected on the table below, the aggregate pre-tax gain on the divestiture of Auburn, was approximately $26 million. The aggregate pre-tax net gain on the divestiture of San Juan Capestrano in January, 2012 did not have a material impact on our consolidated results of operations during 2012. Assets and liabilities for Peak are reflected as “held for sale” on our Consolidated Balance Sheet as of December 31, 2012, and the assets and liabilities for the Hospital San Juan Capestrano were reflected as “held for sale” on our Consolidated Balance Sheet as of December 31, 2011.

The following table shows the results of operations for Auburn and Peak and the former PSI facilities located in Delaware and Nevada, on a combined basis, which were reflected as discontinued operations during our period of ownership for each of the years presented herein (amounts in thousands):


	Year Ended December 31,
	2012			2011			2010
Net revenues	$	95,226		$	159,218		$	126,218
Income from discontinued operations		(3,472	)		10,422			12,109
Gain on divestiture		26,419			442			0

Income from discontinued operations, before income tax expense		22,947			10,864			12,109
Income tax expense		(8,688	)		(4,113	)		(4,483	)

Income from discontinued operations, net of income tax expense	$	14,259		$	6,751		$	7,626

Year ended December 31, 2011:

2011 Acquisitions of Assets and Businesses:

During 2011, we spent $29 million on the acquisition of businesses and real property, including the following:

•

the acquisition of administrative office buildings located in Pennsylvania, Tennessee and a multi-tenant office building located in Washington D.C.;

•

a deposit in made connection with execution of a purchase agreement for an acute care hospital in Texas which has since been terminated and the deposit returned to us in 2012, and;

•

the acquisition of a cardiology practice in Texas

The aggregate net cash expenditure related to the properties and/or businesses was allocated to assets and liabilities based on their estimated fair values as follows:


	Amount (000s)
Property, plant & equipment	$	35,000
Other assets/deposits		11,000
Debt		(17,000	)

Cash paid in 2011 for acquisitions and deposits	$	29,000

2011 Divestitures of Assets and Businesses:

During 2011, we received $68 million from the divestiture of assets and businesses, including the following:

•

the above-mentioned sale of three behavioral healthcare facilities (one located in Delaware and two located in Nevada) pursuant to our agreement with the FTC in connection with our acquisition of PSI;

•

sale of our majority ownership interest in a radiation oncology center located in Nevada, and;

•

the real property of a closed acute care hospital

The aggregate pre-tax net gain on the divestitures of the above-mentioned facilities located in Delaware and Nevada did not have a material impact on our 2011 consolidated results of operations.

Year ended December 31, 2010:

2010 Acquisitions of Assets and Businesses:

During 2010, we spent $1.96 billion and assumed $1.08 billion of debt on the acquisition of businesses and real property, including the following:

•

the acquisition of PSI on November 15, 2010 for a total purchase price of $3.04 billion consisting of $1.96 billion in cash plus the assumption of approximately $1.08 billion of PSI’s debt, the majority of which has since been refinanced, and;

•

the acquisition of substantially all of the assets of an outpatient surgery center located in Florida in which we previously held a 20% minority ownership interest. The purchase price consideration in connection with this transaction, which occurred during the first quarter, consisted of acquisition of the net assets less the assumption of the outstanding liabilities and third-party debt.

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their estimated fair values as follows:


	Amount (000s)
Working capital, net	$	60,000
Assets held for sale		67,000
Property, plant & equipment		932,000
Goodwill		1,921,000
Other assets		132,000
Income tax assets, net of deferred tax liabilities		(14,000	)
Debt		(1,082,000	)
Liabilities held for sale		(1,000	)
Redeemable noncontrolling interests		(5,000	)
Other liabilities		(52,000	)

Cash paid in 2010 for acquisitions	$	1,958,000

Assuming the acquisition of PSI occurred on January 1, 2009, our 2010 pro forma net revenues would have been approximately $7.30 billion and our pro forma net income attributable to UHS and pro forma net income attributable to UHS per diluted share would have been $342 million and $3.47 per diluted share, respectively.

During the period of November 16, 2010 through December 31, 2010, the facilities acquired from PSI generated $227 million of net revenues which are included in our consolidated net revenues for the year ended December 31, 2010. The aggregate effect of the earnings generated by these facilities since the date of acquisition, less the cost on the borrowings utilized to finance the acquisition, was not material to our 2010 net income attributable to UHS and net income attributable to UHS per diluted share.

Year ended December 31, 2010:

2010 Divestitures of Assets and Businesses:

During 2010, we received $21 million from the divestiture of assets and businesses, including the following:

•

the sale of our minority ownership interest in a healthcare technology company;

•

the sale of a portion of our ownership interest in an outpatient surgery center located in Texas, and;

•

the sale of the real property of Methodist Hospital located in Louisiana that was severely damaged and closed in 2005 as a result of Hurricane Katrina.

The pre-tax gain, net of losses, resulting from the above-mentioned transactions did not have a material impact on our 2010 financial statements.

FINANCIAL INSTRUMENTS

12 Months Ended

Dec. 31, 2012

FINANCIAL INSTRUMENTS

3) FINANCIAL INSTRUMENTS

Fair Value Hedges:

During 2012, 2011 and 2010, we had no fair value hedges outstanding.

Cash Flow Hedges:

We manage our ratio of fixed and floating rate debt with the objective of achieving a mix that management believes is appropriate. To manage this risk in a cost-effective manner, we, from time to time, enter into interest rate swap agreements in which we agree to exchange various combinations of fixed and/or variable interest rates based on agreed upon notional amounts. We account for our derivative and hedging activities using the Financial Accounting Standard Board’s (“FASB”) guidance which requires all derivative instruments, including certain derivative instruments embedded in other contracts, to be carried at fair value on the balance sheet. For derivative transactions designated as hedges, we formally document all relationships between the hedging instrument and the related hedged item, as well as its risk-management objective and strategy for undertaking each hedge transaction.

Derivative instruments designated in a hedge relationship to mitigate exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Cash flow hedges are accounted for by recording the fair value of the derivative instrument on the balance sheet as either an asset or liability, with a corresponding amount recorded in accumulated other comprehensive income (“AOCI”) within shareholders’ equity. Amounts are reclassified from AOCI to the income statement in the period or periods the hedged transaction affects earnings. We use interest rate derivatives in our cash flow hedge transactions. Such derivatives are designed to be highly effective in offsetting changes in the cash flows related to the hedged liability. For derivative instruments designated as cash flow hedges, the ineffective portion of the change in expected cash flows of the hedged item are recognized currently in the income statement.

The fair value of interest rate swap agreements approximates the amount at which they could be settled, based on estimates obtained from the counterparties. We assess the effectiveness of our hedge instruments on a quarterly basis. We performed periodic assessments of the cash flow hedge instruments during 2012 and 2011 and determined the hedges to be highly effective. We also determined that any portion of the hedges deemed to be ineffective was de minimis and therefore there was no material effect on our consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose us to credit risk in the event of nonperformance. However, at December 31, 2012, each swap agreement entered into by us was in a net liability position which would require us to make the net settlement payments to the counterparties. We do not anticipate nonperformance by our counterparties. We do not hold or issue derivative financial instruments for trading purposes.

During the first quarter of 2011, we entered into an interest rate cap on a total notional amount of $275 million whereby we paid a premium of $30,000 in exchange for the counterparty agreeing to pay the difference between 2.25% and three-month LIBOR if the three-month LIBOR rate rises above 2.25% during the term of the cap, which expired in December, 2011. The three-month LIBOR never reached 2.25% during the term of the cap. Therefore, no payment was made to us. We also entered into a forward starting interest rate cap on a total notional amount of $450 million from December, 2011 to December, 2012 reducing to $400 million from December, 2012 to December, 2013 whereby we paid a premium of $740,000 in exchange for the counterparty agreeing to pay the difference between 7.00% and three-month LIBOR if the three-month LIBOR rate rises above 7.00% during the term of the cap. If the three-month LIBOR does not reach 7.00% during the term of the cap, no payment is made to us.

We also entered into six additional forward starting interest rate swaps in the first quarter of 2011 whereby we pay a fixed rate on a total notional amount of $425 million and receive three-month LIBOR. Three of these swaps with a total notional amount of $225 million became effective in March, 2011 and will mature in May, 2015. The average fixed rate payable on these swaps is 1.91%. The three remaining interest rate swaps with total notional amounts of $100 million, $25 million and $75 million became effective in December, 2011 and have fixed rates of 2.50%, 1.96% and 1.32%, and maturity dates in December, 2014, December, 2013 and December, 2012, respectively.

During the fourth quarter of 2010, we entered into three interest rate caps on a total notional amount of $1 billion whereby we paid a premium of $240,000 in exchange for the counterparties agreeing to pay the difference between 2.25% and three-month LIBOR if the three-month LIBOR rate rises above 2.25% during the term of the caps. All of these caps expired in December, 2011. The three-month LIBOR rate never rose above 2.25% during the term of the caps. Therefore, no payments were made to us. We also entered into four forward starting interest rate swaps in the fourth quarter of 2010 whereby we pay a fixed rate on a total notional amount of $600 million and receive three-month LIBOR. Each of the four swaps became effective in December, 2011 and will mature in May, 2015. The average fixed rate payable on these swaps is 2.38%.

During the fourth quarter of 2007, we entered into two interest rate swaps whereby we pay a fixed rate on a total notional principal amount of $150 million and receive three-month LIBOR. Each of the two interest rate swaps had an initial notional principal amount of $75 million. The notional amount of the first interest rate swap reduced to $50 million in October, 2010. The fixed rate payable was 4.76% and it matured in October, 2012. The fixed rate payable on the second interest rate swap was 4.87% and it matured in October, 2011.

We measure our interest rate swaps at fair value on a recurring basis. The fair value of our interest rate swaps is based primarily on quotes from banks. We consider those inputs to be “level 2” in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with derivative instruments and hedging activities. The fair value of our interest rate swaps was a liability of $41 million at December 31, 2012, substantially all of which is included in other noncurrent liabilities on the accompanying balance sheet. At December 31, 2011, the fair value of our interest rate swaps was a liability of $48 million, of which $4 million is included in other current liabilities and $44 million is included in other noncurrent liabilities on the accompanying balance sheet.

LONG-TERM DEBT

12 Months Ended

Dec. 31, 2012

LONG-TERM DEBT

4) LONG-TERM DEBT

A summary of long-term debt follows:


	December 31,
	2012			2011
	(amounts in thousands)
Long-term debt:
Notes payable and Mortgages payable (including obligations under capitalized leases of $8,267 in 2012 and 9,982 in 2011) and term loans with varying maturities through 2038; weighted average interest at 5.9% in 2012 and 6.1% in 2011 (see Note 7 regarding capitalized leases)	$	47,216		$	51,841
Revolving credit and on-demand credit facility		163,500			249,600
Term Loan A, net of unamortized discount of $4,612 in 2012 and $6,103 in 2011		983,438			1,017,647
Term Loan B, net of unamortized discount of $8,724 in 2012 and $19,500 in 2011		737,176			1,439,500
Term Loan A2		894,375			—
Revenue bonds, interest at floating rates of 0.2% at December 31, 2012 and 2011, with varying maturities through 2015		5,300			5,300
Accounts receivable securitization program		249,000			240,000
7.125% Senior Secured Notes due 2016, including unamortized net premium of $15 in 2012 and $19 in 2011		400,015			400,019
7.00% Senior Unsecured Notes due 2018		250,000			250,000

		3,730,020			3,653,907
Less-Amounts due within one year		(2,589	)		(2,479	)

	$	3,727,431		$	3,651,428

On September 21, 2012, we entered into a second amendment (“Second Amendment”) to our credit agreement, dated as of November 15, 2010, as amended on March 15, 2011, with several banks and other financial institutions (“Credit Agreement”). The Second Amendment, provides for a new $900 million Term Loan-A (“Term Loan A2”) at the same interest rates as our existing Term Loan A and a final maturity date of August 15, 2016. The Second Amendment also provides for the extension of the maturity date on approximately $777 million of our existing $800 million revolving credit facility, and $943 million of our existing Term Loan-A facility, by nine months to mature on August 15, 2016. Approximately $23 million of our revolving credit facility commitment and $45 million of our existing Term Loan-A was not extended and is scheduled to mature on November 15, 2015. The Second Amendment also provides for increased flexibility for refinancing and certain other modifications but substantially all other terms of the Credit Agreement, dated as of November 15, 2010 and as previously amended in March, 2011, including interest rates, remain unchanged.

On September 21, 2012, we used $700 million of the proceeds from the new Term Loan-A2 facility to extinguish a portion of our higher priced, Term Loan-B facility. Current pricing under the new Term Loan-A2 facility is 1% lower than the Term Loan-B facility and does not include a LIBOR Floor whereas the Term Loan-B facility has a 1% LIBOR Floor. During the third quarter of 2012, in connection with the extinguishment of a portion of our Term Loan-B facility, we recorded a pre-tax charge of $29 million to write-off the related portion of the Term Loan-B deferred financing costs.

The Credit Agreement, as amended on September 21, 2012, is a senior secured facility which provides for an initial aggregate commitment amount of $3.43 billion, comprised of an $800 million revolving credit facility, a $988 million Term Loan-A facility, a $746 million Term Loan-B facility and a $900 million Term Loan-A2 facility. The revolving credit facility includes a $125 million sub-limit for letters of credit. The Credit Agreement is secured by substantially all of the assets of the Company and our material subsidiaries and guaranteed by our material subsidiaries.

Borrowings under the Credit Agreement bear interest at either (1) the ABR rate which is defined as the rate per annum equal to, at our election: the greatest of (a) the lender’s prime rate, (b) the weighted average of the federal funds rate, plus 0.5% and (c) one month Eurodollar rate plus 1%, in each case, plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 0.50% to 1.25% for revolving credit, Term Loan-A and Term Loan- A2 borrowings and 1.75% to 2.00% for Term Loan B borrowings or (2) the one, two, three or six month Eurodollar rate (at our election), plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 1.50% to 2.25% for revolving credit, Term Loan-A and Term Loan- A2 borrowings and ranging from 2.75% to 3.00% for Term Loan-B borrowings. The current applicable margins are 0.75% for ABR-based loans, 1.75% for Eurodollar-based loans under the revolving credit, Term Loan-A and Term Loan-A2 facilities and 2.75% under the Term Loan-B facility. The minimum Eurodollar rate for the Term Loan-B facility is 1.00% (“LIBOR Floor”).

As of December 31, 2012, we had $574 million of available borrowing capacity pursuant to the terms of our $800 million revolving credit facility, net of $164 million of outstanding borrowings (including borrowings outstanding pursuant to a short-term, on-demand credit facility) and $62 million of outstanding letters of credit. As of December 31, 2012, we had $14 million of outstanding borrowings under a short-term, on-demand credit facility. Outstanding borrowings pursuant to this facility are classified as long-term on our Consolidated Balance Sheet since we have the intent and ability to refinance through available borrowings under the terms of our Credit Agreement.

Quarterly installment payments (“Installment Payments”) are due on the Term Loan-A and Term Loan-A2 facilities which are equal to approximately $72 million in 2013, $72 million in 2014, $77 million in 2015 and $46 million in 2016. No Installment Payments are due on the Term Loan-B facility. During 2012, we made scheduled principal payments of $13 million on the Term Loan B facility and $42 million on the Term Loan-A and Term Loan A2 facilities. In 2011, we made scheduled principal payments of $16 million on the Term Loan-B facility and $26 million on the Term Loan-A facility. The Installment Payments due in 2013 on the Term Loan-A and Term Loan-A2 facilities are classified as long-term on our Consolidated Balance Sheet since we expect to have the borrowing capacity and would intend to refinance through available borrowings under the terms of our Credit Agreement.

Our accounts receivable securitization program (“Securitization”) with a group of conduit lenders and liquidity banks was amended in October, 2010. We increased the size of the Securitization from $200 million to $240 million (the “Commitments”), and extended the maturity date to October 25, 2013. In May, 2012, we further increased the size of the securitization by $35 million to $275 million. Substantially all of the patient-related accounts receivable of our acute care hospitals (“Receivables”) serve as collateral for the outstanding borrowings. The interest rate on the borrowings is based on the commercial paper rate plus a spread of 0.475% and there is a facility fee of 0.375% required on 102% on the Commitments. We have accounted for this Securitization as borrowings. We maintain effective control over the Receivables since, pursuant to the terms of the Securitization; the Receivables are sold from certain of our subsidiaries to special purpose entities that are wholly-owned by us. The Receivables, however, are owned by the special purpose entities, can be used only to satisfy the debts of the wholly-owned special purpose entities, and thus are not available to us except through our ownership interest in the special purpose entities. The wholly-owned special purpose entities use the Receivables to collateralize the loans obtained from the group of third-party conduit lenders and liquidity banks. The group of third-party conduit lenders and liquidity banks do not have recourse to us beyond the assets of the wholly-owned special purpose entities that securitize the loans. At December 31, 2012, we had $249 million of outstanding borrowings and $26 million of additional capacity pursuant to the terms of our accounts receivable securitization program. In the event we do not either enter into a new financing agreement, or an agreement to extend the scheduled maturity date of the Securitization, we expect to have the borrowing capacity and would intend to refinance the Securitization upon its scheduled maturity utilizing borrowings under our Credit Agreement. Therefore, outstanding borrowings as of December 31, 2012 under the Securitization are classified as long-term on our Consolidated Balance Sheet.

Our $250 million, 7.00% senior unsecured notes (the “Unsecured Notes”) are scheduled to mature on October 1, 2018. The Unsecured Notes were issued on September 29, 2010 and registered in April, 2011. Interest on the Unsecured Note is payable semiannually in arrears on April 1st and October 1st of each year. The Unsecured Notes can be redeemed in whole at anytime subject to a make-whole call at treasury rate plus 50 basis points prior to October 1, 2014. They are also redeemable in whole or in part at a price of: (i) 103.5% on or after October 1, 2014; (ii) 101.75% on or after October 1, 2015, and; (iii) 100% on or after October 1, 2016. These Unsecured Notes are guaranteed by a group of subsidiaries (each of which is a 100% directly owned subsidiary of Universal Health Services, Inc.) which fully and unconditionally guarantee the Unsecured Notes on a joint and several basis, subject to certain customary automatic release provisions.

On June 30, 2006, we issued $250 million of senior notes which have a 7.125% coupon rate and mature on June 30, 2016 (the “7.125% Notes”). Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year. In June, 2008, we issued an additional $150 million of 7.125% Notes which formed a single series with the original 7.125% Notes issued in June, 2006. Other than their date of issuance and initial price to the public, the terms of the 7.125% Notes issued in June, 2008 are identical to and trade interchangeably with, the 7.125% Notes which were originally issued in June, 2006.

During 2001, we issued $200 million of senior notes which have a 6.75% coupon rate and which matured and were paid in full on November 15, 2011 (the “6.75% Notes”).

In connection with the entering into of the Credit Agreement on November 15, 2010, and in accordance with the Indenture dated January 20, 2000 governing the rights of our existing notes, we entered into a supplemental indenture pursuant to which our 7.125% Notes (due in 2016) and our 6.75% Notes (which matured and were paid in full in November, 2011) were equally and ratably secured with the lenders under the Credit Agreement with respect to the collateral for so long as the lenders under the Credit Agreement are so secured.

The average amounts outstanding during 2012, 2011 and 2010 under the current and prior Credit Agreements, demand notes and accounts receivable securitization programs were $2.9 billion, $2.9 billion and $610 million, respectively, with corresponding interest rates of 2.9%, 3.4% and 3.4% including commitment and facility fees. The maximum amounts outstanding at any month-end were $3.06 billion in 2012, $3.03 billion in 2011 and $3.11 billion in 2010. The effective interest rate on our current and prior Credit Agreements, accounts receivable securitization programs, and demand notes, which includes the respective interest expense, commitment and facility fees, designated interest rate swaps expense and amortization of deferred financing costs and original issue discounts, was 4.5% in 2012, 4.6% in 2011 and 5.0% in 2010.

Our Credit Agreement includes a material adverse change clause that must be represented at each draw. The Credit Agreement contains covenants that include a limitation on sales of assets, mergers, change of ownership, liens and indebtedness, transactions with affiliates and dividends; and requires compliance with financial covenants including maximum leverage and minimum interest coverage ratios. We are in compliance with all required covenants as of December 31, 2012.

The carrying values of our debt at December 31, 2012 and 2011 are reflected above. The fair values of our debt at December 31, 2012 and 2011 were $3.8 billion and $3.7 billion, respectively. The fair value of our debt was computed based upon quotes received from financial institutions. We consider these to be “level 2” in the fair value hierarchy as outlined in the authoritative guidance for disclosures in connection with debt instruments.

Aggregate maturities follow:


	(000s)
2013	$	2,589
2014		2,012
2015		68,588
2016		3,382,793
2017		1,262
Later		272,776

Total	$	3,730,020

Amounts outstanding under our on-demand credit facility and Securitization program, as well as the scheduled Installment Payments due on our Term Loan-A and Term Loan-A2 facilities, as discussed above, are included in the Credit Agreement maturities which are due in 2016.

COMMON STOCK

12 Months Ended

Dec. 31, 2012

COMMON STOCK

5) COMMON STOCK

Dividends

Cash dividends of $.60 per share ($58.3 million in the aggregate), including a $.40 per share special cash dividend ($38.9 million) were declared and paid during 2012. Cash dividends of $.20 per share ($19 million in the aggregate) were declared and paid during each of 2011 and 2010. All classes of our common stock have similar economic rights.

Stock Repurchase Programs

In various prior years, our Board of Directors has approved stock repurchase programs authorizing us to purchase shares of our outstanding Class B Common Stock on the open market at prevailing market prices or in negotiated transactions off the market. There is no expiration date for our stock repurchase programs. The most recent approval occurred during 2007 at which time our Board of Directors authorized the purchase of up to 10 million shares, a portion of which (as reflected below) remains available for purchase as of December 31, 2012. The following schedule provides information related to our stock repurchase programs for each of the three years ended December 31, 2012:


	Total number of shares purchased as part of publicly announced programs		Total price paid for shares purchased as part of publicly announced programs (in thousands)		Total number of shares purchased related to stock-based compensation plans (a.)		Total price paid for shares purchased related to stock-based compensation plans (in thousands)		Aggregate number of shares purchased		Aggregate price paid for shares purchased (in thousands)		Maximum number of shares that may yet be purchased under the publicly announced program
Balance as of January 1, 2010														2,152,339
2010……		—		—		301,933	$	11,528		301,933	$	11,528		2,152,339
2011……		1,384,637	$	50,576		217,649	$	9,906		1,602,286	$	60,482		767,702
2012……		—		—		433,312	$	19,154		433,312	$	19,154		767,702

Total for three year period ended December 31, 2012		1,384,637	$	50,576		952,894	$	40,588		2,337,531	$	91,164

(a.)

During 2012, there were 432,562 shares repurchased at an average price of $44.28 per share related to income tax withholding obligations in connection with stock-based compensation programs, and 750 shares repurchased at an average of $.01 per share related to restricted shares that were forfeited by former employees pursuant to the terms of our restricted stock purchase plan. During 2011, there were 217,649 shares repurchased at an average price of $45.51 per share related to income tax withholding obligations in connection with stock-based compensation programs. During 2010, there were 293,933 shares repurchased at an average price of $39.22 per share related to income tax withholding obligations in connection with stock-based compensation programs and 8,000 shares repurchased at an average price of $.01 per share related to restricted shares that were forfeited by former employees pursuant to the terms of our restricted stock purchase plan.

Stock-based Compensation Plans

At December 31, 2012, we have a number of stock-based employee compensation plans. Pursuant to the FASB’s guidance, we expense the grant-date fair value of stock options and other equity-based compensation pursuant to the straight-line method over the stated vesting period of the award using the Black-Scholes option-pricing model.

Compensation costs related to outstanding stock options were recognized as follows: (i) a pre-tax charge of $20.1 million ($12.5 million after-tax) or $.13 per diluted share during 2012; (ii) a pre-tax charge of $15.8 million ($9.8 million after-tax) or $.10 per diluted share during 2011, and; (ii) a pre-tax charge of $13.3 million ($8.3 million after-tax) or $.08 per diluted share during 2010. In addition, during the years ended 2012, 2011 and 2010, compensation costs of $2.3 million ($1.4 million after-tax), $2.0 million ($1.2 million after-tax) and $3.1 million ($2.0 million after-tax) respectively, were recognized related to restricted stock.

We adopted the 2005 Stock Incentive Plan, as amended in 2008 and 2010, (the “Stock Incentive Plan”) which replaced our Amended and Restated 1992 Stock Option Plan which expired in July of 2005. An aggregate of twenty-three million shares of Class B Common Stock has been reserved under the Stock Incentive Plan. There were 2,760,050, 2,561,250 and 69,500 stock options, net of cancellations, granted during 2012, 2011 and 2010, respectively. The per option weighted-average grant-date fair value of options granted during 2012, 2011 and 2010, was $10.73, $11.62 and $7.84, respectively. Stock options to purchase Class B Common Stock have been granted to our officers, key employees and directors under our above referenced stock option plans. All stock options were granted with an exercise price equal to the fair market value on the date of the grant. Options are exercisable ratably over a four-year period beginning one year after the date of the grant. All outstanding options expire five years after the date of the grant.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions derived from averaging the number of options granted during the most recent five-year period that were granted or have vestings after January 1, 2006. The 2010 weighted-average assumptions were based upon seventeen option grants, the 2011 and 2012 weighted-average assumptions were based upon seventeen option grants, the 2011 and 2012 weighted-average assumptions were each based upon eighteen option grants.


Year Ended December 31,	2012			2011			2010
Volatility		33	%		29	%		27	%
Interest rate		1	%		2	%		3	%
Expected life (years)		3.5			3.5			3.6
Forfeiture rate		10	%		9	%		10	%
Dividend yield		0.6	%		0.7	%		0.7	%

The risk-free rate is based on the U.S. Treasury zero coupon four year yield in effect at the time of grant. The expected life of the stock options granted was estimated using the historical behavior of employees. Expected volatility was based on historical volatility for a period equal to the stock option’s expected life. Expected dividend yield is based on our actual dividend yield at the time of grant.

The table below summarizes our stock option activity during each of the last three years:


Outstanding Options	Number of Shares			Average Option Price		Range (High-Low)
Balance, January 1, 2010		8,802,450		$	25.03	$	31.70 -$16.22
Granted		94,000		$	30.40	$	32.28 -$30.32
Exercised		(2,000,250	)	$	24.87	$	31.70 -$16.22
Cancelled		(301,250	)	$	24.91	$	31.18 -$16.22

Balance, January 1, 2011		6,594,950		$	25.16	$	32.28 -$16.22
Granted		2,894,500		$	43.66	$	54.79 -$38.12
Exercised		(1,563,255	)	$	26.38	$	32.28 -$16.22
Cancelled		(367,250	)	$	32.60	$	46.97 -$16.22

Balance, January 1, 2012		7,558,945		$	31.63	$	54.79 -$16.22
Granted		2,966,850		$	37.01	$	44.83 -$36.95
Exercised		(2,608,007	)	$	23.22	$	46.97 -$16.22
Cancelled		(481,550	)	$	38.00	$	46.97 -$16.22

Balance, December 31, 2012		7,436,238		$	36.31	$	54.79 -$16.22

Outstanding options vested and exercisable as of December 31, 2012		2,185,312		$	30.40	$	54.79 -$16.22

The following table provides information about unvested options for the year December 31, 2012:


	Shares			Weighted Average Grant Date Fair Value
Unvested options as of January 1, 2012		4,579,000		$	9.50
Granted		2,966,850		$	10.73
Vested		(1,845,249	)	$	7.75
Cancelled		(449,675	)	$	10.32

Unvested options as of December 31, 2012		5,250,926		$	10.74

The following table provides information about all outstanding options, and exercisable options, at December 31, 2012:


	Options Outstanding		Options Exercisable
Number		7,436,238		2,185,312
Weighted average exercise price	$	36.31	$	30.40
Aggregate intrinsic value as of December 31, 2012	$	89,595,385	$	39,256,370
Weighted average remaining contractual life		3.0		2.0

The total in-the-money value of all stock options exercised during the years ended December 31, 2012, 2011 and 2010 were $54.4 million, $28.9 million and $26.8 million, respectively.

The weighted average remaining contractual life for options outstanding and weighted average exercise price per share for exercisable options at December 31, 2012 were as follows:


	Options Outstanding						Exercisable Options				Expected to Vest Options(a)
Exercise Price	Shares		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in Years)		Shares		Weighted Average Exercise Price Per Share		Shares		Weighted Average Exercise Price Per Share
$16.22 – $16.22		586,000	$	16.22		.9		586,000	$	16.22		N/A		N/A
$30.32 – $31.18		1,616,000		31.16		2.0		1,032,750		31.17		525,275		31.14
$36.95 – $43.46		2,797,050		37.03		2.9		11,250		39.09		2,508,891		37.02
$43.67 – $54.79		2,437,188		43.75		3.1		555,312		43.75		1,694,818		43.75

Total		7,436,238	$	36.31		3.0		2,185,312	$	30.40		4,728,984	$	38.78

(a)	Assumes a weighted average forfeiture rate of 9.94%.

In addition to the Stock Incentive Plan, we have the following stock incentive and purchase plans: (i) the 2010 Employees’ Restricted Stock Purchase Plan (“2010 Plan”), which replaced the Second Amended and Restated 2001 Employees’ Restricted Stock Purchase Plan (“2001 Plan”), which allows eligible participants to purchase shares of Class B Common Stock at par value, subject to certain restrictions, and; (ii) a 2005 Employee Stock Purchase Plan which allows eligible employees to purchase shares of Class B Common Stock at a ten percent discount. There were 117,901, 98,366 and 94,955 shares issued pursuant to the Employee Stock Purchase Plan during 2012, 2011 and 2010, respectively. Compensation expense recorded in connection with this plan was $533,000, $461,000 and $339,000 during 2012, 2011 and 2010, respectively.

We have reserved 6.0 million shares of Class B Common Stock for issuance under these various plans (excluding terminated plans) and have issued approximately 900,000 shares, net of cancellations, pursuant to the terms of these plans (excluding terminated plans) as of December 31, 2012.

During 2012, pursuant to the 2010 Plan, the Compensation Committee ("Committee") approved the issuance of 54,127 restricted shares of our Class B Common Stock at a weighted average price of $36.95 per share ($2.0 million in the aggregate) to our CEO and Chairman of the Board. These shares are scheduled to vest as follows: 50% on the first anniversary date of the grant, and 25% on each of the second and third anniversary dates of the grant, assuming our CEO remains employed by us. In the event that our CEO’s employment is terminated for reasons other than death, disability or retirement, any unvested shares will be forfeited, unless otherwise specified in a separation agreement between us and our CEO. We recorded compensation expense of approximately $1 million during 2012 in connection with this grant. The remaining expense associated with these awards (estimated at approximately $1 million as of December 31, 2012) will be recorded over the remaining vesting periods of the awards, assuming the recipient remain employed by us.

During 2011, pursuant to the 2010 Plan, the Committee approved the issuance of 21,500 restricted shares of our Class B Common Stock at a weighted average price of $53.21 per share ($1.1 million in the aggregate) to various employees. 750 of these shares became vested during 2012 and 750 of these shares were cancelled during 2012. The remaining 20,000 shares are scheduled to vest ratably on the second and third anniversaries of the grant date. We recorded compensation expense of $370,000 during 2012 and $198,000 during 2011 in connection with these grants. The remaining expense associated with these awards (estimated at $537,000 as of December 31, 2012) will be recorded over the remaining vesting periods of the awards, assuming the recipients remain employed by us.

The 2001 Plan, as described above, expired in March, 2010. Under this plan, we had 2.4 million shares of Class B Common Stock reserved for issuance and have issued approximately 1.2 million shares, net of cancellations, pursuant to the terms of this plan as of December 31, 2010, of which 62,044 became fully vested during 2012, 78,133 became fully vested during 2011 and 313,770 became fully vested during 2010.

During the first quarter of 2010, pursuant to the 2001 Plan and prior to its expiration, the Committee approved the issuance of 49,472 restricted shares of our Class B Common Stock at $30.32 per share ($1.5 million in the aggregate) to our CEO and Chairman of the Board. These shares, which were issued pursuant to a provision in our CEO’s employment agreement, are scheduled to vest ratably on the first, second, third and fourth anniversary dates of the grant, assuming our CEO remains employed by us. In the event that our CEO’s employment is terminated by reason of disability, death, without proper cause or due to breach of the CEO’s employment agreement by us, the vesting of these awards will occur immediately. 12,368 of these shares became fully vested in each of 2012 and 2011. In connection with this grant, we recorded compensation expense of $375,000 in each of 2012 and 2011 and $355,000 during 2010, and the remaining expense associated with this award (estimated at $395,000 as of December 31, 2012) will be recorded over the remaining vesting periods of the award.

During the first quarter of 2009, pursuant to the 2001 Plan, the Committee approved the issuance of 109,850 restricted shares of our Class B Common Stock at $20.26 per share ($2.2 million in the aggregate) to our CEO. These shares are scheduled to vest ratably on the first, second, third and fourth anniversary dates of the grant and are subject to the same conditions and terms as mentioned above in connection with the grant of restricted shares during the first quarter of 2010. 27,462 of these shares became fully vested in each of 2012 and 2011 and 27,463 of these shares became fully vested in 2010. In connection with this grant, we recorded compensation expense of $556,000 during each of 2012, 2011 and 2010 and $482,000 during 2009. The remaining expense associated with this award (estimated at $74,000 as of December 31, 2012) will be recorded over the remaining vesting periods of the award.

During the first quarter of 2008, pursuant to the 2001 Plan, the Committee approved the issuance of 62,190 restricted shares of our Class B Common Stock at $24.12 per share ($1.5 million in the aggregate) to our CEO. These shares are scheduled to vest ratably on the first, second, third and fourth anniversary dates of the grant and are subject to the same conditions and terms as mentioned above in connection with the grant of restricted shares during the first quarter of 2010. 15,548 and 15,546 of these shares became fully vesting during 2012 and 2011, respectively, and 15,548 of these shares became fully vested in each of 2010 and 2009. In connection with this grant, we recorded compensation expense of $15,000 during 2012 and $375,000 during each of 2011 and 2010. This award was fully vested at December 31, 2012.

During the fourth quarter of 2007, pursuant to the 2001 Plan, the Committee approved the issuance of 61,362 restricted shares of our Class B Common Stock at $24.45 per share ($1.5 million in the aggregate) to our CEO. These shares were scheduled to vest ratably on the first, second, third and fourth anniversary dates of the grant and were subject to the same conditions and terms as mentioned above in connection with the grant of restricted shares during the first quarter of 2010. 15,341 of these shares became fully vested in each of 2011 and 2010 and 15,340 of these shares became fully vested in each of 2009 and 2008. In connection with this grant, we recorded compensation expense of $333,000 during 2011 and $375,000 during 2010. This award was fully vested at December 31, 2011.

Additionally, during 2007, pursuant to the 2001 Plan, the Committee approved the issuance of 22,250 restricted shares of our Class B Common stock at a weighted average of $29.62 per share ($659,000 in the aggregate) to various employees. These shares have various vesting schedules. We recorded compensation expense of $42,000 during 2012, $120,000 during 2011 and $135,000 during 2010, in connection with these grants. These awards were fully vested at December 31, 2012.

During the fourth quarter of 2006, pursuant to the 2001 Plan, the Committee approved the issuance of 247,000 restricted shares (net of cancellations) of our Class B Common Stock at $25.71 per share ($6.4 million in the aggregate) to various officers and employees. These shares became fully vested in November, 2010. In connection with this grant, we recorded compensation expense of $1.3 million during 2010. These awards were fully vested at December 31, 2010.

At December 31, 2012, 28,083,325 shares of Class B Common Stock were reserved for issuance upon conversion of shares of Class A, C and D Common Stock outstanding, for issuance upon exercise of options to purchase Class B Common Stock and for issuance of stock under other incentive plans. Class A, C and D Common Stock are convertible on a share for share basis into Class B Common Stock.

In connection with the long-term incentive plans described above, we recorded compensation expense of $2.8 million in 2012, $2.4 million in 2011 and $3.5 million in 2010. Including the compensation expense recognized related to outstanding stock options of $20.1 million in 2012, $15.8 million in 2011 and $13.3 million in 2010, we recorded a total stock compensation expense of $22.9 million in 2012, $18.2 million in 2011 and $16.8 million in 2010.

INCOME TAXES

12 Months Ended

Dec. 31, 2012

INCOME TAXES

6) INCOME TAXES

Components of income tax expense/(benefit) are as follows (amounts in thousands):


	Year Ended December 31,
	2012			2011		2010
Current
Federal	$	254,021		$	165,409	$	105,077
Foreign		9,084			300		2,555
State		39,076			22,901		16,547

		302,181			188,610		124,179
Deferred
Federal and foreign		(21,408	)		53,056		26,419
State		(6,157	)		5,800		1,704

		(27,565	)		58,856		28,123

Total	$	274,616		$	247,466	$	152,302

Deferred taxes are required to be classified based on the financial statement classification of the related assets and liabilities which give rise to temporary differences. Deferred taxes result from temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities. The components of deferred taxes are as follows (amounts in thousands):


	Year Ended December 31,
	2012			2011
Deferred income tax assets:
Self-insurance reserves	$	112,587		$	115,201
Compensation accruals		47,571			49,717
State and foreign net operating loss carryforwards and other state and foreign deferred tax assets		54,874			52,506
Other currently non-deductible accrued liabilities		29,934			19,699
Net pension liability—OCI only		12,061			13,959
Doubtful accounts and other reserves		17,562			17,345
Other combined items—OCI only		15,282			17,684

		289,871			286,111
Less: Valuation Allowance		(44,511	)		(42,143	)

Net deferred income tax assets:		245,360			243,968
Deferred income tax liabilities:
Depreciable and amortizable assets		(322,317	)		(342,655	)
Other deferred tax liabilities		(2,329	)		(2,581	)

Net deferred income tax liabilities	$	(79,286	)	$	(101,268	)

There was no material impact of deferred taxes recorded in conjunction with the acquisition of Ascend Health Corporation.

The effective tax rates, as calculated by dividing the provision for income taxes by income before income taxes, were as follows for each of the years ended December 31, 2012, 2011 and 2010 (dollar amounts in thousands):


	2012			2011			2010
Provision for income taxes	$	274,616		$	247,466		$	152,302
Income before income taxes		763,663			696,336			428,097

Effective tax rate		36.0	%		35.5	%		35.6	%

Impacting the effective tax rates during 2012 was approximately $1 million favorable discrete tax item recorded to adjust the estimated liabilities for uncertain tax positions. Impacting the effective tax rates during 2011 was approximately $1 million favorable discrete tax item recorded to adjust the estimated liabilities for uncertain tax positions. Impacting the effective tax rates during 2010 were the following items: (i) $5 million unfavorable discrete tax item recorded to adjust the non-deductible portion of certain transaction costs incurred during 2010 in connection with our acquisition of PSI; (ii) a $4 million unfavorable discrete tax item recorded to adjust for the non-deductible, $9 million charge incurred from split-dollar life insurance agreements entered into during 2010 on the lives of our chief executive officer and his wife, partially offset by; (iii) a $4 million favorable discrete tax item recorded during 2010 to adjust the estimated non-deductible portion of the previously disclosed South Texas Health System settlement with the government based upon the final agreement.

A reconciliation between the federal statutory rate and the effective tax rate is as follows:


	Year Ended December 31,
	2012			2011			2010
Federal statutory rate		35.0	%		35.0	%		35.0	%
State taxes, net of federal income tax benefit		3.0			2.9			3.1
Nondeductible transaction costs		0.2			—			1.3
Other items		0.1			0.4			0.4
Impact of income attributable to noncontrolling interests		(2.3	)		(2.8	)		(4.2	)

Effective tax rate		36.0	%		35.5	%		35.6	%

Included in “Other current assets” on our Consolidated Balance Sheet are prepaid federal, foreign, and state income taxes amounting to approximately $7 million and $25 million as of December 31, 2012 and 2011, respectively.

The net deferred tax assets and liabilities are comprised as follows (amounts in thousands):


	Year Ended December 31,
	2012			2011
Current deferred taxes
Assets	$	105,639		$	109,297
Liabilities		(1,178	)		(973	)

Total deferred taxes-current		104,461			108,324

Noncurrent deferred taxes
Assets		142,065			135,189
Liabilities		(325,812	)		(344,781	)

Total deferred taxes-noncurrent		(183,747	)		(209,592	)

Total deferred tax liabilities	$	(79,286	)	$	(101,268	)

The assets and liabilities classified as current relate primarily to the allowance for uncollectible patient accounts, compensation-related accruals and the current portion of the temporary differences related to self- insurance reserves. At December 31, 2012, state net operating loss carryforwards (expiring in years 2013 through 2032), and credit carryforwards available to offset future taxable income approximated $959 million, representing approximately $48 million in deferred state tax benefit (net of the federal benefit). At December 31, 2012, related to the acquisition of PSI, there were federal net operating losses of approximately $1 million expiring in 2022 representing approximately $0.4 million in deferred federal tax benefits and foreign net operating loss carryforwards of approximately $9 million expiring through 2021 representing approximately $3 million in deferred foreign tax benefit.

A valuation allowance is required when it is more likely than not that some portion of the deferred tax assets will not be realized. Based on available evidence, it is more likely than not that certain of our state tax benefits will not be realized. Therefore, valuation allowances of approximately $41 million and $39 million have been reflected as of December 31, 2012 and 2011, respectively. During 2012, the valuation allowance on these state tax benefits increased by approximately $2 million due to additional net operating losses incurred. In addition, valuation allowances of approximately $3 million have been reflected as of December 31, 2012 and 2011 related to foreign net operating losses. There were no significant increases in valuation allowances as a result of the acquisition of Ascend Health Corporation.

We adopted the provisions of Accounting for Uncertainty in Income Taxes effective January 1, 2007. During 2012 and 2011, the estimated liabilities for uncertain tax positions (including accrued interest and penalties) were increased in the amount of approximately $1 million due to tax positions taken in the current and prior years. There was no significant increase in 2012 attributable to tax positions taken by Ascend Health Corporation on pre-acquisition tax return years. Also during 2012, the estimated liabilities for uncertain tax positions (including accrued interest and penalties) were reduced due to the lapse of the statute of limitations resulting in a net income tax benefit of approximately $1 million. The balance at each of December 31, 2012 and 2011, if subsequently recognized, that would favorably affect the effective tax rate and the provision for income taxes is approximately $4 million and $5 million respectively.

We recognize accrued interest and penalties associated with uncertain tax positions as part of the tax provision. As of December 31, 2012 and 2011, we have approximately $1 million of accrued interest and penalties. The U.S. federal statute of limitations remains open for the 2009 and subsequent years. Foreign and U.S. state and local jurisdictions have statutes of limitations generally ranging for 3 to 4 years. The statute of limitations on certain jurisdictions could expire within the next twelve months. It is reasonably possible that the amount of unrecognized tax benefits will change during the next 12 months however it is anticipated that any such change, if it were to occur, would not have a material impact on our results of operations.

The tabular reconciliation of unrecognized tax benefits for the years ended December 31, 2012, 2011 and 2010 is as follows (amounts in thousands).


	As of December 31,
	2012			2011			2010
Balance at January 1,	$	7,403		$	7,923		$	5,754
Additions based on tax positions related to the current year		200			750			1,219
Additions for tax positions of prior years		386			419			2,076
Reductions for tax positions of prior years		(1,165	)		(1,628	)		(907	)
Settlements		—			(61	)		(219	)

Balance at December 31,	$	6,824		$	7,403		$	7,923

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 136, 172
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 43, 44, 45, 46, 47, 48, 49
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

LEASE COMMITMENTS

12 Months Ended

Dec. 31, 2012

LEASE COMMITMENTS

7) LEASE COMMITMENTS

Four of our hospital facilities are held under operating leases with Universal Health Realty Income Trust with terms expiring in 2014 and 2016 (see Note 9 for additional disclosure). We also lease the real property of certain facilities acquired by us in connection with the acquisition of PSI in November, 2010 and the acquisition of Ascend in October, 2012 (see Item 2. Properties for additional disclosure).

A summary of property under capital lease follows (amounts in thousands):


	As of December 31,
	2012			2011
Land, buildings and equipment	$	27,836		$	37,037
Less: accumulated amortization		(26,540	)		(35,264	)

	$	1,296		$	1,773

Future minimum rental payments under lease commitments with a term of more than one year as of December 31, 2012, are as follows (amounts in thousands):


Year	Capital Leases			Operating Leases
	(000s)
2013	$	2,162		$	58,638
2014		1,369			50,973
2015		1,158			43,496
2016		1,068			36,952
2017		1,077			21,906
Later years		5,117			102,722

Total minimum rental	$	11,951		$	314,687

Less: Amount representing interest		(3,684	)

Present value of minimum rental commitments		8,267
Less: Current portion of capital lease obligations		(1,585	)

Long-term portion of capital lease obligations	$	6,682

We incurred no additional capital lease obligations during 2012.

- Definition

The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.

+ References + Details

COMMITMENTS AND CONTINGENCIES

12 Months Ended

Dec. 31, 2012

COMMITMENTS AND CONTINGENCIES

8) COMMITMENTS AND CONTINGENCIES

Professional and General Liability, Workers’ Compensation Liability and Property Insurance

Professional and General Liability and Workers Compensation Liability:

Effective January 1, 2008, most of our subsidiaries became self-insured for professional and general liability exposure up to $10 million per occurrence. Prior to our acquisition of Psychiatric Solutions, Inc. (“PSI”) in November, 2010, our subsidiaries purchased several excess policies through commercial insurance carriers which provide for coverage in excess of $10 million up to $200 million per occurrence and in the aggregate. However, we are liable for 10% of the claims paid pursuant to the commercially insured coverage in excess of $10 million up to $60 million per occurrence and in the aggregate.

Prior to our acquisition in November, 2010, the PSI subsidiaries were commercially insured for professional and general liability insurance claims in excess of a $3 million self-insured retention to a limit of $75 million. PSI utilized its captive insurance company and that captive insurance company remains in place after our acquisition of PSI to manage the self-insured retention for all former PSI subsidiaries for claims incurred prior to January 1, 2011. The captive insurance company also continues to insure all professional and general liability claims, regardless of date incurred, for the former PSI subsidiaries located in Florida and Puerto Rico.

Since our acquisition of PSI on November 15, 2010, the former PSI subsidiaries are self-insured for professional and general liability exposure up to $3 million per occurrence and our legacy subsidiaries (which are not former PSI subsidiaries) are self-insured for professional and general liability exposure up to $10 million per occurrence. Effective November, 2010, our subsidiaries (including the former PSI subsidiaries) were provided with several excess policies through commercial insurance carriers which provide for coverage in excess of the applicable per occurrence self-insured retention (either $3 million or $10 million) up to $200 million per occurrence and in the aggregate. We remain liable for 10% of the claims paid pursuant to the commercially insured coverage in excess of $10 million up to $60 million per occurrence and in the aggregate. The 9 behavioral health facilities acquired from Ascend Health Corporation in October, 2012 have general and professional liability policies through commercial insurance carriers which provide for up to $20 million of aggregate coverage, subject to a $10,000 per occurrence deductible. These facilities, like our other facilities, are also provided excess coverage through commercial insurance carriers for coverage in excess of the underlying commercial policy limitations up to $200 million per occurrence and in the aggregate.

Our estimated liability for self-insured professional and general liability claims is based on a number of factors including, among other things, the number of asserted claims and reported incidents, estimates of losses for these claims based on recent and historical settlement amounts, estimates of incurred but not reported claims based on historical experience, and estimates of amounts recoverable under our commercial insurance policies. While we continuously monitor these factors, our ultimate liability for professional and general liability claims could change materially from our current estimates due to inherent uncertainties involved in making this estimate. Given our significant self-insured exposure for professional and general liability claims, there can be no assurance that a sharp increase in the number and/or severity of claims asserted against us will not have a material adverse effect on our future results of operations.

As of December 31, 2012, the total accrual for our professional and general liability claims, including the estimated claims related to the facilities acquired from PSI, was $279 million, of which $48 million is included in current liabilities. As of December 31, 2011, the total accrual for our professional and general liability claims, including the estimated claims related to the facilities acquired from PSI, was $292 million, of which $60 million is included in current liabilities.

We recorded reductions to our professional and general liability self-insurance reserves (relating to prior years) amounting to $27 million during 2012, $11 million during 2011 and $49 million during 2010. The favorable change recorded during 2012 resulted from favorable changes in our estimated future claims payments pursuant to a reserve analysis. The favorable change recorded during 2011 consisted primarily of third-party recoveries and reserve reductions in connection with PHICO–related claims which we became liable for upon PHICO’s (a former commercial insurance carrier) liquidation in 2002. The favorable changes in our estimated future claims payments recorded during 2010 were due to: (i) an increased weighting given to company-specific metrics (to 75% from 50%), and decreased general industry metrics (to 25% from 50%), related to projected incidents per exposure, historical claims experience and loss development factors; (ii) historical data which measured the realized favorable impact of medical malpractice tort reform experienced in several states in which we operate, and; (iii) a decrease in claims related to certain higher risk specialties (such as obstetrical) due to a continuation of the company-wide patient safety initiative undertaken during the last several years. As the number of our facilities and our patient volumes have increased, thereby providing for a statistically significant data group, and taking into consideration our long-history of company-specific risk management programs and claims experience, our reserve analyses have included a greater emphasis on our historical professional and general liability experience which has developed favorably as compared to general industry trends.

As of December 31, 2012, the total accrual for our workers’ compensation liability claims was $66 million, of which $35 million is included in current liabilities. As of December 31, 2011, the total accrual for our workers’ compensation liability claims was $65 million, of which $34 million is included in current liabilities.

There were no material adjustments to our prior year reserves for workers’ compensation claims recorded during 2012 or 2011. Based upon the results of workers’ compensation reserves analyses, during 2010, we recorded a reduction to our prior year reserves for workers’ compensation claims amounting to $4 million.

Property Insurance:

We have commercial property insurance policies covering catastrophic losses, including windstorm damage, up to a $1 billion policy limit per occurrence, subject to a $250,000 deductible for the majority of our properties (the properties acquired from Psychiatric Solutions, Inc. are subject to a $50,000 deductible). Losses resulting from named windstorms are subject to deductibles between 3% and 5% of the declared total insurable value of the property. In addition, we have commercial property insurance policies covering catastrophic losses resulting from earthquake and flood damage, each subject to aggregated loss limits (as opposed to per occurrence losses). Our earthquake limit is $250 million, subject to a deductible of $250,000, except for facilities located within documented fault zones. Earthquake losses that affect facilities located in fault zones within the United States are subject to a $100 million limit and will have applied deductibles ranging from 1% to 5% of the declared total insurable value of the property. The earthquake limit in Puerto Rico is $25 million. Flood losses have either a $250,000 or $500,000 deductible, based upon the location of the facility. The 9 behavioral health facilities acquired from Ascend Health Corporation in October, 2012 have commercial property insurance policies which provide for full replacement cost coverage, subject to a $10,000 deductible.

Legal Proceedings

We are subject to claims and suits in the ordinary course of business, including those arising from care and treatment afforded by our hospitals and are party to litigation, as outlined below.

Two Rivers Psychiatric Hospital:

In April, 2011, the Centers for Medicare and Medicaid Services (“CMS”) issued notice of its decision terminating Two Rivers Psychiatric Hospital (“Two Rivers”) in Kansas City, Missouri from participation in the Medicare and Medicaid program. The termination notice was issued as a result of surveys conducted which allegedly found Two Rivers to be out of compliance with the conditions of participation required for participation in the Medicare program and for Two Rivers’ alleged failure to alleviate an “immediate jeopardy” situation. Two Rivers filed an administrative appeal with the U.S. Department of Health and Human Services, Departmental Appeal Board, Civil Remedies Division, seeking review and reversal of that decision. In addition, Two Rivers filed a complaint in the U.S. District Court for the Western District of Missouri seeking a temporary restraining order and preliminary injunction against CMS rescinding the termination action. Later in April, 2011, the District Court issued a temporary restraining order abating the termination action pending a preliminary injunction hearing or an agreement with CMS. In May, 2011, Two Rivers and CMS entered into a settlement agreement which resulted in the rescission of the termination notice and actions by CMS. Pursuant to the terms of the agreement, Two Rivers was required to submit an acceptable plan of correction relative to the immediate jeopardy citation and engage independent experts in various disciplines to analyze and develop implementation plans for Two Rivers to meet the applicable Medicare conditions of participation. Both of these actions have occurred. Pursuant to the agreement, CMS conducted an initial survey of Two Rivers in April 2012 to determine if the Medicare conditions of participation, which formed the basis of the termination action in April 2011, had been met. In late April, 2012, CMS advised Two Rivers that it has successfully passed this initial survey. Pursuant to the terms of the agreement, a second survey will be conducted in early 2013 to further confirm that Two Rivers is in compliance with all Medicare/Medicaid Conditions of Participation. During the term of this agreement, Two Rivers remains eligible to receive reimbursements for services rendered to Medicare and Medicaid beneficiaries. Two Rivers remains fully committed to providing high-quality healthcare to their patients and the community it serves. We therefore intend to work expeditiously and collaboratively with CMS in an effort to resolve these matters. We can provide no assurance that Two Rivers will not ultimately lose its Medicare certification. The operating results of Two Rivers did not have a material impact on our consolidated results of operations or financial condition for the years ended December 31, 2012 or 2011.

Office of Inspector General (“OIG”) and Other Government Investigations

In September, 2010, we, along with many other companies in the healthcare industry, received a letter from the United States Department of Justice (“DOJ”) advising of a False Claim Act investigation being conducted in connection with the implantation of implantable cardioverter defibrillators (“ICDs”) from 2003 to the present at several of our acute care facilities. The DOJ alleges that ICDs were implanted and billed by our facilities in contravention of a National Claims Determination regarding these devices. We have established a reserve in connection with this matter which did not have a material impact on our consolidated financial statements.

In July, 2012, one of our subsidiaries, Peachford Behavioral Health System of Atlanta located in Atlanta, Georgia, received a subpoena from the OIG for the Department of Health and Human Services requesting various documents from 2004 to the present. We are in the process of securing and collecting the requested documents for production. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

In February, 2013, the OIG served a subpoena requesting various documents from January 2008 to the present directed at Universal Health Services, Inc. (“UHS”) concerning it and UHS of Delaware, Inc., and several UHS owned facilities including: Keys of Carolina, Old Vineyard Behavioral Health, The Meadows Psychiatric Center, Streamwood Behavioral Health, Hartgrove Hospital, Rock River Academy and Residential Treatment Center, Roxbury Treatment Center, Harbor Point Behavioral Health Center, f/k/a, The Pines Residential Treatment Center, including the Crawford, Brighton and Kempsville campuses, Wekiva Springs Center and River Point Behavioral Health. Prior to receiving this subpoena: (i) the Keys of Carolina and Old Vineyard received notification during the second half of 2012 from the United States Department of Justice of its intent to proceed with an investigation following requests for documents from January, 2007 to the present from the North Carolina state Attorney General’s Office; (ii) Harbor Point Behavioral Health Center received a subpoena in December, 2012 from the Attorney General of the Commonwealth of Virginia requesting various documents from July 2006 to the present, and; (iii) The Meadows Psychiatric Center received a subpoena from the OIG in February, 2013 requesting certain documents from 2008 to the present. At present, we are uncertain as to the focus, scope or extent of the investigations, liability of the facilities and/or potential financial exposure, if any, in connection with these matters. Unrelated to these matters, the Keys of Carolina was closed and the real property was sold in January, 2013.

Matters Relating to PSI:

The following matters pertain to PSI or former PSI facilities (owned by subsidiaries of Psychiatric Solutions, Inc.) which were in existence prior to the acquisition of PSI and for which we have assumed the defense as a result of our acquisition which was completed in November, 2010:

Garden City Employees’ Retirement System v. PSI:

This is a purported shareholder class action lawsuit filed in the United States District Court for the Middle District of Tennessee against PSI and the former directors in 2009 alleging violations of federal securities laws. We intend to defend the case vigorously. Should we be deemed liable in this matter, we believe we would be entitled to commercial insurance recoveries for amounts paid by us, subject to certain limitations and deductibles. Included in our consolidated balance sheets as of December 31, 2012 and 2011, is an estimated reserve (current liability) and corresponding commercial insurance recovery (current asset) which did not have a material impact on our financial statements. Although we believe the commercial insurance recoveries are adequate to satisfy potential liability and related legal fees in connection with this matter, we can provide no assurance that the ultimate liability will not exceed the commercial insurance recoveries which would make us liable for the excess.

Department of Justice Investigation of Friends Hospital:

In October, 2010, Friends Hospital in Philadelphia, Pennsylvania, received a subpoena from the DOJ requesting certain documents from the facility. The requested documents have been collected and provided to the DOJ for review and examination. Another subpoena was issued to the facility in July 2011 requesting additional documents, which have been collected and delivered to the DOJ. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

Department of Justice Investigation of Riveredge Hospital:

In 2008, Riveredge Hospital in Chicago, Illinois received a subpoena from the DOJ requesting certain information from the facility. Additional requests for documents were also received from the DOJ in 2009 and 2010. The requested documents have been provided to the DOJ. At present, we are uncertain as to the focus, scope or extent of the investigation, liability of the facility and/or potential financial exposure, if any, in connection with this matter.

Virginia Department of Medical Assistance Services Recoupment Claims:

The Virginia Department of Medical Assistance Services (“DMAS”) has conducted audits at seven former PSI Residential Treatment Centers operated in the Commonwealth of Virginia to confirm compliance with provider rules under the state’s Medicaid Provider Services Manual (“Manual”). As a result of those audits, DMAS claims the facilities failed to comply with the requirements of the Manual and has requested repayment of Medicaid payments to those facilities. PSI had previously filed appeals to repayment demands at each facility which are currently pending. We have recently reached a preliminary settlement of this matter which requires finalization of a definitive agreement and approval of Virginia state officials. The aggregate refund of Medicaid payments made to those facilities, as requested by DMAS, and the settlement amount is not material to our consolidated financial position or results of operations.

General:

The healthcare industry is subject to numerous laws and regulations which include, among other things, matters such as government healthcare participation requirements, various licensure, certifications, and accreditations, reimbursement for patient services, and Medicare and Medicaid fraud and abuse. Government action has increased with respect to investigations and/or allegations concerning possible violations of fraud and abuse and false claims statutes and/or regulations by healthcare providers. Currently, and from time to time, some of our facilities are subjected to inquiries and/or actions and receive notices of potential non-compliance of laws and regulations from various federal and state agencies. Providers that are found to have violated these laws and regulations may be excluded from participating in government healthcare programs, subjected to potential licensure, certification, and/or accreditation revocation, subjected to fines or penalties or required to repay amounts received from the government for previously billed patient services. We monitor all aspects of our business and have developed a comprehensive ethics and compliance program that is designed to meet or exceed applicable federal guidelines and industry standards. Because the law in this area is complex and constantly evolving, governmental investigation or litigation may result in interpretations that are inconsistent with industry practices, including ours. Although we believe our policies, procedures and practices comply with governmental regulations, there is no assurance that we will not be faced with sanctions, fines or penalties in connection with such inquiries or actions, including with respect to the investigations and other matters discussed herein. Even if we were to ultimately prevail, such inquiries and/or actions could have a material adverse effect on us.

The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities. We record accruals for such contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because the inherently unpredictable nature of legal proceedings may be exacerbated by various factors, including, but not limited to: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties, or; (vii) there is a wide range of potential outcomes. It is possible that the outcome of these matters could have a material adverse impact on our future results of operations, financial position, cash flows and, potentially, our reputation.

In addition, various suits and claims arising against us in the ordinary course of business are pending. In the opinion of management, the outcome of such claims and litigation will not materially affect our consolidated financial position or results of operations.

In addition to our long-term debt obligations as discussed in Note 4-Long-Term Debt and our operating lease obligations as discussed in Note 7-Lease Commitments, we have various other contractual commitments outstanding as of December 31, 2012 as follows: (i) other combined estimated future purchase obligations of $290 million related to a long-term contract with third-parties consisting primarily of certain revenue cycle data processing services for our acute care facilities ($106 million), expected future costs to be paid to a third-party vendor in connection with the purchase, implementation and on-going operation of an electronic health records application for each of our acute care facilities ($181 million) and estimated minimum liabilities for physician commitments expected to be paid in the future ($3 million), and; (ii) combined estimated future payments of $225 million related to our non-contributory, defined benefit pension plan ($208 million consisting of estimated payments through 2087) and other retirement plan liabilities ($17 million).

As of December 31, 2012 we were party to certain off balance sheet arrangements consisting of standby letters of credit and surety bonds. Our outstanding letters of credit and surety bonds as of December 31, 2012 totaled $80 million consisting of: (i) $66 million related to our self-insurance programs, and; (ii) $14 million of other debt and public utility guarantees.

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 14
-Paragraph 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

RELATIONSHIP WITH UNIVERSAL HEALTH REALTY INCOME TRUST AND RELATED PARTY TRANSACTIONS

12 Months Ended

Dec. 31, 2012

RELATIONSHIP WITH UNIVERSAL HEALTH REALTY INCOME TRUST AND RELATED PARTY TRANSACTIONS

9) RELATIONSHIP WITH UNIVERSAL HEALTH REALTY INCOME TRUST AND RELATED PARTY TRANSACTIONS

Relationship with Universal Health Realty Income Trust:

At December 31, 2012, we held approximately 6.2% of the outstanding shares of Universal Health Realty Income Trust (the “Trust”). We serve as Advisor to the Trust under an annually renewable advisory agreement pursuant to the terms of which we conduct the Trust’s day-to-day affairs, provide administrative services and present investment opportunities. In addition, certain of our officers and directors are also officers and/or directors of the Trust. Management believes that it has the ability to exercise significant influence over the Trust, therefore we account for our investment in the Trust using the equity method of accounting. We earned an advisory fee from the Trust, which is included in net revenues in the accompanying consolidated statements of income, of approximately $2.1 million during 2012, $2.0 million during 2011 and $1.8 million during 2010.

Our pre-tax share of income from the Trust was $1.2 million during 2012, $4.6 million during 2011 and $1.0 million during 2010, and is included in net revenues in the accompanying consolidated statements of income for each year. Included in our share of the Trust’s income for 2011 was approximately $3.7 million related to our share of the following: (i) an aggregate gain realized by the Trust during 2011 in connection with the sale of medical office buildings by various limited liability companies (“LLCs”) in which the Trust formerly held noncontrolling, majority ownership interests; (ii) an aggregate gain recorded by the Trust during 2011 in connection with its purchases of third-party minority ownership interests in various LLCs in which the Trust formerly held noncontrolling majority ownership interests (the Trust now owns 100% of each of these entities), partially offset by; (iii) a provision for asset impairment recorded by the Trust during 2011 in connection with a medical office building located in Atlanta, Georgia.

The carrying value of our investment in the Trust was $9.3 million and $9.9 million at December 31, 2012 and 2011, respectively, and is included in other assets in the accompanying consolidated balance sheets. The market value of our investment in the Trust was $39.9 million at December 31, 2012 and $30.7 million at December 31, 2011, based on the closing price of the Trust’s stock on the respective dates.

Total rent expense under the operating leases on the four hospital facilities with the Trust (as discussed below) was $16.3 million during each of 2012 and 2011 and $16.2 million during 2010. In addition, certain of our subsidiaries are tenants in several medical office buildings owned by limited liability companies in which the Trust holds either 100% of the ownership interest or various noncontrolling, majority ownership interests.

The Trust commenced operations in 1986 by purchasing certain properties from us and immediately leasing the properties back to our respective subsidiaries. Most of the leases were entered into at the time the Trust commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. Each lease also provided for additional or bonus rental, as discussed below. The base rents are paid monthly and the bonus rents are computed and paid on a quarterly basis, based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The leases with our subsidiaries are unconditionally guaranteed by us and are cross-defaulted with one another.

Pursuant to the terms of the leases with the Trust, we have the option to renew the leases at the lease terms described above by providing notice to the Trust at least 90 days prior to the termination of the then current term. In addition, we have rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. We also have the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at their appraised fair market value as well as purchase any or all of the four leased hospital properties at their appraised fair market value upon one month’s notice should a change of control of the Trust occur.

The table below details the renewal options and terms for each of our four hospital facilities leased from the Trust, giving effect to the above-mentioned renewals:

Hospital Name

Type of Facility

Annual
Minimum
Rent

End of Lease Term

Renewal
Term
(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

The Bridgeway

Behavioral Health

930,000

December, 2014

(c)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal options at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

(c)	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

Split-dollar Life Insurance Agreements:

In December, 2010, our Board of Directors approved the Company’s entering into supplemental life insurance plans and agreements on the lives of our chief executive officer and his wife. As a result of these agreements, based on actuarial tables and other assumptions, during the life expectancies of the insureds, we would pay approximately $25 million in premiums and certain trusts, owned by our chief executive officer, would pay approximately $8 million in premiums. Based on the projected premiums mentioned above, and assuming the policies remain in effect until the death of the insureds, we will be entitled to receive death benefit proceeds of no less than $33 million representing the $25 million of aggregate premiums paid by us as well as the $8 million of aggregate premiums paid by the trusts. During each of 2012 and 2011, we paid approximately $1.4 million in premium payments and during the fourth quarter of 2010, we paid approximately $6 million in premium payments. These agreements did not have a material effect on our consolidated financial statements or results of operations during 2012 and 2011. Included in our financial statements during 2010, was a pre-tax and after-tax expense of $9 million recorded during the fourth quarter of 2010 representing the present value of our projected premium funding commitment over the terms of the policies.

Other Related Party Transactions:

A member of our Board of Directors and member of the Executive Committee is Of Counsel to the law firm used by us as our principal outside counsel. This Board member is also the trustee of certain trusts for the benefit of our CEO and his family. This law firm also provides personal legal services to our CEO.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph b
-Article 3A

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph k
-Article 4

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 57
-Paragraph 1-4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

PENSION PLAN

12 Months Ended

Dec. 31, 2012

PENSION PLAN

10) PENSION PLAN

We maintain contributory and non-contributory retirement plans for eligible employees. Our contributions to the contributory plan amounted to $27.3 million, $21.7 million and $20.8 million in 2012, 2011 and 2010, respectively. The non-contributory plan is a defined benefit pension plan which covers employees of one of our subsidiaries. The benefits are based on years of service and the employee’s highest compensation for any five years of employment. Our funding policy is to contribute annually at least the minimum amount that should be funded in accordance with the provisions of ERISA.

The following table shows the reconciliation of the defined benefit pension plan as of December 31, 2012 and 2011:


	2012			2011
	(000s)
Change in plan assets:
Fair value of plan assets at beginning of year	$	87,940		$	73,402
Actual return (loss) on plan assets		13,824			5,689
Employer contributions		7,786			14,065
Benefits paid		(4,946	)		(4,541	)
Administrative expenses		(530	)		(675	)

Fair value of plan assets at end of year	$	104,074		$	87,940
Change in benefit obligation:
Benefit obligation at beginning of year	$	108,446		$	93,513
Service cost		1,144			1,162
Interest cost		4,659			5,047
Benefits paid		(4,946	)		(4,541	)
Actuarial (gain) loss		5,226			13,265

Benefit obligation at end of year	$	114,529		$	108,446
Amounts recognized in the Consolidated Balance Sheet:
Other noncurrent liabilities		10,455			20,506

Total liability at end of year	$	10,455		$	20,506

Additional year end information for Pension Plan
Projected benefit obligation	$	114,529		$	108,446
Accumulated benefit obligation		112,675			106,609
Fair value of plan assets		104,074			87,940


	2012			2011			2010
	(000s)
Components of net periodic cost (benefit)
Service cost	$	1,144		$	1,162		$	1,140
Interest cost		4,659			5,047			4,958
Expected return on plan assets		(7,301	)		(6,566	)		(5,151	)
Recognized actuarial loss		4,219			2,427			2,538

Net periodic cost	$	2,721		$	2,070		$	3,485


	2012		2011
Measurement Dates
Benefit obligations		12/31/2012		12/31/2011
Fair value of plan assets		12/31/2012		12/31/2011


	2012			2011
Weighted average assumptions as of December 31
Discount rate		4.05	%		4.40	%
Rate of compensation increase		4.00	%		4.00	%


	2012			2011			2010
Weighted-average assumptions for net periodic benefit cost calculations
Discount rate		4.40	%		5.54	%		5.96	%
Expected long-term rate at return on plan assets		8.00	%		8.00	%		8.00	%
Rate of compensation increase		4.00	%		4.00	%		4.00	%

The accumulated benefit obligation was $112,675 and $106,609 as of December 31, 2012 and 2011, respectively. The accumulated benefit obligation exceeded the fair value of plan assets as of December 31, 2012 and 2011. In 2012 and 2011, the accrued pension cost is included in non-current liabilities in the accompanying Consolidated Balance Sheet. We estimate that there will be $3,305 of net loss that will be amortized from accumulated other comprehensive income over the next fiscal year.

Our pension plans assets were $104,074 and $87,940 at December 31, 2012 and 2011, respectively. The market values of our pension plan assets at December 31, 2012 and December 31, 2011 by asset category are as follows:


December 31, 2012	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	22,800	$	—	$	22,800	$	—
U.S. Mid Cap		1,566		—		1,566		—
U.S. Small-Mid Cap		7,738		—		7,738		—
U.S. Small Cap		1,583		—		1,583		—
International Developed		10,779		—		10,779		—
Emerging Markets		3,912		—		3,912		—
Fixed income:
Long Duration Fixed Income		51,355		—		51,355		—
Real Estate:
REIT Fund		3,904		—		3,904		—
Cash/Currency:
Cash Equivalents		437		—		437		—

Total market value	$	104,074	$	—	$	104,074	$	—


December 31, 2011	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	18,921	$	—	$	18,921	$	—
U.S. Mid Cap		1,281		—		1,281		—
U.S. Small-Mid Cap		6,332		—		6,332		—
U.S. Small Cap		1,282		—		1,282		—
International Developed		8,692		—		8,692		—
Emerging Markets		3,123		—		3,123		—
Fixed income:
Long Duration Fixed Income		44,587		—		44,587		—
Real Estate:
REIT Fund		3,269		—		3,269		—
Cash/Currency:
Cash Equivalents		453		—		453		—

Total market value	$	87,940	$	—	$	87,940	$	—

To develop the expected long-term rate of return on plan assets assumption, we considered the historical returns and the future expectations for returns for each asset class, as well as the target asset allocation of the pension portfolio.

The following table shows expected benefit payments for the years ended December 31, 2012 through 2022 for our defined pension plan. There will be benefit payments under this plan beyond 2022.


Estimated Future Benefit Payments (000s)
2013	$	5,451
2014		5,724
2015		5,692
2016		6,182
2017		6,379
2018-2022		34,251

Total	$	63,679


	2012			2011
Plan Assets
Asset Category
Equity securities		47	%		45	%
Fixed income securities		49	%		50	%
Other		4	%		5	%

Total		100	%		100	%

Investment Policy, Guidelines and Objectives have been established for the defined benefit pension plan. The investment policy is in keeping with the fiduciary requirements under existing federal laws and managed in accordance with the Prudent Investor Rule. Total portfolio risk is regularly evaluated and compared to that of the plan’s policy target allocation and judged on a relative basis over a market cycle. The following asset allocation policy and ranges have been established in accordance with the overall risk and return objectives of the portfolio:


	Policy			As of 12/31/12			Permitted Range
Total Equity		46	%		47	%		43-49	%
Total Fixed Income		50	%		49	%		45-55	%
Other		4	%		4	%		0-10	%

In accordance with the investment policy, the portfolio will invest in high quality, large and small capitalization companies traded on national exchanges, and investment grade securities. The investment managers will not write or buy options for speculative purposes; securities may not be margined or sold short. The manager may employ futures or options for the purpose of hedging exposure, and will not purchase unregistered sectors, private placements, partnerships or commodities.

- Definition

The entire disclosure for pension and other postretirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Implementation Guide (Q and A)
-Number FAS88
-Paragraph 63
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 106
-Paragraph 518
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 03-2
-Paragraph 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 87
-Paragraph 264
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph q
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph h
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 8
-Subparagraph m
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 158
-Paragraph 7, 21, 22
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS106-2
-Paragraph 20, 21, 22
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 30
-Paragraph 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

SEGMENT REPORTING

12 Months Ended

Dec. 31, 2012

SEGMENT REPORTING

11) SEGMENT REPORTING

Our reportable operating segments consist of acute care hospital services and behavioral health care services. The “Other” segment column below includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting as well as the operating results for our other operating entities including outpatient surgery and radiation centers. The chief operating decision making group for our acute care hospital services and behavioral health care services is comprised of our Chief Executive Officer, the President and the Presidents of each operating segment. The Presidents for each operating segment also manage the profitability of each respective segment’s various facilities. The operating segments are managed separately because each operating segment represents a business unit that offers different types of healthcare services or operates in different healthcare environments. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies included in this Annual Report on Form 10-K for the year ended December 31, 2012. The corporate overhead allocations, as reflected below, are utilized for internal reporting purposes and are comprised of each period’s projected corporate-level operating expenses (excluding interest expense). The overhead expenses are captured and allocated directly to each segment, to the extent possible, with the non-directly allocated overhead expenses allocated based upon each segment’s respective percentage of total facility-based operating expenses.


2012	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	12,406,567		$	5,764,370			—		$	18,170,937
Gross outpatient revenues	$	6,134,615		$	646,177		$	48,183		$	6,828,975
Total net revenues	$	3,461,416		$	3,460,141		$	39,843		$	6,961,400
Income (loss) before allocation of corporate overhead and income taxes	$	337,385		$	838,603		($	412,325	)	$	763,663
Allocation of corporate overhead	($	162,056	)	($	84,597	)	$	246,653		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	175,329		$	754,006		($	165,672	)	$	763,663
Total assets	$	2,984,169		$	4,979,965		$	236,709		$	8,200,843


2011	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	11,770,248		$	5,507,728			—		$	17,277,976
Gross outpatient revenues	$	5,431,146		$	606,876		$	53,240		$	6,091,262
Total net revenues	$	3,423,957		$	3,308,862		$	27,403		$	6,760,222
Income (loss) before allocation of corporate overhead and income taxes	$	352,931		$	729,142		($	385,737	)	$	696,336
Allocation of corporate overhead	($	131,225	)	($	62,710	)	$	193,935		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	221,706		$	666,432		($	191,802	)	$	696,336
Total assets	$	2,782,102		$	4,373,379		$	509,764		$	7,665,245


2010	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	10,623,407		$	2,563,867			—		$	13,187,274
Gross outpatient revenues	$	4,596,317		$	350,192		$	49,245		$	4,995,754
Total net revenues	$	3,272,488		$	1,597,022		$	30,637		$	4,900,147
Income (loss) before allocation of corporate overhead and income taxes	$	352,334		$	353,046		($	277,283	)	$	428,097
Allocation of corporate overhead	($	128,588	)	($	43,362	)	$	171,950		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	223,746		$	309,684		($	105,333	)	$	428,097
Total assets	$	2,681,803		$	4,360,262		$	485,871		$	7,527,936

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 131
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

QUARTERLY RESULTS

12 Months Ended

Dec. 31, 2012

QUARTERLY RESULTS

12) QUARTERLY RESULTS (unaudited)

The following tables summarize the quarterly financial data for the two years ended December 31, 2012 and 2011:


2012	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,793,036	$	1,723,084	$	1,680,353	$	1,764,927	$	6,961,400
Net income	$	142,570	$	117,444	$	81,373	$	147,660	$	489,047
Less: Net income attributable to noncontrolling interests	$	13,963	$	9,883	$	9,556	$	12,199	$	45,601

Net income attributable to UHS	$	128,607	$	107,561	$	71,817	$	135,461	$	443,446

Earnings per share attributable to UHS-Basic:

Total basic earnings per share	$	1.33	$	1.11	$	0.74	$	1.39	$	4.57

Earnings per share attributable to UHS-Diluted:

Total diluted earnings per share	$	1.31	$	1.10	$	0.73	$	1.39	$	4.53

The 2012 quarterly financial data presented above includes the following:

First Quarter:

•

a favorable $30.2 million pre-tax impact ($18.8 million, or $.19 per diluted share, net of taxes) resulting from an agreement entered into with the United States Department of Health and Human Services, the Secretary of Health and Human Services, and the Centers for Medicare and Medicaid Services (referred to collectively as “HHS”). This agreement, which was part of an industry-wide settlement with HHS related to litigation that was pending for several years contending that acute care hospitals in the U.S. were underpaid from the Medicare inpatient prospective payment system during a number of prior years;

•

a favorable $7.0 million pre-tax impact ($4.3 million, or $.04 per diluted share, net of taxes) representing the 2011 portion of the net Medicaid supplemental reimbursements we expect to receive pursuant to the Oklahoma Supplemental Hospital Offset Payment Program;

•

an aggregate unfavorable $8.3 million pre-tax impact ($5.1 million, or $.05 per diluted share, net of taxes) resulting from: (i) the revised Supplemental Security Income ratios utilized for calculating Medicare disproportionate share hospital reimbursements for federal fiscal years 2006 through 2009 ($2.4 million unfavorable after-tax impact), and; (ii) the write-off of receivables related to revenues recorded during 2011 at two of our acute care hospitals located in Florida resulting from reductions in certain county reimbursements due to reductions in federal matching Inter-Governmental Transfer funds ($2.7 million unfavorable after-tax impact).

Second Quarter:

•

an unfavorable $8.0 million pre-tax impact ($5.0 million, or $.05 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

•

a favorable $5.5 million pre-tax impact ($3.4 million, or $.03 per diluted share, net of taxes) representing net Medicaid reimbursements related to prior years.

Third Quarter:

• a favorable $2.2 million pre-tax impact ($1.3 million, or $.01 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

• an unfavorable $29.2 million pre-tax impact ($18.1 million, or $0.19 per diluted share, net of taxes) resulting from the write-off of deferred financing costs related to the portion of our Term Loan B credit facility that was extinguished during the third quarter of 2012.

Fourth Quarter:

•

a favorable $26.4 million pre-tax impact ($16.4 million, or $0.17 per diluted share, net of taxes) gain resulting from the sale of an acute care facility located in Auburn, Washington;

•

a favorable $8.9 million pre-tax impact ($5.5 million, or $.06 per diluted share, net of taxes) recorded in connection with the implementation of EHR applications;

•

a favorable $27.2 million pre-tax impact reduction ($15.5 million, or $.16 per diluted share, net of taxes) to our professional and general liability self-insurance reserves relating to years prior to 2012, as discussed in Self-Insured Risks.


2011	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,723,296	$	1,711,255	$	1,662,675	$	1,662,996	$	6,760,222
Net income	$	129,987	$	116,034	$	94,842	$	108,007	$	448,870
Less: Net income attributable to noncontrolling interests	$	15,794	$	12,385	$	9,788	$	12,736	$	50,703

Net income attributable to UHS	$	114,193	$	103,649	$	85,054	$	95,271	$	398,167

Earnings per share attributable to UHS-Basic:

Total basic earnings per share	$	1.17	$	1.06	$	0.87	$	0.99	$	4.09

Earnings per share attributable to UHS-Diluted:

Total diluted earnings per share	$	1.15	$	1.04	$	0.86	$	0.98	$	4.04

The 2011 quarterly financial data presented above includes the following:

Fourth Quarter:

•

a favorable $10.4 million pre-tax reduction ($6.4 million, or $.07 per diluted share, net of taxes) to our professional and general liability self-insurance reserves relating to years prior to 2011, as discussed in Self-Insured Risks.

- Definition

The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.

+ References + Details

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

12 Months Ended

Dec. 31, 2012

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

13) SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

Certain of our senior notes are guaranteed by a group of subsidiaries (the “Guarantors”). The Guarantors, each of which is a 100% directly owned subsidiary of Universal Health Services, Inc., fully and unconditionally guarantee the senior notes on a joint and several basis, subject to certain customary release provisions.

The following financial statements present condensed consolidating financial data for (i) Universal Health Services, Inc. (on a parent company only basis), (ii) the combined Guarantors, (iii) the combined non guarantor subsidiaries (all other subsidiaries), (iv) an elimination column for adjustments to arrive at the information for the parent company, Guarantors, and non guarantors on a consolidated basis, and (v) the parent company and our subsidiaries on a consolidated basis.

Investments in subsidiaries are accounted for by the parent company and the Guarantors using the equity method for this presentation. Results of operations of subsidiaries are therefore classified in the parent company’s and Guarantors’ investment in subsidiaries accounts. The elimination entries set forth in the following condensed consolidating financial statements eliminate distributed and undistributed income of subsidiaries, investments in subsidiaries, and intercompany balances and transactions between the parent, Guarantors, and non guarantors.

Certain revisions have been made to correct immaterial errors in the condensed consolidating balance sheet as of December 31, 2011 and the condensed consolidating statements of operations for the twelve months ended December 31, 2011 and 2010, which had the following impact: (i) on the condensed consolidating balance sheet certain noncurrent assets decreased by $53.8 million of the Non-guarantor subsidiaries, with corresponding offsetting adjustments to the same items in the Consolidating Adjustments column; (ii) on the condensed consolidating balance sheet certain noncurrent liabilities decreased by $53.8 million of the Guarantor subsidiaries, with corresponding offsetting adjustments to the same items in the Eliminations column; (iii) on the condensed consolidating statements of operations for the twelve months ended December 31, 2011 interest expense decreased by $87.2 million for the Guarantor Subsidiaries and interest expense increased by $87.2 million for the Non-guarantor Subsidiaries for the twelve months ended December 31, 2011; (iv) net income and net income attributable to UHS for the Guarantor subsidiaries increased by $53.8 million for the twelve months ended December 31, 2011, and net income and Net income attributable to UHS decreased for the Non-guarantor subsidiaries by $53.8 million; (iv) on the condensed consolidating statements of operations for the twelve months ended December 31, 2010, net revenues and other operating expenses increased by $0.3 million for the Parent with corresponding offsetting adjustment to the same items in the Consolidating Adjustments column.

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	5,152,816		$	2,562,781		$	(27,526	)	$	7,688,071
Less: Provision for doubtful accounts		0			411,538			315,133			0			726,671

Net Revenues		0			4,741,278			2,247,648			(27,526	)		6,961,400
Operating charges:
Salaries, wages and benefits		0			2,452,187			988,730			0			3,440,917
Other operating expenses		0			899,274			502,592			(25,744	)		1,376,122
Supplies expense		0			496,848			302,773			0			799,621
Depreciation and amortization		0			210,867			91,559			0			302,426
Lease and rental expense		0			59,596			37,071			(1,782	)		94,885
Transaction costs		0			5,716			0			0			5,716
EHR incentive income		0			(14,284	)		(15,754	)		0			(30,038	)
Costs related to extinguishment of debt		29,170			0			0			0			29,170

		29,170			4,110,204			1,906,971			(27,526	)		6,018,819

Income (loss) from operations		(29,170	)		631,074			340,677			0			942,581
Interest expense		172,467			3,749			2,702			0			178,918
Interest (income) expense, affiliate		0			93,363			(93,363	)		0			0
Equity in net income of consolidated affiliates		(567,906	)		(141,983	)		0			709,889			0

Income before income taxes		366,269			675,945			431,338			(709,889	)		763,663
Provision (benefit) for income taxes		(77,177	)		237,072			114,721			0			274,616

Net income		443,446			438,873			316,617			(709,889	)		489,047
Less: Income attributable to noncontrolling interests		0			0			45,601			0			45,601

Net income attributable to UHS	$	443,446		$	438,873		$	271,016		$	(709,889	)	$	443,446

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2011

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	4,917,358		$	2,465,916		$	(26,476	)	$	7,356,798
Less: Provision for doubtful accounts		0			340,121			256,455			0			596,576

Net revenues		0			4,577,237			2,209,461			(26,476	)		6,760,222
Operating charges:
Salaries, wages and benefits		0			2,371,961			954,417			0			3,326,378
Other operating expenses		200			923,579			454,601			(24,687	)		1,353,693
Supplies expense		0			499,200			306,289			0			805,489
Depreciation and amortization		0			207,981			79,230			0			287,211
Lease and rental expense		0			60,768			31,344			(1,789	)		90,323

		200			4,063,489			1,825,881			(26,476	)		5,863,094

Income (loss) from operations		(200	)		513,748			383,580			0			897,128
Interest expense		195,404			3,212			2,176			0			200,792
Interest (income) expense, affiliate		0			87,205			(87,205	)		0			0
Equity in net income of consolidated affiliates		(518,797	)		(157,009	)		0			675,806			0

Income before income taxes		323,193			580,340			468,609			(675,806	)		696,336
Provision (benefit) for income taxes		(74,974	)		198,091			124,349			0			247,466

Net income		398,167			382,249			344,260			(675,806	)		448,870
Less: Income attributable to noncontrolling interests		0			0			50,703			0			50,703

Net income attributable to UHS	$	398,167		$	382,249		$	293,557		$	(675,806	)	$	398,167

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2010

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	903		$	3,494,351		$	1,981,571		$	(47,592	)	$	5,429,233
Less: Provision for doubtful accounts		0			272,335			256,751			0			529,086

Net revenues		903			3,222,016			1,724,820			(47,592	)		4,900,147
Operating charges:
Salaries, wages and benefits		0			1,611,394			751,989			0			2,363,383
Other operating expenses		0			633,838			381,218			(46,444	)		968,612
Supplies expense		0			422,877			294,048			0			716,925
Depreciation and amortization		0			147,645			69,285			0			216,930
Lease and rental expense		0			48,872			27,639			(1,148	)		75,363
Transaction costs		0			53,220			0			0			53,220

		0			2,917,846			1,524,179			(47,592	)		4,394,433

Income from operations		903			304,170			200,641			0			505,714
Interest expense, net		70,283			6,729			605			0			77,617
Interest (income) expense, affiliate		0			60,876			(60,876	)		0			0
Equity in net income of consolidated affiliates		(271,944	)		(134,760	)		0			406,704			0

Income before income taxes		202,564			371,325			260,912			(406,704	)		428,097
Provision (benefit) for income taxes		(27,619	)		134,547			45,374			0			152,302

Net income		230,183			236,778			215,538			(406,704	)		275,795
Less: Income attributable to noncontrolling interests		0			0			45,612			0			45,612

Net income attributable to UHS	$	230,183		$	236,778		$	169,926		$	(406,704	)	$	230,183

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	443,446		$	438,873	$	316,617	$	(709,889	)	$	489,047
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		6,677			0		0		0			6,677
Amortization of terminated hedge		(336	)		0		0		0			(336	)
Minimum Pension Liability		0			4,986		0		0			4,986

Other comprehensive income before tax		6,341			4,986		0		0			11,327
Income tax expense related to items of other comprehensive income		2,408			1,898		0		0			4,306

Total other comprehensive income, net of tax		3,933			3,088		0		0			7,021

Comprehensive income		447,379			441,961		316,617		(709,889	)		496,068
Less: Comprehensive income attributable to noncontrolling interests		0			0		45,601		0			45,601

Comprehensive income attributable to UHS	$	447,379		$	441,961	$	271,016	$	(709,889	)	$	450,467

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2011

(amounts in thousands)


	Parent			Guarantors			Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	398,167		$	382,249		$	344,260	$	(675,806	)	$	448,870
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		(37,477	)		0			0		0			(37,477	)
Amortization of terminated hedge		(336	)		0			0		0			(336	)
Minimum Pension Liability		0			(12,397	)		0		0			(12,397	)

Other comprehensive income before tax		(37,813	)		(12,397	)		0		0			(50,210	)
Income tax expense related to items of other comprehensive income		(14,483	)		(4,691	)		0		0			(19,174	)

Total other comprehensive income, net of tax		(23,330	)		(7,706	)		0		0			(31,036	)

Comprehensive income		374,837			374,543			344,260		(675,806	)		417,834
Less: Comprehensive income attributable to noncontrolling interests		0			0			50,703		0			50,703

Comprehensive income attributable to UHS	$	374,837		$	374,543		$	293,557	$	(675,806	)	$	367,131

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2010

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	230,183		$	236,778	$	215,538	$	(406,704	)	$	275,795
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		1,396			0		0		0			1,396
Amortization of terminated hedge		(336	)		0		0		0			(336	)
Minimum Pension Liability		0			743		0		0			743

Other comprehensive income before tax		1,060			743		0		0			1,803
Income tax expense related to items of other comprehensive income		408			281		0		0			689

Total other comprehensive income, net of tax		652			462		0		0			1,114

Comprehensive income		230,835			237,240		215,538		(406,704	)		276,909
Less: Comprehensive income attributable to noncontrolling interests		0			0		45,612		0			45,612

Comprehensive income attributable to UHS	$	230,835		$	237,240	$	169,926	$	(406,704	)	$	231,297

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2012

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	11,949		$	11,522		$	0		$	23,471
Accounts receivable, net		7,154		741,983			318,060			0			1,067,197
Supplies		0		61,100			37,900			0			99,000
Deferred income taxes		61,364		43,555			322			(780	)		104,461
Other current assets		2,188		75,117			10,631			0			87,936
Current assets held for sale		0		0			25,431			0			25,431

Total current assets		70,706		933,704			403,866			(780	)		1,407,496

Investments in subsidiaries		5,781,479		1,323,832			0			(7,105,311	)		0
Intercompany receivable		644,105		0			360,538			(1,004,643	)		0
Intercompany note receivable		0		0			1,007,453			(1,007,453	)		0
Property and equipment		0		3,867,471			1,500,874			0			5,368,345
Less: accumulated depreciation		0		(1,288,975	)		(697,135	)		0			(1,986,110	)

		0		2,578,496			803,739			0			3,382,235

Other assets:
Goodwill		820		2,554,531			481,414			0			3,036,765
Deferred charges		67,831		5,839			2,218			0			75,888
Other		9,645		209,558			79,256			0			298,459

	$	6,574,586	$	7,605,960		$	3,138,484		$	(9,118,187	)	$	8,200,843

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	0		990			1,599			0		$	2,589
Accounts payable and accrued liabilities		10,985		740,484			138,088			0			889,557
Current liabilities held for sale		0		0			850			0			850
Federal and state taxes		0		900			620			(458	)		1,062

Total current liabilities		10,985		742,374			141,157			(458	)		894,058

Intercompany payable		0		1,004,643			0			(1,004,643	)		0
Other noncurrent liabilities		46,048		243,478			105,829			0			395,355
Long-term debt		3,676,940		5,372			45,119			0			3,727,431
Intercompany note payable		0		1,007,453			0			(1,007,453	)		0
Deferred income taxes		127,268		56,801			0			(322	)		183,747
Redeemable noncontrolling interests		0		0			234,303			0			234,303
UHS common stockholders’ equity		2,713,345		4,545,839			2,559,472			(7,105,311	)		2,713,345
Noncontrolling interest		0		0			52,604			0			52,604

Total equity		2,713,345		4,545,839			2,612,076			(7,105,311	)		2,765,949

	$	6,574,586	$	7,605,960		$	3,138,484		$	(9,118,187	)	$	8,200,843

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2011

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	33,221		$	8,008		$	0		$	41,229
Accounts receivable, net		8,891		663,593			297,318			0			969,802
Supplies		0		59,467			37,308			0			96,775
Deferred income taxes		67,189		41,755			322			(942	)		108,324
Other current assets		33,057		56,864			9,938			0			99,859
Current assets held for sale		0		48,916			0			0			48,916

Total current assets		109,137		903,816			352,894			(942	)		1,364,905

Investments in subsidiaries		5,213,573		1,181,849			0			(6,395,422	)		0
Intercompany receivable		669,112		0			20,375			(689,487	)		0
Intercompany note receivable		0		0			1,148,839			(1,148,839	)		0
Property and equipment		0		3,650,025			1,456,135			0			5,106,160
Less: accumulated depreciation		0		(1,184,283	)		(633,897	)		0			(1,818,180	)

		0		2,465,742			822,238			0			3,287,980

Other assets:
Goodwill		820		2,132,103			494,679			0			2,627,602
Deferred charges		103,434		5,972			2,374			0			111,780
Other		10,412		241,107			21,459			0			272,978

	$	6,106,488	$	6,930,589		$	2,862,858		$	(8,234,690	)	$	7,665,245

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	0	$	1,133		$	1,346		$	0		$	2,479
Accounts payable and accrued liabilities		14,201		616,026			201,898			0			832,125
Current liabilities held for sale		0		2,329			0			0			2,329
Federal and state taxes		0		0			620			(620	)		0

Total current liabilities		14,201		619,488			203,864			(620	)		836,933

Intercompany payable		0		689,487			0			(689,487	)		0
Other noncurrent liabilities		49,840		249,033			103,035			0			401,908
Long-term debt		3,594,182		3,616			53,630			0			3,651,428
Intercompany note payable		0		1,148,839			0			(1,148,839	)		0
Deferred income taxes		151,913		58,001			0			(322	)		209,592
Redeemable noncontrolling interests		0		0			218,266			0			218,266
UHS common stockholders’ equity		2,296,352		4,162,125			2,233,297			(6,395,422	)		2,296,352
Noncontrolling interest		0		0			50,766			0			50,766

Total equity		2,296,352		4,162,125			2,284,063			(6,395,422	)		2,347,118

	$	6,106,488	$	6,930,589		$	2,862,858		$	(8,234,690	)	$	7,665,245

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net cash provided by (used in) operating activities	$	(21,608	)	$	594,606		$	242,273		$	0		$	815,271

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(312,190	)		(51,002	)		0			(363,192	)
Acquisition of property and businesses		0			(513,596	)		(14,251	)		0			(527,847	)
Proceeds received from sale of assets and businesses		0			142,667			6,644			0			149,311
Costs incurred for purchase and development of electronic health records application		0			(54,362	)		0			0			(54,362	)
Return of Deposit on terminated purchase agreement		6,500			0			0			0			6,500

Net cash provided by (used in) investing activities		6,500			(737,481	)		(58,609	)		0			(789,590	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(843,002	)		0			(8,258	)		1,613			(849,647	)
Additional borrowings		913,500			1,613			0			(1,613	)		913,500
Financing costs		(8,283	)		0			0			0			(8,283	)
Repurchase of common shares		(19,154	)		0			0			0			(19,154	)
Dividends paid		(58,395	)		0			0			0			(58,395	)
Issuance of common stock		5,435			0			0			0			5,435
Profit distributions to noncontrolling interests		0			0			(26,895	)		0			(26,895	)
Changes in intercompany balances with affiliates, net		25,007			119,990			(144,997	)		0			0

Net cash provided by (used in) financing activities		15,108			121,603			(180,150	)		0			(43,439	)

Increase (decrease) in cash and cash equivalents		0			(21,272	)		3,514			0			(17,758	)
Cash and cash equivalents, beginning of period		0			33,221			8,008			0			41,229

Cash and cash equivalents, end of period	$	0		$	11,949		$	11,522		$	0		$	23,471

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2011

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net cash provided by (used in) operating activities	$	(4,990	)	$	518,462		$	204,779		$	0		$	718,251


Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(226,848	)		(58,834	)		0			(285,682	)
Acquisition of property and businesses		0			0			(29,466	)		0			(29,466	)
Proceeds received from sale of assets and businesses		0			0			67,592			0			67,592
Costs incurred for purchase and development of electronic health records application		0			(38,249	)		0			0			(38,249	)

Net cash used in investing activities		0			(265,097	)		(20,708	)		0			(285,805	)


Cash Flows from Financing Activities:
Reduction of long-term debt		(382,060	)		(1,442	)		0			1,985			(381,517	)
Additional borrowings		98,100			0			1,985			(1,985	)		98,100
Financing costs		(23,608	)		0			0			0			(23,608	)
Repurchase of common shares		(60,482	)		0			0			0			(60,482	)
Dividends paid		(19,466	)		0			0			0			(19,466	)
Issuance of common stock		4,779			0			0			0			4,779
Profit distributions to noncontrolling interests		0			0			(38,497	)		0			(38,497	)
Changes in intercompany balances with affiliates, net		387,727			(240,087	)		(147,640	)		0			0

Net cash provided by (used in) financing activities		4,990			(241,529	)		(184,152	)		0			(420,691	)

Increase (decrease) in cash and cash equivalents		0			11,836			(81	)		0			11,755
Cash and cash equivalents, beginning of period		0			21,385			8,089			0			29,474

Cash and cash equivalents, end of period	$	0		$	33,221		$	8,008		$	0		$	41,229

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2010

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by (used in) operating activities	$	(139,226	)	$	342,633		$	297,937		$	0	$	501,344

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(186,967	)		(52,307	)		0		(239,274	)
Acquisition of property and businesses		0			(1,958,904	)		606			0		(1,958,298	)
Proceeds received from sale of assets and businesses		0			21,460			0			0		21,460
Costs incurred for purchase and development of electronic health records application		0			(17,971	)		0			0		(17,971	)

Net cash used in investing activities		0			(2,142,382	)		(51,701	)		0		(2,194,083	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(1,388,679	)		(753	)		(2,654	)		0		(1,392,086	)
Additional borrowings		3,266,146			0			0			0		3,266,146
Financing costs		(101,815	)		0			0			0		(101,815	)
Repurchase of common shares		(11,528	)		0			0			0		(11,528	)
Dividends paid		(19,422	)		0			0			0		(19,422	)
Issuance of common stock		3,594			0			0			0		3,594
Profit distributions to noncontrolling interests		0			0			(32,456	)		0		(32,456	)
Proceeds from sale of noncontrolling interest in majority owned business		0			0			600			0		600
Changes in intercompany balances with affiliates, net		(1,609,070	)		1,816,520			(207,450	)		0		0

Net cash provided by (used in) by financing activities		139,226			1,815,767			(241,960	)		0		1,713,033

Increase (decrease) in cash and cash equivalents		0			16,018			4,276			0		20,294
Cash and cash equivalents, beginning of period		0			5,367			3,813			0		9,180

Cash and cash equivalents, end of period	$	0		$	21,385		$	8,089		$	0	$	29,474

- Definition

The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.

+ References + Details

SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS

12 Months Ended

Dec. 31, 2012

SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

(amounts in thousands)


Description	Balance at beginning of period		Charges to costs and expenses		Acquisitions of business		Write-off of uncollectible accounts			Balance at end of period
Allowance for doubtful accounts receivable:
Year ended December 31, 2012	$	253,405	$	726,671	$	5,632	$	(674,321	)	$	311,387

Year ended December 31, 2011	$	248,622	$	613,619	$	—	$	(608,836	)	$	253,405

Year ended December 31, 2010	$	168,876	$	546,909	$	56,596	$	(523,759	)	$	248,622

Included in the charges to costs and expenses are $17,043 in 2011 and $17,823 in 2010, related to facilities that were divested or recorded as held for sale during 2012.

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Dec. 31, 2012

Principles of Consolidation

Revenue Recognition

Provision for Doubtful Accounts

Concentration of Revenues

Charity Care and Uninsured Discounts:

Uncompensated care:


	(dollar amounts in thousands)
	2012					2011					2010
	Amount		%			Amount		%			Amount		%
Charity care	$	778,268		74	%	$	804,301		84	%	$	664,212		82	%
Uninsured discounts		267,304		26	%		151,447		16	%		142,467		18	%

Total uncompensated care	$	1,045,572		100	%	$	955,748		100	%	$	806,679		100	%

The estimated cost of providing uncompensated care:


	(amounts in thousands)
	2012		2011		2010
Estimated cost of providing charity care	$	131,890	$	145,350	$	129,820
Estimated cost of providing uninsured discounts related care		45,299		27,363		27,845

Estimated cost of providing uncompensated care	$	177,189	$	172,713	$	157,665

Accounting for Medicare and Medicaid Electronic Health Records Incentive Payments

Cash and Cash Equivalents

G) Cash and Cash Equivalents: We consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents.

Property and Equipment

Long-Lived Assets

Goodwill

Changes in the carrying amount of goodwill for the two years ended December 31, 2012 were as follows (in thousands):


	Acute Care Services			Behavioral Health Services			Total Consolidated
Balance, January 1, 2011	$	389,484		$	2,200,430		$	2,589,914
Adjustments to goodwill (a)		—			37,688			37,688

Balance, January 1, 2012		389,484			2,238,118			2,627,602
Goodwill acquired during the period		11,110			434,551			445,661
Goodwill divested during the period		(17,450	)		(1,902	)		(19,352	)
Adjustments to goodwill (b)		(448	)		(16,698	)		(17,146	)

Balance, December 31, 2012	$	382,696		$	2,654,069		$	3,036,765

(a)	Consists of adjustments to prior year purchase price allocations.

(b)

Other Assets

Physician Guarantees and Commitments

Self-Insured Risks

Income Taxes

See Note 6 for additional disclosure regarding income taxes.

Other Noncurrent Liabilities

Redeemable Noncontrolling Interests and Noncontrolling Interest

Comprehensive Income and Accumulated Other Comprehensive Income

The amounts recognized in AOCI for the two years ended December 31, 2012 were as follows (in thousands):


	Net Unrealized Gains (Losses) on Effective Cash Flow Hedges			Minimum Pension Liability			Total AOCI
Balance, January 1, 2011, net of income tax	$	(5,130	)	$	(15,009	)	$	(20,139	)
2011 activity:
Pre-tax amount		(37,813	)		(12,397	)		(50,210	)
Income tax effect		14,483			4,691			19,174

Change, net of income tax		(23,330	)		(7,706	)		(31,036	)

Balance, January 1, 2012, net of income tax		(28,460	)		(22,715	)		(51,175	)
2012 activity:
Pre-tax amount		6,341			4,986			11,327
Income tax effect		(2,408	)		(1,898	)		(4,306	)

Change, net of income tax		3,933			3,088			7,021

Balance, December 31, 2012, net of income tax	$	(24,527	)	$	(19,627	)	$	(44,154	)

Accounting for Derivative Financial Investments and Hedging Activities

Stock-Based Compensation

Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:


	Twelve Months Ended December 31,
	2012			2011			2010
Basic and diluted:
Net Income	$	489,047		$	448,870		$	275,795
Less: Net income attributable to noncontrolling interest		(45,601	)		(50,703	)		(45,612	)
Less: Net income attributable to unvested restricted share grants		(497	)		(521	)		(918	)

Net income attributable to UHS—basic and diluted	$	442,949		$	397,646		$	229,265

Basic earnings per share attributable to UHS:
Weighted average number of common shares—basic		96,821			97,199			96,786

Total basic earnings per share	$	4.57		$	4.09		$	2.37

Diluted earnings per share attributable to UHS:
Weighted average number of common shares		96,821			97,199			96,786
Net effect of dilutive stock options and grants based on the treasury stock method		890			1,338			1,187

Weighted average number of common shares and equivalents—diluted		97,711			98,537			97,973

Total diluted earnings per share	$	4.53		$	4.04		$	2.34

Fair Value of Financial Instruments

Use of Estimates

Mergers and Acquisitions

Accounting Standards

X) Accounting Standards:

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2012

Uncompensated Care


	(dollar amounts in thousands)
	2012					2011					2010
	Amount		%			Amount		%			Amount		%
Charity care	$	778,268		74	%	$	804,301		84	%	$	664,212		82	%
Uninsured discounts		267,304		26	%		151,447		16	%		142,467		18	%

Total uncompensated care	$	1,045,572		100	%	$	955,748		100	%	$	806,679		100	%

Estimated Cost of Providing Uncompensated Care


	(amounts in thousands)
	2012		2011		2010
Estimated cost of providing charity care	$	131,890	$	145,350	$	129,820
Estimated cost of providing uninsured discounts related care		45,299		27,363		27,845

Estimated cost of providing uncompensated care	$	177,189	$	172,713	$	157,665

Changes in Carrying Amount of Goodwill

Changes in the carrying amount of goodwill for the two years ended December 31, 2012 were as follows (in thousands):


	Acute Care Services			Behavioral Health Services			Total Consolidated
Balance, January 1, 2011	$	389,484		$	2,200,430		$	2,589,914
Adjustments to goodwill (a)		—			37,688			37,688

Balance, January 1, 2012		389,484			2,238,118			2,627,602
Goodwill acquired during the period		11,110			434,551			445,661
Goodwill divested during the period		(17,450	)		(1,902	)		(19,352	)
Adjustments to goodwill (b)		(448	)		(16,698	)		(17,146	)

Balance, December 31, 2012	$	382,696		$	2,654,069		$	3,036,765

(a)	Consists of adjustments to prior year purchase price allocations.

(b)

Amounts Recognized in AOCI

The amounts recognized in AOCI for the two years ended December 31, 2012 were as follows (in thousands):


	Net Unrealized Gains (Losses) on Effective Cash Flow Hedges			Minimum Pension Liability			Total AOCI
Balance, January 1, 2011, net of income tax	$	(5,130	)	$	(15,009	)	$	(20,139	)
2011 activity:
Pre-tax amount		(37,813	)		(12,397	)		(50,210	)
Income tax effect		14,483			4,691			19,174

Change, net of income tax		(23,330	)		(7,706	)		(31,036	)

Balance, January 1, 2012, net of income tax		(28,460	)		(22,715	)		(51,175	)
2012 activity:
Pre-tax amount		6,341			4,986			11,327
Income tax effect		(2,408	)		(1,898	)		(4,306	)

Change, net of income tax		3,933			3,088			7,021

Balance, December 31, 2012, net of income tax	$	(24,527	)	$	(19,627	)	$	(44,154	)

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:


	Twelve Months Ended December 31,
	2012			2011			2010
Basic and diluted:
Net Income	$	489,047		$	448,870		$	275,795
Less: Net income attributable to noncontrolling interest		(45,601	)		(50,703	)		(45,612	)
Less: Net income attributable to unvested restricted share grants		(497	)		(521	)		(918	)

Net income attributable to UHS—basic and diluted	$	442,949		$	397,646		$	229,265

Basic earnings per share attributable to UHS:
Weighted average number of common shares—basic		96,821			97,199			96,786

Total basic earnings per share	$	4.57		$	4.09		$	2.37

Diluted earnings per share attributable to UHS:
Weighted average number of common shares		96,821			97,199			96,786
Net effect of dilutive stock options and grants based on the treasury stock method		890			1,338			1,187

Weighted average number of common shares and equivalents—diluted		97,711			98,537			97,973

Total diluted earnings per share	$	4.53		$	4.04		$	2.34

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References + Details

ACQUISITIONS AND DIVESTITURES (Tables)

12 Months Ended

Dec. 31, 2012

Aggregate Net Purchase Price of Facilities Allocated to Assets and Liabilities Based on their Estimated Fair Values

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their estimated fair values as follows:


	Amount (000s)
Working capital, net	$	21,000
Property, plant & equipment		60,000
Goodwill		446,000
Other assets		9,000
Income tax assets, net of deferred tax liabilities		(1,000	)
Other liabilities		(7,000	)

Cash paid in 2012 for acquisitions	$	528,000

The aggregate net purchase price of the facilities was allocated to assets and liabilities based on their estimated fair values as follows:


	Amount (000s)
Working capital, net	$	60,000
Assets held for sale		67,000
Property, plant & equipment		932,000
Goodwill		1,921,000
Other assets		132,000
Income tax assets, net of deferred tax liabilities		(14,000	)
Debt		(1,082,000	)
Liabilities held for sale		(1,000	)
Redeemable noncontrolling interests		(5,000	)
Other liabilities		(52,000	)

Cash paid in 2010 for acquisitions	$	1,958,000

Results of Operations for Former PSI Facilities Reflected as Discontinued Operations


	Year Ended December 31,
	2012			2011			2010
Net revenues	$	95,226		$	159,218		$	126,218
Income from discontinued operations		(3,472	)		10,422			12,109
Gain on divestiture		26,419			442			0

Income from discontinued operations, before income tax expense		22,947			10,864			12,109
Income tax expense		(8,688	)		(4,113	)		(4,483	)

Income from discontinued operations, net of income tax expense	$	14,259		$	6,751		$	7,626

Net Purchase Price Allocation to Assets and Liabilities based on their Estimated Fair Value

The aggregate net cash expenditure related to the properties and/or businesses was allocated to assets and liabilities based on their estimated fair values as follows:


	Amount (000s)
Property, plant & equipment	$	35,000
Other assets/deposits		11,000
Debt		(17,000	)

Cash paid in 2011 for acquisitions and deposits	$	29,000

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References + Details

LONG-TERM DEBT (Tables)

12 Months Ended

Dec. 31, 2012

Long-Term Debt

A summary of long-term debt follows:


	December 31,
	2012			2011
	(amounts in thousands)
Long-term debt:
Notes payable and Mortgages payable (including obligations under capitalized leases of $8,267 in 2012 and 9,982 in 2011) and term loans with varying maturities through 2038; weighted average interest at 5.9% in 2012 and 6.1% in 2011 (see Note 7 regarding capitalized leases)	$	47,216		$	51,841
Revolving credit and on-demand credit facility		163,500			249,600
Term Loan A, net of unamortized discount of $4,612 in 2012 and $6,103 in 2011		983,438			1,017,647
Term Loan B, net of unamortized discount of $8,724 in 2012 and $19,500 in 2011		737,176			1,439,500
Term Loan A2		894,375			—
Revenue bonds, interest at floating rates of 0.2% at December 31, 2012 and 2011, with varying maturities through 2015		5,300			5,300
Accounts receivable securitization program		249,000			240,000
7.125% Senior Secured Notes due 2016, including unamortized net premium of $15 in 2012 and $19 in 2011		400,015			400,019
7.00% Senior Unsecured Notes due 2018		250,000			250,000

		3,730,020			3,653,907
Less-Amounts due within one year		(2,589	)		(2,479	)

	$	3,727,431		$	3,651,428

Aggregate Maturities

Aggregate maturities follow:


	(000s)
2013	$	2,589
2014		2,012
2015		68,588
2016		3,382,793
2017		1,262
Later		272,776

Total	$	3,730,020

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6584090&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5

+ Details

COMMON STOCK (Tables)

12 Months Ended

Dec. 31, 2012

The following schedule provides information related to our stock repurchase programs for each of the three years ended December 31, 2012:


	Total number of shares purchased as part of publicly announced programs		Total price paid for shares purchased as part of publicly announced programs (in thousands)		Total number of shares purchased related to stock-based compensation plans (a.)		Total price paid for shares purchased related to stock-based compensation plans (in thousands)		Aggregate number of shares purchased		Aggregate price paid for shares purchased (in thousands)		Maximum number of shares that may yet be purchased under the publicly announced program
Balance as of January 1, 2010														2,152,339
2010……		—		—		301,933	$	11,528		301,933	$	11,528		2,152,339
2011……		1,384,637	$	50,576		217,649	$	9,906		1,602,286	$	60,482		767,702
2012……		—		—		433,312	$	19,154		433,312	$	19,154		767,702

Total for three year period ended December 31, 2012		1,384,637	$	50,576		952,894	$	40,588		2,337,531	$	91,164

(a.)

Weighted-Average Assumptions Fair Value of Option Grants

The 2010 weighted-average assumptions were based upon seventeen option grants, the 2011 and 2012 weighted-average assumptions were each based upon eighteen option grants.


Year Ended December 31,	2012			2011			2010
Volatility		33	%		29	%		27	%
Interest rate		1	%		2	%		3	%
Expected life (years)		3.5			3.5			3.6
Forfeiture rate		10	%		9	%		10	%
Dividend yield		0.6	%		0.7	%		0.7	%

Stock Option Activity

The table below summarizes our stock option activity during each of the last three years:


Outstanding Options	Number of Shares			Average Option Price		Range (High-Low)
Balance, January 1, 2010		8,802,450		$	25.03	$	31.70 -$16.22
Granted		94,000		$	30.40	$	32.28 -$30.32
Exercised		(2,000,250	)	$	24.87	$	31.70 -$16.22
Cancelled		(301,250	)	$	24.91	$	31.18 -$16.22

Balance, January 1, 2011		6,594,950		$	25.16	$	32.28 -$16.22
Granted		2,894,500		$	43.66	$	54.79 -$38.12
Exercised		(1,563,255	)	$	26.38	$	32.28 -$16.22
Cancelled		(367,250	)	$	32.60	$	46.97 -$16.22

Balance, January 1, 2012		7,558,945		$	31.63	$	54.79 -$16.22
Granted		2,966,850		$	37.01	$	44.83 -$36.95
Exercised		(2,608,007	)	$	23.22	$	46.97 -$16.22
Cancelled		(481,550	)	$	38.00	$	46.97 -$16.22

Balance, December 31, 2012		7,436,238		$	36.31	$	54.79 -$16.22

Outstanding options vested and exercisable as of December 31, 2012		2,185,312		$	30.40	$	54.79 -$16.22

Information About Unvested Options

The following table provides information about unvested options for the year December 31, 2012:


	Shares			Weighted Average Grant Date Fair Value
Unvested options as of January 1, 2012		4,579,000		$	9.50
Granted		2,966,850		$	10.73
Vested		(1,845,249	)	$	7.75
Cancelled		(449,675	)	$	10.32

Unvested options as of December 31, 2012		5,250,926		$	10.74

Information About All Outstanding Options and Exercisable Options

The following table provides information about all outstanding options, and exercisable options, at December 31, 2012:


	Options Outstanding		Options Exercisable
Number		7,436,238		2,185,312
Weighted average exercise price	$	36.31	$	30.40
Aggregate intrinsic value as of December 31, 2012	$	89,595,385	$	39,256,370
Weighted average remaining contractual life		3.0		2.0

Weighted Average Remaining Contractual Life for Options Outstanding and Weighted Average Exercise Price Per Share for Exercisable Options

The weighted average remaining contractual life for options outstanding and weighted average exercise price per share for exercisable options at December 31, 2012 were as follows:


	Options Outstanding						Exercisable Options				Expected to Vest Options(a)
Exercise Price	Shares		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in Years)		Shares		Weighted Average Exercise Price Per Share		Shares		Weighted Average Exercise Price Per Share
$16.22 – $16.22		586,000	$	16.22		.9		586,000	$	16.22		N/A		N/A
$30.32 – $31.18		1,616,000		31.16		2.0		1,032,750		31.17		525,275		31.14
$36.95 – $43.46		2,797,050		37.03		2.9		11,250		39.09		2,508,891		37.02
$43.67 – $54.79		2,437,188		43.75		3.1		555,312		43.75		1,694,818		43.75

Total		7,436,238	$	36.31		3.0		2,185,312	$	30.40		4,728,984	$	38.78

(a)	Assumes a weighted average forfeiture rate of 9.94%.

INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2012

Components of Income Tax Expense (Benefit)

Components of income tax expense/(benefit) are as follows (amounts in thousands):


	Year Ended December 31,
	2012			2011		2010
Current
Federal	$	254,021		$	165,409	$	105,077
Foreign		9,084			300		2,555
State		39,076			22,901		16,547

		302,181			188,610		124,179
Deferred
Federal and foreign		(21,408	)		53,056		26,419
State		(6,157	)		5,800		1,704

		(27,565	)		58,856		28,123

Total	$	274,616		$	247,466	$	152,302

Components of Deferred Taxes

The components of deferred taxes are as follows (amounts in thousands):


	Year Ended December 31,
	2012			2011
Deferred income tax assets:
Self-insurance reserves	$	112,587		$	115,201
Compensation accruals		47,571			49,717
State and foreign net operating loss carryforwards and other state and foreign deferred tax assets		54,874			52,506
Other currently non-deductible accrued liabilities		29,934			19,699
Net pension liability—OCI only		12,061			13,959
Doubtful accounts and other reserves		17,562			17,345
Other combined items—OCI only		15,282			17,684

		289,871			286,111
Less: Valuation Allowance		(44,511	)		(42,143	)

Net deferred income tax assets:		245,360			243,968
Deferred income tax liabilities:
Depreciable and amortizable assets		(322,317	)		(342,655	)
Other deferred tax liabilities		(2,329	)		(2,581	)

Net deferred income tax liabilities	$	(79,286	)	$	(101,268	)

Effective Tax Rates Calculation


	2012			2011			2010
Provision for income taxes	$	274,616		$	247,466		$	152,302
Income before income taxes		763,663			696,336			428,097

Effective tax rate		36.0	%		35.5	%		35.6	%

Reconciliation Between Federal Statutory Rate and Effective Tax Rate

A reconciliation between the federal statutory rate and the effective tax rate is as follows:


	Year Ended December 31,
	2012			2011			2010
Federal statutory rate		35.0	%		35.0	%		35.0	%
State taxes, net of federal income tax benefit		3.0			2.9			3.1
Nondeductible transaction costs		0.2			—			1.3
Other items		0.1			0.4			0.4
Impact of income attributable to noncontrolling interests		(2.3	)		(2.8	)		(4.2	)

Effective tax rate		36.0	%		35.5	%		35.6	%

Net Deferred Tax Assets and Liabilities

The net deferred tax assets and liabilities are comprised as follows (amounts in thousands):


	Year Ended December 31,
	2012			2011
Current deferred taxes
Assets	$	105,639		$	109,297
Liabilities		(1,178	)		(973	)

Total deferred taxes-current		104,461			108,324

Noncurrent deferred taxes
Assets		142,065			135,189
Liabilities		(325,812	)		(344,781	)

Total deferred taxes-noncurrent		(183,747	)		(209,592	)

Total deferred tax liabilities	$	(79,286	)	$	(101,268	)

Reconciliation of Unrecognized Tax Benefits

The tabular reconciliation of unrecognized tax benefits for the years ended December 31, 2012, 2011 and 2010 is as follows (amounts in thousands).


	As of December 31,
	2012			2011			2010
Balance at January 1,	$	7,403		$	7,923		$	5,754
Additions based on tax positions related to the current year		200			750			1,219
Additions for tax positions of prior years		386			419			2,076
Reductions for tax positions of prior years		(1,165	)		(1,628	)		(907	)
Settlements		—			(61	)		(219	)

Balance at December 31,	$	6,824		$	7,403		$	7,923

- Definition

Tabular disclosure of tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities (i.e., uncertain tax positions) and other types of income tax contingencies, including: (1) the policy on classification of interest and penalties; (2) a tabular reconciliation of the total amounts of unrecognized tax benefits at the beginning and end of the period; the total amount(s) of: (3) unrecognized tax benefits that, if recognized, would affect the effective tax rate, and (4) interest and penalties recognized in each of the income statement and balance sheet; (5) for positions for which it is reasonably possible that the total amounts unrecognized will significantly change within 12 months of the reporting date the: (i) nature of the uncertainty, (ii) nature of the event that could occur that would cause the change, and (iii) an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made; and (6) a description of tax years that remain subject to examination by major tax jurisdictions.

+ References + Details

LEASE COMMITMENTS (Tables)

12 Months Ended

Dec. 31, 2012

Summary of Property Under Capital Lease

A summary of property under capital lease follows (amounts in thousands):


	As of December 31,
	2012			2011
Land, buildings and equipment	$	27,836		$	37,037
Less: accumulated amortization		(26,540	)		(35,264	)

	$	1,296		$	1,773

Future Minimum Rental Payments Under Lease Commitments

Future minimum rental payments under lease commitments with a term of more than one year as of December 31, 2012, are as follows (amounts in thousands):


Year	Capital Leases			Operating Leases
	(000s)
2013	$	2,162		$	58,638
2014		1,369			50,973
2015		1,158			43,496
2016		1,068			36,952
2017		1,077			21,906
Later years		5,117			102,722

Total minimum rental	$	11,951		$	314,687

Less: Amount representing interest		(3,684	)

Present value of minimum rental commitments		8,267
Less: Current portion of capital lease obligations		(1,585	)

Long-term portion of capital lease obligations	$	6,682

RELATIONSHIP WITH UNIVERSAL HEALTH REALTY INCOME TRUST AND RELATED PARTY TRANSACTIONS (Tables)

12 Months Ended

Dec. 31, 2012

Renewal Options and Terms for Each of Four Hospital Facilities Leased from Trust

The table below details the renewal options and terms for each of our four hospital facilities leased from the Trust, giving effect to the above-mentioned renewals:

Hospital Name

Type of Facility

Annual
Minimum
Rent

End of Lease Term

Renewal
Term
(years)

McAllen Medical Center

Acute Care

5,485,000

December, 2016

(a)

Wellington Regional Medical Center

Acute Care

3,030,000

December, 2016

(b)

Southwest Healthcare System, Inland Valley Campus

Acute Care

2,648,000

December, 2016

(b)

The Bridgeway

Behavioral Health

930,000

December, 2014

(c)

(a)	We have three 5-year renewal options at existing lease rates (through 2031).

(b)	We have one 5-year renewal options at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

(c)	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

- Definition

Tabular disclosure of a lessee's leasing arrangements including: (1) the basis on which contingent rental payments are determined, (2) the existence and terms of renewal or purchase options and escalation clauses, (3) restrictions imposed by lease arrangements, such as those concerning dividends, additional debt, and further leasing, (4) rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions. Disclosure may also include the specific period used to amortize material leasehold improvements made at the inception of the lease or during the lease term. Additionally, for operating leases having initial or remaining noncancelable lease terms in excess of one year: (a) future minimum rental payments required as of the date of the latest balance sheet presented, in the aggregate and for each of the five succeeding fiscal years, (b) the total of minimum rentals to be received in the future under noncancelable subleases as of the date of the latest balance sheet presented, and (c) for all operating leases, rental expense for each period for which an income statement is presented, with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included.

+ References + Details

PENSION PLAN (Tables)

12 Months Ended

Dec. 31, 2012

Reconciliation of Defined Benefit Pension Plan

The following table shows the reconciliation of the defined benefit pension plan as of December 31, 2012 and 2011:


	2012			2011
	(000s)
Change in plan assets:
Fair value of plan assets at beginning of year	$	87,940		$	73,402
Actual return (loss) on plan assets		13,824			5,689
Employer contributions		7,786			14,065
Benefits paid		(4,946	)		(4,541	)
Administrative expenses		(530	)		(675	)

Fair value of plan assets at end of year	$	104,074		$	87,940
Change in benefit obligation:
Benefit obligation at beginning of year	$	108,446		$	93,513
Service cost		1,144			1,162
Interest cost		4,659			5,047
Benefits paid		(4,946	)		(4,541	)
Actuarial (gain) loss		5,226			13,265

Benefit obligation at end of year	$	114,529		$	108,446
Amounts recognized in the Consolidated Balance Sheet:
Other noncurrent liabilities		10,455			20,506

Total liability at end of year	$	10,455		$	20,506

Additional year end information for Pension Plan
Projected benefit obligation	$	114,529		$	108,446
Accumulated benefit obligation		112,675			106,609
Fair value of plan assets		104,074			87,940

Component of Net Periodic Cost (Benefit)


	2012			2011			2010
	(000s)
Components of net periodic cost (benefit)
Service cost	$	1,144		$	1,162		$	1,140
Interest cost		4,659			5,047			4,958
Expected return on plan assets		(7,301	)		(6,566	)		(5,151	)
Recognized actuarial loss		4,219			2,427			2,538

Net periodic cost	$	2,721		$	2,070		$	3,485

Measurement Dates


	2012		2011
Measurement Dates
Benefit obligations		12/31/2012		12/31/2011
Fair value of plan assets		12/31/2012		12/31/2011

Weighted Average Assumptions


	2012			2011
Weighted average assumptions as of December 31
Discount rate		4.05	%		4.40	%
Rate of compensation increase		4.00	%		4.00	%

Weighted-average Assumptions for Net Periodic Benefit Cost


	2012			2011			2010
Weighted-average assumptions for net periodic benefit cost calculations
Discount rate		4.40	%		5.54	%		5.96	%
Expected long-term rate at return on plan assets		8.00	%		8.00	%		8.00	%
Rate of compensation increase		4.00	%		4.00	%		4.00	%

Market Values of Our Pension Plan Assets

The market values of our pension plan assets at December 31, 2012 and December 31, 2011 by asset category are as follows:


December 31, 2012	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	22,800	$	—	$	22,800	$	—
U.S. Mid Cap		1,566		—		1,566		—
U.S. Small-Mid Cap		7,738		—		7,738		—
U.S. Small Cap		1,583		—		1,583		—
International Developed		10,779		—		10,779		—
Emerging Markets		3,912		—		3,912		—
Fixed income:
Long Duration Fixed Income		51,355		—		51,355		—
Real Estate:
REIT Fund		3,904		—		3,904		—
Cash/Currency:
Cash Equivalents		437		—		437		—

Total market value	$	104,074	$	—	$	104,074	$	—


December 31, 2011	Total		Level 1		Level 2		Level 3
Equities:
U.S. Large Cap	$	18,921	$	—	$	18,921	$	—
U.S. Mid Cap		1,281		—		1,281		—
U.S. Small-Mid Cap		6,332		—		6,332		—
U.S. Small Cap		1,282		—		1,282		—
International Developed		8,692		—		8,692		—
Emerging Markets		3,123		—		3,123		—
Fixed income:
Long Duration Fixed Income		44,587		—		44,587		—
Real Estate:
REIT Fund		3,269		—		3,269		—
Cash/Currency:
Cash Equivalents		453		—		453		—

Total market value	$	87,940	$	—	$	87,940	$	—

Estimated Future Benefit

There will be benefit payments under this plan beyond 2022.


Estimated Future Benefit Payments (000s)
2013	$	5,451
2014		5,724
2015		5,692
2016		6,182
2017		6,379
2018-2022		34,251

Total	$	63,679

Plan Assets


	2012			2011
Plan Assets
Asset Category
Equity securities		47	%		45	%
Fixed income securities		49	%		50	%
Other		4	%		5	%

Total		100	%		100	%

Assset Allocation Policy and Ranges Established in accordance with Overall Risk and Return Objectives of Portfolio:

The following asset allocation policy and ranges have been established in accordance with the overall risk and return objectives of the portfolio:


	Policy			As of 12/31/12			Permitted Range
Total Equity		46	%		47	%		43-49	%
Total Fixed Income		50	%		49	%		45-55	%
Other		4	%		4	%		0-10	%

- Definition

Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e2439-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e2417-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e2410-114920

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=21916443&loc=d3e4179-114921

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 158
-Paragraph 4, 7, 16, 20, 21
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5, 6, 7
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

SEGMENT REPORTING (Tables)

12 Months Ended

Dec. 31, 2012

Segment Reporting


2012	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	12,406,567		$	5,764,370			—		$	18,170,937
Gross outpatient revenues	$	6,134,615		$	646,177		$	48,183		$	6,828,975
Total net revenues	$	3,461,416		$	3,460,141		$	39,843		$	6,961,400
Income (loss) before allocation of corporate overhead and income taxes	$	337,385		$	838,603		($	412,325	)	$	763,663
Allocation of corporate overhead	($	162,056	)	($	84,597	)	$	246,653		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	175,329		$	754,006		($	165,672	)	$	763,663
Total assets	$	2,984,169		$	4,979,965		$	236,709		$	8,200,843


2011	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	11,770,248		$	5,507,728			—		$	17,277,976
Gross outpatient revenues	$	5,431,146		$	606,876		$	53,240		$	6,091,262
Total net revenues	$	3,423,957		$	3,308,862		$	27,403		$	6,760,222
Income (loss) before allocation of corporate overhead and income taxes	$	352,931		$	729,142		($	385,737	)	$	696,336
Allocation of corporate overhead	($	131,225	)	($	62,710	)	$	193,935		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	221,706		$	666,432		($	191,802	)	$	696,336
Total assets	$	2,782,102		$	4,373,379		$	509,764		$	7,665,245


2010	Acute Care Hospital Services			Behavioral Health Services			Other			Total Consolidated
	(Dollar amounts in thousands)
Gross inpatient revenues	$	10,623,407		$	2,563,867			—		$	13,187,274
Gross outpatient revenues	$	4,596,317		$	350,192		$	49,245		$	4,995,754
Total net revenues	$	3,272,488		$	1,597,022		$	30,637		$	4,900,147
Income (loss) before allocation of corporate overhead and income taxes	$	352,334		$	353,046		($	277,283	)	$	428,097
Allocation of corporate overhead	($	128,588	)	($	43,362	)	$	171,950		$	0
Income (loss) after allocation of corporate overhead and before income taxes	$	223,746		$	309,684		($	105,333	)	$	428,097
Total assets	$	2,681,803		$	4,360,262		$	485,871		$	7,527,936

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details

QUARTERLY RESULTS (Tables)

12 Months Ended

Dec. 31, 2012

Summary of Quarterly Financial Data

The following tables summarize the quarterly financial data for the two years ended December 31, 2012 and 2011:


2012	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,793,036	$	1,723,084	$	1,680,353	$	1,764,927	$	6,961,400
Net income	$	142,570	$	117,444	$	81,373	$	147,660	$	489,047
Less: Net income attributable to noncontrolling interests	$	13,963	$	9,883	$	9,556	$	12,199	$	45,601

Net income attributable to UHS	$	128,607	$	107,561	$	71,817	$	135,461	$	443,446

Earnings per share attributable to UHS-Basic:

Total basic earnings per share	$	1.33	$	1.11	$	0.74	$	1.39	$	4.57

Earnings per share attributable to UHS-Diluted:

Total diluted earnings per share	$	1.31	$	1.10	$	0.73	$	1.39	$	4.53


2011	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Total
	(amounts in thousands, except per share amounts)
Net revenues	$	1,723,296	$	1,711,255	$	1,662,675	$	1,662,996	$	6,760,222
Net income	$	129,987	$	116,034	$	94,842	$	108,007	$	448,870
Less: Net income attributable to noncontrolling interests	$	15,794	$	12,385	$	9,788	$	12,736	$	50,703

Net income attributable to UHS	$	114,193	$	103,649	$	85,054	$	95,271	$	398,167

Earnings per share attributable to UHS-Basic:

Total basic earnings per share	$	1.17	$	1.06	$	0.87	$	0.99	$	4.09

Earnings per share attributable to UHS-Diluted:

Total diluted earnings per share	$	1.15	$	1.04	$	0.86	$	0.98	$	4.04

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Tables)

12 Months Ended

Dec. 31, 2012

Condensed Consolidating Statements of Income

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	5,152,816		$	2,562,781		$	(27,526	)	$	7,688,071
Less: Provision for doubtful accounts		0			411,538			315,133			0			726,671

Net Revenues		0			4,741,278			2,247,648			(27,526	)		6,961,400
Operating charges:
Salaries, wages and benefits		0			2,452,187			988,730			0			3,440,917
Other operating expenses		0			899,274			502,592			(25,744	)		1,376,122
Supplies expense		0			496,848			302,773			0			799,621
Depreciation and amortization		0			210,867			91,559			0			302,426
Lease and rental expense		0			59,596			37,071			(1,782	)		94,885
Transaction costs		0			5,716			0			0			5,716
EHR incentive income		0			(14,284	)		(15,754	)		0			(30,038	)
Costs related to extinguishment of debt		29,170			0			0			0			29,170

		29,170			4,110,204			1,906,971			(27,526	)		6,018,819

Income (loss) from operations		(29,170	)		631,074			340,677			0			942,581
Interest expense		172,467			3,749			2,702			0			178,918
Interest (income) expense, affiliate		0			93,363			(93,363	)		0			0
Equity in net income of consolidated affiliates		(567,906	)		(141,983	)		0			709,889			0

Income before income taxes		366,269			675,945			431,338			(709,889	)		763,663
Provision (benefit) for income taxes		(77,177	)		237,072			114,721			0			274,616

Net income		443,446			438,873			316,617			(709,889	)		489,047
Less: Income attributable to noncontrolling interests		0			0			45,601			0			45,601

Net income attributable to UHS	$	443,446		$	438,873		$	271,016		$	(709,889	)	$	443,446

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2011

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	0		$	4,917,358		$	2,465,916		$	(26,476	)	$	7,356,798
Less: Provision for doubtful accounts		0			340,121			256,455			0			596,576

Net revenues		0			4,577,237			2,209,461			(26,476	)		6,760,222
Operating charges:
Salaries, wages and benefits		0			2,371,961			954,417			0			3,326,378
Other operating expenses		200			923,579			454,601			(24,687	)		1,353,693
Supplies expense		0			499,200			306,289			0			805,489
Depreciation and amortization		0			207,981			79,230			0			287,211
Lease and rental expense		0			60,768			31,344			(1,789	)		90,323

		200			4,063,489			1,825,881			(26,476	)		5,863,094

Income (loss) from operations		(200	)		513,748			383,580			0			897,128
Interest expense		195,404			3,212			2,176			0			200,792
Interest (income) expense, affiliate		0			87,205			(87,205	)		0			0
Equity in net income of consolidated affiliates		(518,797	)		(157,009	)		0			675,806			0

Income before income taxes		323,193			580,340			468,609			(675,806	)		696,336
Provision (benefit) for income taxes		(74,974	)		198,091			124,349			0			247,466

Net income		398,167			382,249			344,260			(675,806	)		448,870
Less: Income attributable to noncontrolling interests		0			0			50,703			0			50,703

Net income attributable to UHS	$	398,167		$	382,249		$	293,557		$	(675,806	)	$	398,167

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2010

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net revenues before provision for doubtful accounts	$	903		$	3,494,351		$	1,981,571		$	(47,592	)	$	5,429,233
Less: Provision for doubtful accounts		0			272,335			256,751			0			529,086

Net revenues		903			3,222,016			1,724,820			(47,592	)		4,900,147
Operating charges:
Salaries, wages and benefits		0			1,611,394			751,989			0			2,363,383
Other operating expenses		0			633,838			381,218			(46,444	)		968,612
Supplies expense		0			422,877			294,048			0			716,925
Depreciation and amortization		0			147,645			69,285			0			216,930
Lease and rental expense		0			48,872			27,639			(1,148	)		75,363
Transaction costs		0			53,220			0			0			53,220

		0			2,917,846			1,524,179			(47,592	)		4,394,433

Income from operations		903			304,170			200,641			0			505,714
Interest expense, net		70,283			6,729			605			0			77,617
Interest (income) expense, affiliate		0			60,876			(60,876	)		0			0
Equity in net income of consolidated affiliates		(271,944	)		(134,760	)		0			406,704			0

Income before income taxes		202,564			371,325			260,912			(406,704	)		428,097
Provision (benefit) for income taxes		(27,619	)		134,547			45,374			0			152,302

Net income		230,183			236,778			215,538			(406,704	)		275,795
Less: Income attributable to noncontrolling interests		0			0			45,612			0			45,612

Net income attributable to UHS	$	230,183		$	236,778		$	169,926		$	(406,704	)	$	230,183

Condensed Consolidating Statements of Comprehensive Income

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	443,446		$	438,873	$	316,617	$	(709,889	)	$	489,047
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		6,677			0		0		0			6,677
Amortization of terminated hedge		(336	)		0		0		0			(336	)
Minimum Pension Liability		0			4,986		0		0			4,986

Other comprehensive income before tax		6,341			4,986		0		0			11,327
Income tax expense related to items of other comprehensive income		2,408			1,898		0		0			4,306

Total other comprehensive income, net of tax		3,933			3,088		0		0			7,021

Comprehensive income		447,379			441,961		316,617		(709,889	)		496,068
Less: Comprehensive income attributable to noncontrolling interests		0			0		45,601		0			45,601

Comprehensive income attributable to UHS	$	447,379		$	441,961	$	271,016	$	(709,889	)	$	450,467

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2011

(amounts in thousands)


	Parent			Guarantors			Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	398,167		$	382,249		$	344,260	$	(675,806	)	$	448,870
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		(37,477	)		0			0		0			(37,477	)
Amortization of terminated hedge		(336	)		0			0		0			(336	)
Minimum Pension Liability		0			(12,397	)		0		0			(12,397	)

Other comprehensive income before tax		(37,813	)		(12,397	)		0		0			(50,210	)
Income tax expense related to items of other comprehensive income		(14,483	)		(4,691	)		0		0			(19,174	)

Total other comprehensive income, net of tax		(23,330	)		(7,706	)		0		0			(31,036	)

Comprehensive income		374,837			374,543			344,260		(675,806	)		417,834
Less: Comprehensive income attributable to noncontrolling interests		0			0			50,703		0			50,703

Comprehensive income attributable to UHS	$	374,837		$	374,543		$	293,557	$	(675,806	)	$	367,131

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2010

(amounts in thousands)


	Parent			Guarantors		Non Guarantors		Consolidating Adjustments			Total Consolidated Amounts
Net income	$	230,183		$	236,778	$	215,538	$	(406,704	)	$	275,795
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges		1,396			0		0		0			1,396
Amortization of terminated hedge		(336	)		0		0		0			(336	)
Minimum Pension Liability		0			743		0		0			743

Other comprehensive income before tax		1,060			743		0		0			1,803
Income tax expense related to items of other comprehensive income		408			281		0		0			689

Total other comprehensive income, net of tax		652			462		0		0			1,114

Comprehensive income		230,835			237,240		215,538		(406,704	)		276,909
Less: Comprehensive income attributable to noncontrolling interests		0			0		45,612		0			45,612

Comprehensive income attributable to UHS	$	230,835		$	237,240	$	169,926	$	(406,704	)	$	231,297

Condensed Consolidating Balance Sheet

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2012

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	11,949		$	11,522		$	0		$	23,471
Accounts receivable, net		7,154		741,983			318,060			0			1,067,197
Supplies		0		61,100			37,900			0			99,000
Deferred income taxes		61,364		43,555			322			(780	)		104,461
Other current assets		2,188		75,117			10,631			0			87,936
Current assets held for sale		0		0			25,431			0			25,431

Total current assets		70,706		933,704			403,866			(780	)		1,407,496

Investments in subsidiaries		5,781,479		1,323,832			0			(7,105,311	)		0
Intercompany receivable		644,105		0			360,538			(1,004,643	)		0
Intercompany note receivable		0		0			1,007,453			(1,007,453	)		0
Property and equipment		0		3,867,471			1,500,874			0			5,368,345
Less: accumulated depreciation		0		(1,288,975	)		(697,135	)		0			(1,986,110	)

		0		2,578,496			803,739			0			3,382,235

Other assets:
Goodwill		820		2,554,531			481,414			0			3,036,765
Deferred charges		67,831		5,839			2,218			0			75,888
Other		9,645		209,558			79,256			0			298,459

	$	6,574,586	$	7,605,960		$	3,138,484		$	(9,118,187	)	$	8,200,843

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	0		990			1,599			0		$	2,589
Accounts payable and accrued liabilities		10,985		740,484			138,088			0			889,557
Current liabilities held for sale		0		0			850			0			850
Federal and state taxes		0		900			620			(458	)		1,062

Total current liabilities		10,985		742,374			141,157			(458	)		894,058

Intercompany payable		0		1,004,643			0			(1,004,643	)		0
Other noncurrent liabilities		46,048		243,478			105,829			0			395,355
Long-term debt		3,676,940		5,372			45,119			0			3,727,431
Intercompany note payable		0		1,007,453			0			(1,007,453	)		0
Deferred income taxes		127,268		56,801			0			(322	)		183,747
Redeemable noncontrolling interests		0		0			234,303			0			234,303
UHS common stockholders’ equity		2,713,345		4,545,839			2,559,472			(7,105,311	)		2,713,345
Noncontrolling interest		0		0			52,604			0			52,604

Total equity		2,713,345		4,545,839			2,612,076			(7,105,311	)		2,765,949

	$	6,574,586	$	7,605,960		$	3,138,484		$	(9,118,187	)	$	8,200,843

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

AS OF DECEMBER 31, 2011

(amounts in thousands)


	Parent		Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Assets
Current assets:
Cash and cash equivalents	$	0	$	33,221		$	8,008		$	0		$	41,229
Accounts receivable, net		8,891		663,593			297,318			0			969,802
Supplies		0		59,467			37,308			0			96,775
Deferred income taxes		67,189		41,755			322			(942	)		108,324
Other current assets		33,057		56,864			9,938			0			99,859
Current assets held for sale		0		48,916			0			0			48,916

Total current assets		109,137		903,816			352,894			(942	)		1,364,905

Investments in subsidiaries		5,213,573		1,181,849			0			(6,395,422	)		0
Intercompany receivable		669,112		0			20,375			(689,487	)		0
Intercompany note receivable		0		0			1,148,839			(1,148,839	)		0
Property and equipment		0		3,650,025			1,456,135			0			5,106,160
Less: accumulated depreciation		0		(1,184,283	)		(633,897	)		0			(1,818,180	)

		0		2,465,742			822,238			0			3,287,980

Other assets:
Goodwill		820		2,132,103			494,679			0			2,627,602
Deferred charges		103,434		5,972			2,374			0			111,780
Other		10,412		241,107			21,459			0			272,978

	$	6,106,488	$	6,930,589		$	2,862,858		$	(8,234,690	)	$	7,665,245

Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	0	$	1,133		$	1,346		$	0		$	2,479
Accounts payable and accrued liabilities		14,201		616,026			201,898			0			832,125
Current liabilities held for sale		0		2,329			0			0			2,329
Federal and state taxes		0		0			620			(620	)		0

Total current liabilities		14,201		619,488			203,864			(620	)		836,933

Intercompany payable		0		689,487			0			(689,487	)		0
Other noncurrent liabilities		49,840		249,033			103,035			0			401,908
Long-term debt		3,594,182		3,616			53,630			0			3,651,428
Intercompany note payable		0		1,148,839			0			(1,148,839	)		0
Deferred income taxes		151,913		58,001			0			(322	)		209,592
Redeemable noncontrolling interests		0		0			218,266			0			218,266
UHS common stockholders’ equity		2,296,352		4,162,125			2,233,297			(6,395,422	)		2,296,352
Noncontrolling interest		0		0			50,766			0			50,766

Total equity		2,296,352		4,162,125			2,284,063			(6,395,422	)		2,347,118

	$	6,106,488	$	6,930,589		$	2,862,858		$	(8,234,690	)	$	7,665,245

Condensed Consolidating Statements of Cash Flows

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net cash provided by (used in) operating activities	$	(21,608	)	$	594,606		$	242,273		$	0		$	815,271

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(312,190	)		(51,002	)		0			(363,192	)
Acquisition of property and businesses		0			(513,596	)		(14,251	)		0			(527,847	)
Proceeds received from sale of assets and businesses		0			142,667			6,644			0			149,311
Costs incurred for purchase and development of electronic health records application		0			(54,362	)		0			0			(54,362	)
Return of Deposit on terminated purchase agreement		6,500			0			0			0			6,500

Net cash provided by (used in) investing activities		6,500			(737,481	)		(58,609	)		0			(789,590	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(843,002	)		0			(8,258	)		1,613			(849,647	)
Additional borrowings		913,500			1,613			0			(1,613	)		913,500
Financing costs		(8,283	)		0			0			0			(8,283	)
Repurchase of common shares		(19,154	)		0			0			0			(19,154	)
Dividends paid		(58,395	)		0			0			0			(58,395	)
Issuance of common stock		5,435			0			0			0			5,435
Profit distributions to noncontrolling interests		0			0			(26,895	)		0			(26,895	)
Changes in intercompany balances with affiliates, net		25,007			119,990			(144,997	)		0			0

Net cash provided by (used in) financing activities		15,108			121,603			(180,150	)		0			(43,439	)

Increase (decrease) in cash and cash equivalents		0			(21,272	)		3,514			0			(17,758	)
Cash and cash equivalents, beginning of period		0			33,221			8,008			0			41,229

Cash and cash equivalents, end of period	$	0		$	11,949		$	11,522		$	0		$	23,471

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2011

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments			Total Consolidated Amounts
Net cash provided by (used in) operating activities	$	(4,990	)	$	518,462		$	204,779		$	0		$	718,251


Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(226,848	)		(58,834	)		0			(285,682	)
Acquisition of property and businesses		0			0			(29,466	)		0			(29,466	)
Proceeds received from sale of assets and businesses		0			0			67,592			0			67,592
Costs incurred for purchase and development of electronic health records application		0			(38,249	)		0			0			(38,249	)

Net cash used in investing activities		0			(265,097	)		(20,708	)		0			(285,805	)


Cash Flows from Financing Activities:
Reduction of long-term debt		(382,060	)		(1,442	)		0			1,985			(381,517	)
Additional borrowings		98,100			0			1,985			(1,985	)		98,100
Financing costs		(23,608	)		0			0			0			(23,608	)
Repurchase of common shares		(60,482	)		0			0			0			(60,482	)
Dividends paid		(19,466	)		0			0			0			(19,466	)
Issuance of common stock		4,779			0			0			0			4,779
Profit distributions to noncontrolling interests		0			0			(38,497	)		0			(38,497	)
Changes in intercompany balances with affiliates, net		387,727			(240,087	)		(147,640	)		0			0

Net cash provided by (used in) financing activities		4,990			(241,529	)		(184,152	)		0			(420,691	)

Increase (decrease) in cash and cash equivalents		0			11,836			(81	)		0			11,755
Cash and cash equivalents, beginning of period		0			21,385			8,089			0			29,474

Cash and cash equivalents, end of period	$	0		$	33,221		$	8,008		$	0		$	41,229

UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2010

(amounts in thousands)


	Parent			Guarantors			Non Guarantors			Consolidating Adjustments		Total Consolidated Amounts
Net cash provided by (used in) operating activities	$	(139,226	)	$	342,633		$	297,937		$	0	$	501,344

Cash Flows from Investing Activities:
Property and equipment additions, net of disposals		0			(186,967	)		(52,307	)		0		(239,274	)
Acquisition of property and businesses		0			(1,958,904	)		606			0		(1,958,298	)
Proceeds received from sale of assets and businesses		0			21,460			0			0		21,460
Costs incurred for purchase and development of electronic health records application		0			(17,971	)		0			0		(17,971	)

Net cash used in investing activities		0			(2,142,382	)		(51,701	)		0		(2,194,083	)

Cash Flows from Financing Activities:
Reduction of long-term debt		(1,388,679	)		(753	)		(2,654	)		0		(1,392,086	)
Additional borrowings		3,266,146			0			0			0		3,266,146
Financing costs		(101,815	)		0			0			0		(101,815	)
Repurchase of common shares		(11,528	)		0			0			0		(11,528	)
Dividends paid		(19,422	)		0			0			0		(19,422	)
Issuance of common stock		3,594			0			0			0		3,594
Profit distributions to noncontrolling interests		0			0			(32,456	)		0		(32,456	)
Proceeds from sale of noncontrolling interest in majority owned business		0			0			600			0		600
Changes in intercompany balances with affiliates, net		(1,609,070	)		1,816,520			(207,450	)		0		0

Net cash provided by (used in) by financing activities		139,226			1,815,767			(241,960	)		0		1,713,033

Increase (decrease) in cash and cash equivalents		0			16,018			4,276			0		20,294
Cash and cash equivalents, beginning of period		0			5,367			3,813			0		9,180

Cash and cash equivalents, end of period	$	0		$	21,385		$	8,089		$	0	$	29,474

Business and Summary of Significant Accounting Policies - Additional Information (Detail) shares in Thousands	12 Months Ended
	Dec. 31, 2012 USD ($) Facility d shares	Dec. 31, 2011 USD ($) shares	Dec. 31, 2010 USD ($) shares
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of uninsured discount extended for unqualified charity patients	30.00%
Establishment of partial reserve in the allowance for doubtful accounts for self-pay balances outstanding from the date of discharge, in days \| d	90
Establishment of fully reserve for self-pay balances outstanding from the date of discharge, in days \| d	90
Establishment of fully reserve in the allowance for doubtful accounts for third party liability accounts from the date of discharge, in days \| d	180
Net of allowance for doubtful accounts	$ 311,000,000	$ 253,000,000
Patients treated at hospitals for non elective services gross income less than federal poverty guidelines	400.00%
Capitalize interest expense	$ 5,700,000	400,000	$ 7,600,000
Depreciation expense	270,500,000	262,100,000	197,300,000
Other intangible assets, net of accumulated amortization	99,000,000	97,000,000
Amount of estimated future payments related to physician-related contractual commitments	3,000,000	7,000,000
Amount of potential future financial obligations	$ 3,000,000
Acute care facilities with outside owners holding non-controlling minority interest \| Facility	5
Redeemable non-controlling interest balances	$ 234,000,000	218,000,000
Non-controlling interest balances	53,000,000	51,000,000
Net excess tax benefits generated	$ 0	$ 0	$ 0
Anti-dilutive weighted average stock options excluded from computation of earnings per share \| shares	2,000	1,400	1
Building Improvements \| Minimum
Summary Of Business And Significant Accounting Policies [Line Items]
Property and equipment, useful lives, maximum years	20 years
Building Improvements \| Maximum
Summary Of Business And Significant Accounting Policies [Line Items]
Property and equipment, useful lives, maximum years	40 years
Equipment \| Minimum
Summary Of Business And Significant Accounting Policies [Line Items]
Property and equipment, useful lives, maximum years	3 years
Equipment \| Maximum
Summary Of Business And Significant Accounting Policies [Line Items]
Property and equipment, useful lives, maximum years	15 years
Medicare And Medicaid
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of revenue	39.00%	41.00%	42.00%
Care Entities
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of revenue	49.00%	47.00%	51.00%
Illinois
Summary Of Business And Significant Accounting Policies [Line Items]
Accounts receivable	$ 70,000,000	$ 54,000,000
Receivables due outstanding in excess of 60 days	$ 51,000,000	$ 41,000,000
Receivables days in excess \| d	60
Las Vegas, Nevada
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of revenue	14.00%	15.00%	20.00%
Las Vegas, Nevada \| Acute Care Facilities
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of non-controlling, minority ownership interests held by outside owners	28.00%
Mcallen Edinburg Texas
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of revenue	4.00%	5.00%	6.00%
Washington, D.C. \| Acute Care Facilities
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of non-controlling, minority ownership interests held by outside owners	20.00%
Laredo, Texas \| Acute Care Facilities
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of non-controlling, minority ownership interests held by outside owners	11.00%
Philadelphia, Pennsylvania \| Behavioral Health Care Facility
Summary Of Business And Significant Accounting Policies [Line Items]
Percentage of non-controlling, minority ownership interests held by outside owners	20.00%

Uncompensated Care (Detail) - USD ($) $ in Thousands	12 Months Ended
Uncompensated Care (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Health Care Trust Fund [Line Items]
Uncompensated care	$ 1,045,572	$ 955,748	$ 806,679
Uncompensated care, percentage	100.00%	100.00%	100.00%
Charity Care
Health Care Trust Fund [Line Items]
Uncompensated care	$ 778,268	$ 804,301	$ 664,212
Uncompensated care, percentage	74.00%	84.00%	82.00%
Uninsured Discounts
Health Care Trust Fund [Line Items]
Uncompensated care	$ 267,304	$ 151,447	$ 142,467
Uncompensated care, percentage	26.00%	16.00%	18.00%

Estimated Cost of Providing Uncompensated Care (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Health Care Trust Fund [Line Items]
Estimated cost of providing uncompensated care	$ 177,189	$ 172,713	$ 157,665
Charity Care
Health Care Trust Fund [Line Items]
Estimated cost of providing uncompensated care	131,890	145,350	129,820
Uninsured Discounts
Health Care Trust Fund [Line Items]
Estimated cost of providing uncompensated care	$ 45,299	$ 27,363	$ 27,845

Summary of Changes in Carrying Amount of Goodwill (Detail) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Goodwill [Line Items]

Goodwill, Beginning Balance

$ 2,627,602

$ 2,589,914

Goodwill acquired during the period

445,661

Goodwill divested during the period

(19,352)

Adjustments to goodwill

(17,146)

^[1]

37,688

^[2]

Goodwill, Ending Balance

3,036,765

2,627,602

Acute Care Services

Goodwill [Line Items]

Goodwill, Beginning Balance

389,484

Goodwill acquired during the period

11,110

Goodwill divested during the period

(17,450)

Adjustments to goodwill

^[1]

(448)

Goodwill, Ending Balance

382,696

389,484

Behavioral Health Services

Goodwill [Line Items]

Goodwill, Beginning Balance

2,238,118

2,200,430

Goodwill acquired during the period

434,551

Goodwill divested during the period

(1,902)

Adjustments to goodwill

(16,698)

^[1]

37,688

^[2]

Goodwill, Ending Balance

$ 2,654,069

$ 2,238,118

[1]

The reduction to the Behavioral Health Services' goodwill consists primarily of a reclassification to "assets of facilities held for sale" and represents the goodwill attributable to Peak Behavioral Health Services which we agreed to divest pursuant to our agreement with the Federal Trade Commission in connection with our acquisition of Ascend Health Corporation in October, 2012. Adjustments to prior year purchase price allocations for Acute Care and Behavioral Health Services are also included.

[2]

Consists of adjustments to prior year purchase price allocations.

- Definition

Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 72
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-Clause 1
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph l
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Amounts Recognized in AOCI (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Schedule of Accumulated Other Comprehensive Income (Loss) [Line Items]
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, beginning balance	$ (28,460)	$ (5,130)
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, Pre tax amount	6,677	(37,477)	$ 1,396
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, Income tax effect	(2,408)	14,483
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, Change, net of income tax	3,933	(23,330)
Net Unrealized Gains (Losses) on Effective Cash Flow Hedges, ending balance	(24,527)	(28,460)	(5,130)
Minimum Pension Liability, beginning balance	(22,715)	(15,009)
Minimum Pension Liability, Pre tax amount	4,986	(12,397)
Minimum pension liability, income tax effect	1,898	4,691	281
Minimum Pension Liability, Change, net of income tax	3,088	(7,706)
Minimum Pension Liability, ending balance	(19,627)	(22,715)	(15,009)
Total AOCI, beginning balance	(51,175)	(20,139)
Total AOCI, Pre tax amount	11,327	(50,210)	1,803
Total AOCI, Income tax effect	(4,306)	19,174	(689)
Total AOCI, Change, net of income tax	7,021	(31,036)	1,114
Total AOCI, ending balance	$ (44,154)	$ (51,175)	$ (20,139)

Computation of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Basic and diluted:
Net Income									$ 489,047	$ 448,870	$ 275,795
Less: Net income attributable to noncontrolling interest									(45,601)	(50,703)	(45,612)
Less: Net income attributable to unvested restricted share grants									(497)	(521)	(918)
Net income attributable to UHS-basic and diluted									$ 442,949	$ 397,646	$ 229,265
Weighted average number of common shares-basic									96,821	97,199	96,786
Total basic earnings per share	$ 1.39	$ 0.74	$ 1.11	$ 1.33	$ 0.99	$ 0.87	$ 1.06	$ 1.17	$ 4.57	$ 4.09	$ 2.37
Weighted average number of common shares-basic									96,821	97,199	96,786
Net effect of dilutive stock options and grants based on the treasury stock method									890	1,338	1,187
Weighted average number of common shares and equivalents-diluted									97,711	98,537	97,973
Total diluted earnings per share	$ 1.39	$ 0.73	$ 1.10	$ 1.31	$ 0.98	$ 0.86	$ 1.04	$ 1.15	$ 4.53	$ 4.04	$ 2.34

Acquisitions and Divestitures - Additional Information (Detail) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2010 USD ($)	Dec. 31, 2012 USD ($) Bed Facility	Dec. 31, 2012 USD ($) Bed Facility $ / shares	Dec. 31, 2011 USD ($) Bed $ / shares	Dec. 31, 2010 USD ($) $ / shares	Jan. 31, 2012 Bed	Jul. 31, 2011 Bed	Nov. 15, 2010 USD ($)
Business Acquisition [Line Items]
Aggregate pre-tax net gain on the divestiture			$ 26,419	$ 442	$ 0
Psychiatric Solutions Inc
Business Acquisition [Line Items]
Pro forma net revenues					7,300,000
Pro forma net income attributable to UHS					$ 342,000
Pro forma net income attributable to UHS per diluted share \| $ / shares					$ 3.47
Net revenues	$ 227,000
Meadow Wood Behavioral Health System
Business Acquisition [Line Items]
Number of beds included in divestiture \| Bed							58
Monte Vista
Business Acquisition [Line Items]
Number of beds included in divestiture \| Bed				101
Red Rock Hospital
Business Acquisition [Line Items]
Number of beds included in divestiture \| Bed				21
Hospital San Juan Capestrano
Business Acquisition [Line Items]
Number of beds included in divestiture \| Bed						108
Auburn Regional Medical Center
Business Acquisition [Line Items]
Aggregate pre-tax net gain on the divestiture			26,000
2012 Divestiture of Assets and Businesses
Business Acquisition [Line Items]
Net cash proceeds from divestiture of assets and businesses			149,000
2012 Divestiture of Assets and Businesses \| Peak Behavioral Health Services
Business Acquisition [Line Items]
Net revenues			$ 18,000	$ 14,000
Number of beds \| Bed		104	104
2012 Divestiture of Assets and Businesses \| Hospital San Juan Capestrano
Business Acquisition [Line Items]
Net cash proceeds from divestiture of assets and businesses			$ 50,000
2012 Divestiture of Assets and Businesses \| Auburn Regional Medical Center
Business Acquisition [Line Items]
Net cash proceeds from divestiture of assets and businesses			$ 93,000
Number of acute care hospital beds included in acquisition \| Bed			159
2012 Divestiture of Assets and Businesses \| Behavioral Health Care Facility
Business Acquisition [Line Items]
Net cash proceeds from divestiture of assets and businesses			$ 6,000
Number of non-operating behavioral health facilities \| Facility		2	2
Two Thousand Eleven Divestiture of Assets and Businesses
Business Acquisition [Line Items]
Net cash proceeds from divestiture of assets and businesses				68,000
2010 Divestiture of Assets and Businesses
Business Acquisition [Line Items]
Net cash proceeds from divestiture of assets and businesses					$ 21,000
2012 Acquisitions of Assets and Businesses
Business Acquisition [Line Items]
Acquisition, cash paid		$ 528,000	$ 528,000
Pro forma net revenues			7,110,000	6,900,000
Pro forma net income attributable to UHS			$ 464,000	$ 401,000
Pro forma net income attributable to UHS per diluted share \| $ / shares			$ 4.74	$ 4.06
Transaction costs incurred				$ 5,000
Transaction costs incurred, per diluted share \| $ / shares				$ 0.06
Net revenues		42,000
2012 Acquisitions of Assets and Businesses \| Ascend Health Corporation
Business Acquisition [Line Items]
Acquisition, cash paid		503,000	$ 503,000
2012 Acquisitions of Assets and Businesses \| Physician Practices and Various Real Property
Business Acquisition [Line Items]
Acquisition, cash paid		$ 25,000	$ 25,000
2011 Acquisitions of Assets and Businesses
Business Acquisition [Line Items]
Acquisition, cash paid				$ 29,000
Debt assumed on the acquisition of businesses and real property				$ 17,000
2010 Acquisitions of Assets and Businesses
Business Acquisition [Line Items]
Acquisition, cash paid	1,958,000				1,958,000
Debt assumed on the acquisition of businesses and real property	1,082,000				1,082,000
2010 Acquisitions of Assets and Businesses \| Psychiatric Solutions Inc
Business Acquisition [Line Items]
Acquisition, cash paid	1,958,000				1,958,000			$ 1,960,000
Debt assumed on the acquisition of businesses and real property	$ 1,082,000				$ 1,082,000			1,080,000
Acquisition, total purchase price								$ 3,040,000
Previously held minority ownership interest, percentage	20.00%				20.00%

Net Purchase Price of Facilities' Assets and Liabilities on their Estimated Fair Value (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Nov. 15, 2010
Business Acquisition [Line Items]
Liabilities held for sale	$ (850)	$ (2,329)
Redeemable noncontrolling interests	(234,000)	$ (218,000)
2010 Acquisitions of Assets and Businesses
Business Acquisition [Line Items]
Debt			$ (1,082,000)
Cash paid for acquisitions and deposits			1,958,000
2010 Acquisitions of Assets and Businesses \| Psychiatric Solutions Inc
Business Acquisition [Line Items]
Working capital, net			60,000
Assets held for sale			67,000
Property, plant & equipment			932,000
Goodwill			1,921,000
Other assets			132,000
Income tax assets, net of deferred tax liabilities			(14,000)
Debt			(1,082,000)	$ (1,080,000)
Liabilities held for sale			(1,000)
Redeemable noncontrolling interests			(5,000)
Other liabilities			(52,000)
Cash paid for acquisitions and deposits			$ 1,958,000	$ 1,960,000
2012 Acquisitions of Assets and Businesses
Business Acquisition [Line Items]
Working capital, net	21,000
Property, plant & equipment	60,000
Goodwill	446,000
Other assets	9,000
Income tax assets, net of deferred tax liabilities	(1,000)
Other liabilities	(7,000)
Cash paid for acquisitions and deposits	$ 528,000

Results of Operations for Former PSI Facilities Reflected as Discontinued Operations (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Acquisitions And Discontinued Operations [Line Items]
Net revenues	$ 95,226	$ 159,218	$ 126,218
Income from discontinued operations	(3,472)	10,422	12,109
Gain on divestiture	26,419	442	0
Income from discontinued operations, before income tax expense	22,947	10,864	12,109
Income tax expense	(8,688)	(4,113)	(4,483)
Income from discontinued operations, net of income tax expense	$ 14,259	$ 6,751	$ 7,626

- Definition

Overall income (loss) from a disposal group that is classified as a component of the entity, before income tax, reported as a separate component of income before extraordinary items. Includes the following (before income tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References + Details

- Definition

Tax effect allocated to a disposal group that is classified as a component of the entity reported as a separate component of income before extraordinary items. Includes the tax effects of the following: income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b),(c)
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32672-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=18498875&loc=d3e38679-109324

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 47
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 46
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

Amount of income (loss) from a disposal group, net of income tax before extraordinary items allocable to noncontrolling interests. Includes, net of tax, income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.12)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.14)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 13
-Article 7

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 29
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 47
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 15
-Article 5

+ Details

Net Purchase Price Allocation to Assets and Liabilities based on their Estimated Fair Value (Detail) - 2011 Acquisitions of Assets and Businesses $ in Thousands	Dec. 31, 2011 USD ($)
Business Acquisition [Line Items]
Property, plant & equipment	$ 35,000
Other assets/deposits	11,000
Debt	(17,000)
Cash paid for acquisitions and deposits	$ 29,000

Financial Instruments - Additional Information (Detail)	3 Months Ended
Financial Instruments - Additional Information (Detail)	Mar. 31, 2011 USD ($) Derivative	Dec. 31, 2010 USD ($)	Dec. 31, 2007 USD ($)	Dec. 31, 2012 USD ($)	Dec. 31, 2011 USD ($)
Derivative [Line Items]
Number of interest rate swaps			2
Fair value of our interest rate swaps, liability				$ 41,000,000	$ 48,000,000
Other Current Liabilities
Derivative [Line Items]
Fair value of our interest rate swaps, liability					4,000,000
Other Noncurrent Liabilities
Derivative [Line Items]
Fair value of our interest rate swaps, liability					$ 44,000,000
Interest Rate Cap
Derivative [Line Items]
Total notional amount of interest rate cash flow hedges	$ 275,000,000	$ 1,000,000,000
Premium paid on interest rate cap	$ 30,000	$ 240,000
Interest rate percentage above which counter party agrees to pay the difference	2.25%	2.25%
Maturity date of interest rate cash flow hedges	Dec. 01, 2011	Dec. 01, 2011
Number of interest rate swaps		3
Forward Starting Interest Rate Cap From December Two Thousand Eleven To December Two Thousand Twelve
Derivative [Line Items]
Total notional amount of interest rate cash flow hedges	$ 450,000,000
Forward Starting Interest Rate Cap From December Two Thousand Twelve To December Two Thousand Thirteen
Derivative [Line Items]
Total notional amount of interest rate cash flow hedges	400,000,000
Forward Starting Interest Rate Cap
Derivative [Line Items]
Premium paid on interest rate cap	$ 740,000
Interest rate percentage above which counter party agrees to pay the difference	7.00%
Forward Starting Interest Rate Swaps
Derivative [Line Items]
Total notional amount of interest rate cash flow hedges	$ 425,000,000
Number of additional forward starting interest rate swaps \| Derivative	6
One Point Nine One Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Total notional amount of interest rate cash flow hedges	$ 225,000,000
Fixed rate payable on interest rate swap	1.91%
Two Point Five Zero Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Total notional amount of interest rate cash flow hedges	$ 100,000,000
Maturity date of interest rate cash flow hedges	Dec. 01, 2014
Fixed rate payable on interest rate swap	2.50%
One Point Nine Six Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Total notional amount of interest rate cash flow hedges	$ 25,000,000
Maturity date of interest rate cash flow hedges	Dec. 01, 2013
Fixed rate payable on interest rate swap	1.96%
One Point Three Two Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Total notional amount of interest rate cash flow hedges	$ 75,000,000
Maturity date of interest rate cash flow hedges	Dec. 01, 2012
Fixed rate payable on interest rate swap	1.32%
Interest Rate Swap
Derivative [Line Items]
Total notional amount of interest rate cash flow hedges			$ 150,000,000
Number of interest rate swaps		4
Two Point Three Eight Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Total notional amount of interest rate cash flow hedges		$ 600,000,000
Maturity date of interest rate cash flow hedges		May 01, 2015
Fixed rate payable on interest rate swap		2.38%
Four Point Seven Six Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Total notional amount of interest rate cash flow hedges			$ 75,000,000
Maturity date of interest rate cash flow hedges			Oct. 01, 2012
Fixed rate payable on interest rate swap			4.76%
Reduction in the notional amount of interest rate swap			$ 50,000,000
Four Point Eight Seven Percent Forward Starting Interest Rate Swaps
Derivative [Line Items]
Maturity date of interest rate cash flow hedges			Oct. 01, 2011
Fixed rate payable on interest rate swap			4.87%

Summary of Long-Term Debt (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Sep. 21, 2012	Dec. 31, 2011
Debt Instrument [Line Items]
Line of credit facility amount outstanding		$ 3,430,000
Accounts receivable securitization program	$ 249,000
Long-term debt	3,730,020		$ 3,653,907
Less-Amounts due within one year	(2,589)		(2,479)
Long-term debt, net	3,727,431		3,651,428
Notes Payable And Mortgages Payable
Debt Instrument [Line Items]
Notes payable and Mortgages payable (including obligations under capitalized leases of $8,267 in 2012 and 9,982 in 2011) and term loans with varying maturities through 2038; weighted average interest at 5.9% in 2012 and 6.1% in 2011 (see Note 7 regarding capitalized leases)	47,216		51,841
Revolving Credit And Demand Notes
Debt Instrument [Line Items]
Line of credit facility amount outstanding	163,500		249,600
Term Loan A
Debt Instrument [Line Items]
Line of credit facility amount outstanding	983,438	988,000	1,017,647
Less-Amounts due within one year	(72,000)
Term Loan B Facility
Debt Instrument [Line Items]
Line of credit facility amount outstanding	737,176	746,000	1,439,500
Term Loan- A2
Debt Instrument [Line Items]
Line of credit facility amount outstanding	894,375	$ 900,000
Less-Amounts due within one year	(72,000)
Revenue Bonds
Debt Instrument [Line Items]
Revenue bonds, interest at floating rates of 0.2% at December 31, 2012 and 2011, with varying maturities through 2015	5,300		5,300
Accounts Receivable Securitization Program
Debt Instrument [Line Items]
Accounts receivable securitization program	249,000		240,000
7.125% Senior Secured Notes due 2016
Debt Instrument [Line Items]
Senior Notes	400,015		400,019
7.00% Senior Unsecured Notes due 2018
Debt Instrument [Line Items]
Senior Notes	$ 250,000		$ 250,000

Summary of Long-Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Notes Payable And Mortgages Payable
Debt Instrument [Line Items]
Obligations under capitalized leases	$ 8,267	$ 9,982
Weighted average interest	5.90%	6.10%
Term Loans With Varying Maturities
Debt Instrument [Line Items]
Debt instruments, maturity date	2038
Term Loan A
Debt Instrument [Line Items]
Unamortized discount	$ 4,612	$ 6,103
Term Loan B Facility
Debt Instrument [Line Items]
Unamortized discount	$ 8,724	$ 19,500
Revenue Bonds
Debt Instrument [Line Items]
Interest at floating rates	0.20%	0.20%
Debt instruments, maturity date	2015
7.125% Senior Secured Notes due 2016
Debt Instrument [Line Items]
Debt instruments, maturity date	2016
Interest rate	7.125%
Unamortized net premium	$ 15	$ 19
7.00% Senior Unsecured Notes due 2018
Debt Instrument [Line Items]
Interest rate	7.00%
Debt instruments, maturity date	2018

Long-Term Debt - Additional Information (Detail)	1 Months Ended					3 Months Ended	12 Months Ended
Long-Term Debt - Additional Information (Detail)	Sep. 21, 2012 USD ($)	May 31, 2012 USD ($)	Oct. 31, 2010 USD ($)	Sep. 29, 2010 USD ($)	Jun. 30, 2006 USD ($)	Sep. 30, 2012 USD ($)	Dec. 31, 2012 USD ($)	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2001 USD ($)	Nov. 15, 2010 USD ($)	Jun. 30, 2008 USD ($)
Debt Instrument [Line Items]
Line of credit facility amount outstanding	$ 3,430,000,000
Costs related to extinguishment of debt							$ 29,170,000	$ 0	$ 0
Letters of credit, outstanding	$ 125,000,000
Rate adjustment to weighted average federal funds rate for credit facility borrowings							0.50%
Rate adjustment to one month Eurodollar rate on credit facility borrowings							1.00%
Quarterly installment payments due in 2013							$ 2,589,000	$ 2,479,000
Quarterly installment payments due in 2014							2,012,000
Quarterly installment payments due in 2014							68,588,000
Quarterly installment payments due in 2016							3,382,793,000
Accounts receivable securitization program credit facility, borrowing capacity		$ 275,000,000	$ 240,000,000
Accounts receivable securitization program credit facility original amount			$ 200,000,000
Accounts receivable securitization program credit facility, maturity date			Oct. 25, 2013
Credit facility fee, percentage			0.375%
Commitment percentage for facility fee			102.00%
Accounts receivable securitization program credit facility, amount outstanding							$ 249,000,000
Effective interest rate							4.50%	4.60%	5.00%
Fair value of debt							$ 3,800,000,000	$ 3,700,000,000
ABR-based loans
Debt Instrument [Line Items]
Current applicable margins							0.75%
7.00% Senior Unsecured Notes
Debt Instrument [Line Items]
Accounts receivable securitization program credit facility, maturity date							Oct. 01, 2018
Senior notes, issued				$ 250,000,000
Interest rate				7.00%
Treasury rate plus, basis points				50
Senior notes, repayment terms				Payable semiannually in arrears on April 1st and October 1st of each year
Senior Notes 7.125%
Debt Instrument [Line Items]
Accounts receivable securitization program credit facility, maturity date							Jun. 30, 2016
Senior notes, issued					$ 250,000,000
Interest rate					7.125%
Senior notes, repayment terms					Interest on the 7.125% Notes is payable semiannually in arrears on June 30th and December 30th of each year
Line of credit facility additional borrowing capacity												$ 150,000,000
Senior Notes 6.75% Coupon Rate
Debt Instrument [Line Items]
Accounts receivable securitization program credit facility, maturity date										Nov. 15, 2011
Interest rate										6.75%
Senior notes, issued										$ 200,000,000
Credit Agreement And Securitization
Debt Instrument [Line Items]
Average amounts outstanding under Credit Agreement, Prior Credit Agreement, demand notes and accounts receivable securitization programs							$ 2,900,000,000	$ 2,900,000,000	$ 610,000,000
Effective interest rate							2.90%	3.40%	3.40%
Maximum amounts outstanding at any month-end							$ 3,060,000,000	$ 3,030,000,000	$ 3,110,000,000
Accounts Receivable Securitization Facility
Debt Instrument [Line Items]
Accounts receivable securitization program, increase in size		$ 35,000,000
Accounts receivable securitization program, additional capacity							$ 26,000,000
Commercial Paper Rate Plus
Debt Instrument [Line Items]
Variable interest rate			0.475%
Debtor Optional Redemption Period 1 \| 7.00% Senior Unsecured Notes
Debt Instrument [Line Items]
Unsecured Notes make-whole redemption price				103.50%
Debtor Optional Redemption Period 2 \| 7.00% Senior Unsecured Notes
Debt Instrument [Line Items]
Unsecured Notes make-whole redemption price				101.75%
Debtor Optional Redemption Period 3 \| 7.00% Senior Unsecured Notes
Debt Instrument [Line Items]
Unsecured Notes make-whole redemption price				100.00%
Amendment of Credit Facility \| Extended Maturity
Debt Instrument [Line Items]
Line of credit facility, maturity date	Aug. 15, 2016
Line of credit facility, extension period of maturity date	9 months
Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, maturity date							Nov. 15, 2015
Line of credit facility amount outstanding	$ 800,000,000						$ 164,000,000
Line of credit facility, available borrowing capacity	23,000,000						574,000,000
Letters of credit, outstanding							$ 62,000,000
Revolving Credit Facility \| Eurodollar Based Loans
Debt Instrument [Line Items]
Current applicable margins							1.75%
Revolving Credit Facility \| Minimum \| One Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							0.50%
Revolving Credit Facility \| Minimum \| One Two Three Six Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							1.50%
Revolving Credit Facility \| Maximum \| One Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							1.25%
Revolving Credit Facility \| Maximum \| One Two Three Six Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							2.25%
Revolving Credit Facility \| Amendment of Credit Facility
Debt Instrument [Line Items]
Line of credit facility, borrowing capacity											$ 800,000,000
Revolving Credit Facility \| Amendment of Credit Facility \| Extended Maturity
Debt Instrument [Line Items]
Line of credit facility amount outstanding	777,000,000
Term Loan A
Debt Instrument [Line Items]
Line of credit facility, maturity date							Nov. 15, 2015
Line of credit facility amount outstanding	988,000,000						$ 983,438,000	1,017,647,000
Line of credit facility, available borrowing capacity	45,000,000
Quarterly installment payments due in 2013							72,000,000
Quarterly installment payments due in 2014							72,000,000
Quarterly installment payments due in 2014							77,000,000
Quarterly installment payments due in 2016							46,000,000
Scheduled principal payments							42,000,000	26,000,000
Term Loan A \| Eurodollar Based Loans
Debt Instrument [Line Items]
Current applicable margins							$ 0.0175
Term Loan A \| Minimum \| One Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							0.50%
Term Loan A \| Minimum \| One Two Three Six Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							1.50%
Term Loan A \| Maximum \| One Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							1.25%
Term Loan A \| Maximum \| One Two Three Six Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							2.25%
Term Loan A \| Amendment of Credit Facility \| Extended Maturity
Debt Instrument [Line Items]
Line of credit facility amount outstanding	943,000,000
Term Loan B Facility
Debt Instrument [Line Items]
Line of credit facility amount outstanding	746,000,000						$ 737,176,000	1,439,500,000
Variable rate basis							1.00%
Costs related to extinguishment of debt						$ 29,000,000
Term Loan B Facility \| Eurodollar Based Loans
Debt Instrument [Line Items]
Current applicable margins							2.75%
Term Loan B Facility \| Minimum \| One Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							1.75%
Term Loan B Facility \| Minimum \| One Two Three Six Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							2.75%
Term Loan B Facility \| Maximum \| One Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							2.00%
Term Loan B Facility \| Maximum \| One Two Three Six Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							3.00%
Term Loan- A2
Debt Instrument [Line Items]
Line of credit facility amount outstanding	900,000,000						$ 894,375,000
Proceeds from the new term loan-A2 facility	700,000,000
Current pricing under the new term loan-A2 facility							1.00%
Quarterly installment payments due in 2013							$ 72,000,000
Quarterly installment payments due in 2014							72,000,000
Quarterly installment payments due in 2014							77,000,000
Quarterly installment payments due in 2016							46,000,000
Scheduled principal payments							42,000,000
Term Loan- A2 \| Eurodollar Based Loans
Debt Instrument [Line Items]
Current applicable margins							$ 0.0175
Term Loan- A2 \| Minimum \| One Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							0.50%
Term Loan- A2 \| Minimum \| One Two Three Six Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							1.50%
Term Loan- A2 \| Maximum \| One Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							1.25%
Term Loan- A2 \| Maximum \| One Two Three Six Month Eurodollar Rate Plus Index Based Loans
Debt Instrument [Line Items]
Consolidated leverage ratio							2.25%
Term Loan- A2 \| Amendment of Credit Facility
Debt Instrument [Line Items]
Line of credit facility, borrowing capacity	$ 900,000,000
Line of credit facility, maturity date	Aug. 15, 2016
Short Term on Demand Credit Facility
Debt Instrument [Line Items]
Line of credit facility amount outstanding							$ 14,000,000
Term Loan B
Debt Instrument [Line Items]
Scheduled principal payments							$ 13,000,000	$ 16,000,000

Long-Term Debt Aggregate Maturities (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Long Term Debt Maturities Repayments Of Principal [Line Items]
2013	$ 2,589	$ 2,479
2014	2,012
2015	68,588
2016	3,382,793
2017	1,262
Later	272,776
Total	$ 3,730,020	$ 3,653,907

Common Stock - Additional Information (Detail) - USD ($)	3 Months Ended								12 Months Ended
	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008	Mar. 31, 2010	Mar. 31, 2009	Mar. 31, 2008	Dec. 31, 2007	Dec. 31, 2006
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividends declared and paid, per share									$ 0.60	$ 0.20	$ 0.20
Dividends declared and paid									$ 58,300,000	$ 19,000,000	$ 19,000,000
Stock repurchase programs authorized to purchase, shares	10,000,000								10,000,000
Earnings per share diluted	$ 1.39	$ 0.73	$ 1.10	$ 1.31	$ 0.98	$ 0.86	$ 1.04	$ 1.15	$ 4.53	$ 4.04	$ 2.34
Stock options granted during period (net of cancellations)									2,966,850	2,894,500	94,000
Total in-the-money value of all stock options exercised during the year									$ 54,400,000	$ 28,900,000	$ 26,800,000
Compensation cost recognized									$ 22,518,000	$ 18,225,000	$ 16,799,000
Stock issued during period, net of cancellations									900,000
Fully vested shares									1,845,249
Special Cash Dividend
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividends declared and paid, per share									$ 0.40
Dividends declared and paid									$ 38,900,000
2005 Employees' Restricted Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock issued under employee stock purchase plan									117,901	98,366	94,955
Percentage of discount provided to eligible employees for purchase of shares under employee stock purchase plan									10.00%
Compensation cost recognized									$ 533,000	$ 461,000	$ 339,000
2001 Employees' Restricted Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock issued during period, net of cancellations											1,200,000
Fully vested shares									62,044	78,133	313,770
Stock-based compensation plans expired											2010-03
2001 Employees' Restricted Stock Purchase Plan \| Chief Executive Officer ("CEO") And Chairman Of The Board
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized									$ 375,000	$ 375,000	$ 355,000
Issuance of restricted shares approved, shares														49,472
Restricted shares price, per share														$ 30.32
Issuance of restricted shares, value														$ 1,500,000
Estimated compensation cost									$ 395,000
Fully vested shares									12,368
2001 Employees' Restricted Stock Purchase Plan \| Chief Executive Officer \| First Quarter of 2009 Issuance
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized									$ 556,000	$ 556,000	$ 556,000	$ 482,000
Issuance of restricted shares approved, shares															109,850
Restricted shares price, per share															$ 20.26
Issuance of restricted shares, value															$ 2,200,000
Estimated compensation cost									$ 74,000
Fully vested shares									27,462	27,462	27,463
2001 Employees' Restricted Stock Purchase Plan \| Chief Executive Officer \| First Quarter of 2008 Issuance
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized									$ 15,000	$ 375,000	$ 375,000
Issuance of restricted shares approved, shares																62,190
Restricted shares price, per share																$ 24.12
Issuance of restricted shares, value																$ 1,500,000
Fully vested shares									15,548	15,546	15,548	15,548
2001 Employees' Restricted Stock Purchase Plan \| Chief Executive Officer \| Fourth quarter of 2007 Issuance
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized										$ 333,000	$ 375,000
Issuance of restricted shares approved, shares																	61,362
Restricted shares price, per share																	$ 24.45
Issuance of restricted shares, value																	$ 1,500,000
Fully vested shares										15,341	15,341	15,340	15,340
2001 Employees' Restricted Stock Purchase Plan \| Various Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized									$ 42,000	$ 120,000	$ 135,000
Issuance of restricted shares approved, shares																	22,250
Restricted shares price, per share																	$ 29.62
Issuance of restricted shares, value																	$ 659,000
2001 Employees' Restricted Stock Purchase Plan \| Various Officers And Employees \| Fourth Quarter of 2006 Issuance
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized											$ 1,300,000
Issuance of restricted shares approved, shares																		247,000
Restricted shares price, per share																		$ 25.71
Issuance of restricted shares, value																		$ 6,400,000
Class B
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved	6,000,000								6,000,000
Issuance upon conversion of shares									28,083,325
Class B \| 2010 Employees' Restricted Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized									$ 370,000	$ 198,000
Issuance of restricted shares approved, shares					21,500					21,500
Restricted shares price, per share					$ 53.21					$ 53.21
Issuance of restricted shares, value					$ 1,100,000					$ 1,100,000
Estimated compensation cost										$ 537,000
Fully vested shares									750
Number of shares cancelled									750
Class B \| 2010 Employees' Restricted Stock Purchase Plan \| Third Anniversary Of Grant Date
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fully vested shares										20,000
Class B \| 2010 Employees' Restricted Stock Purchase Plan \| Fourth Anniversary Of Grant Date
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fully vested shares										20,000
Class B \| 2010 Employees' Restricted Stock Purchase Plan \| Chief Executive Officer ("CEO") And Chairman Of The Board
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized									$ 1,000,000
Issuance of restricted shares approved, shares	54,127								54,127
Restricted shares price, per share	$ 36.95								$ 36.95
Issuance of restricted shares, value	$ 2,000,000								$ 2,000,000
Estimated compensation cost									$ 1,000,000
Class B \| 2010 Employees' Restricted Stock Purchase Plan \| Chief Executive Officer ("CEO") And Chairman Of The Board \| First Anniversary
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Purchase Plan, annual vesting percentage									50.00%
Class B \| 2010 Employees' Restricted Stock Purchase Plan \| Chief Executive Officer ("CEO") And Chairman Of The Board \| Second Anniversary
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Purchase Plan, annual vesting percentage									25.00%
Class B \| 2010 Employees' Restricted Stock Purchase Plan \| Chief Executive Officer ("CEO") And Chairman Of The Board \| Third Anniversary
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Purchase Plan, annual vesting percentage									25.00%
Class B \| 2001 Employees' Restricted Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved											2,400,000
Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted during period (net of cancellations)									2,760,050	2,561,250	69,500
Weighted-average grant date fair value of option granted									$ 10.73	$ 11.62	$ 7.84
Stock Incentive Plan \| Class B
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved	23,000,000								23,000,000
Long Term Incentive Plans
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized									$ 2,800,000	$ 2,400,000	$ 3,500,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized, pre-tax charge									20,100,000	15,800,000	13,300,000
Compensation cost recognized, after-tax									$ 12,500,000	$ 9,800,000	$ 8,300,000
Earnings per share diluted									$ 0.13	$ 0.10	$ 0.08
Compensation cost recognized									$ 20,100,000	$ 15,800,000	$ 13,300,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost recognized, after-tax									1,400,000	1,200,000	2,000,000
Compensation cost recognized									$ 2,300,000	$ 2,000,000	$ 3,100,000

Schedule of Information Related To Stock Repurchase Programs (Detail) - USD ($)
$ / shares in Thousands, $ in Thousands

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Class of Stock [Line Items]

Total number of shares purchased as part of publicly announced programs

1,384,637

Total price paid for shares purchased as part of publicly announced programs

$ 50,576

Total number of shares purchased related to stock-based compensation plans

^[1]

952,894

Total price paid for shares purchased related to stock-based compensation plans

$ 40,588

Aggregate number of shares purchased

2,337,531

Aggregate price paid for shares purchased

$ 91,164

Stock Repurchase Programs Two Thousand Ten

Class of Stock [Line Items]

Total number of shares purchased related to stock-based compensation plans

^[1]

301,933

Total price paid for shares purchased related to stock-based compensation plans

$ 11,528

Aggregate number of shares purchased

301,933

Aggregate price paid for shares purchased

$ 11,528

Maximum number of shares that may yet be purchased under the publicly announced program

2,152,339

Stock Repurchase Programs Two Thousand Eleven

Class of Stock [Line Items]

Total number of shares purchased as part of publicly announced programs

1,384,637

Total price paid for shares purchased as part of publicly announced programs

$ 50,576

Total number of shares purchased related to stock-based compensation plans

^[1]

217,649

Total price paid for shares purchased related to stock-based compensation plans

$ 9,906

Aggregate number of shares purchased

1,602,286

Aggregate price paid for shares purchased

$ 60,482

Maximum number of shares that may yet be purchased under the publicly announced program

767,702

Stock Repurchase Programs Twenty Twelve

Class of Stock [Line Items]

Total number of shares purchased related to stock-based compensation plans

^[1]

433,312

Total price paid for shares purchased related to stock-based compensation plans

$ 19,154

Aggregate number of shares purchased

433,312

Aggregate price paid for shares purchased

$ 19,154

Maximum number of shares that may yet be purchased under the publicly announced program

767,702

[1]

Schedule of Information Related To Stock Repurchase Programs (Parenthetical) (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Income Tax Withholding Obligations
Class of Stock [Line Items]
Number of shares repurchased	432,562	217,649	293,933
Shares repurchased at an average price	$ 44.28	$ 45.51	$ 39.22
Restricted Stock
Class of Stock [Line Items]
Number of shares repurchased	750		8,000
Shares repurchased at an average price	$ 0.01		$ 0.01

Assumptions Used in Black-Scholes Model to Determine Fair Value for Stock Option Awards Granted (Detail)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	33.00%	29.00%	27.00%
Interest rate	1.00%	2.00%	3.00%
Expected life (years)	3 years 6 months	3 years 6 months	3 years 7 months 6 days
Forfeiture rate	10.00%	9.00%	10.00%
Dividend yield	0.60%	0.70%	0.70%

Summary of Option Activities (Detail) - $ / shares	12 Months Ended
Summary of Option Activities (Detail) - $ / shares	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Option, Number of shares, beginning balance	7,558,945	6,594,950	8,802,450
Granted, Number of Shares	2,966,850	2,894,500	94,000
Exercised, Number of Shares	(2,608,007)	(1,563,255)	(2,000,250)
Cancelled, Number of Shares	(481,550)	(367,250)	(301,250)
Outstanding Option, Number of shares, ending balance	7,436,238	7,558,945	6,594,950
Outstanding Option, Average Option Price, beginning balance	$ 31.63	$ 25.16	$ 25.03
Outstanding options vested and exercisable, Number of Shares	2,185,312
Granted, Average Option Price	$ 37.01	43.66	30.40
Exercised, Average Option Price	23.22	26.38	24.87
Cancelled, Average Option Price	38.00	32.60	24.91
Outstanding Option, Average Option Price, ending balance	36.31	31.63	25.16
Outstanding options vested and exercisable, Average Option Price	30.40
Thirty One Point Seven Zero To Sixteen Point Two Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High			31.70
Range, Low			16.22
Thirty Two Point Two Eight To Thirty Point Three Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High			32.28
Range, Low			30.32
Thirty One Point One Eight To Sixteen Point Two Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	44.83		31.18
Range, Low	36.95		16.22
Thirty Two Point Two Eight To Sixteen Point Two Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	46.97	32.28	32.28
Range, Low	16.22	16.22	$ 16.22
Fifty Four Point Seven Nine To Thirty Eight Point One Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	54.79	54.79
Range, Low	16.22	38.12
Forty Six Point Nine Seven To Sixteen Point Two Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	46.97	46.97
Range, Low	16.22	16.22
Fifty Four Point Seven Nine To Sixteen Point Two Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Range, High	54.79	54.79
Range, Low	$ 16.22	$ 16.22

Schedule Of Information About Unvested Options (Detail)	12 Months Ended
Schedule Of Information About Unvested Options (Detail)	Dec. 31, 2012 $ / shares shares
Share Based Compensation Arrangements By Share Based Payment Award Options [Line Items]
Unvested options, Shares, beginning balance \| shares	4,579,000
Granted, Shares \| shares	2,966,850
Vested, Shares \| shares	(1,845,249)
Cancelled, Shares \| shares	(449,675)
Unvested options, Shares, ending balance \| shares	5,250,926
Unvested options, Weighted Average Grant Date Fair Value Per Share, beginning balance \| $ / shares	$ 9.50
Granted, Weighted Average Grant Date Fair Value Per Share \| $ / shares	10.73
Vested, Weighted Average Grant Date Fair Value Per Share \| $ / shares	7.75
Canceled, Weighted Average Grant Date Fair Value Per Share \| $ / shares	10.32
Unvested options, Weighted Average Grant Date Fair Value Per Share, ending balance \| $ / shares	$ 10.74

- Definition

The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.

+ References + Details

Schedule Of Information About All Outstanding Options And Exercisable Options (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding By Exercise Price [Line Items]
Number, Options Outstanding	7,436,238	7,558,945	6,594,950	8,802,450
Weighted average exercise price, Options Outstanding	$ 36.31	$ 31.63	$ 25.16	$ 25.03
Aggregate intrinsic value, Options Outstanding	$ 89,595,385
Weighted average remaining contractual life, Options Outstanding	3 years
Number, Options Exercisable	2,185,312
Weighted Average Exercise Price, Options Exercisable	$ 30.40
Aggregate intrinsic value, Options Exercisable	$ 39,256,370
Weighted average remaining contractual life, Options Exercisable	2 years

Schedule Of Weighted Average Remaining Contractual Life For Options Outstanding And Weighted Average Exercise Price Per Share For Exercisable Options (Detail) - $ / shares

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Options Outstanding, Shares

7,436,238

7,558,945

6,594,950

8,802,450

Options Outstanding, Weighted Average Exercise Price Per Share

$ 36.31

$ 31.63

$ 25.16

$ 25.03

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

3 years

Exercisable Options, Shares

2,185,312

Weighted average exercise price per share, Options Exercisable

$ 30.40

Expected to Vest Options , Shares

^[1]

4,728,984

Expected to Vest Options, Weighted Average Exercise Price Per Share

^[1]

$ 38.78

Range One

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Range, Low

16.22

Range, High

$ 16.22

Options Outstanding, Shares

586,000

Options Outstanding, Weighted Average Exercise Price Per Share

$ 16.22

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

10 months 24 days

Exercisable Options, Shares

586,000

Weighted average exercise price per share, Options Exercisable

$ 16.22

Range Two

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Range, Low

30.32

Range, High

$ 31.18

Options Outstanding, Shares

1,616,000

Options Outstanding, Weighted Average Exercise Price Per Share

$ 31.16

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

2 years

Exercisable Options, Shares

1,032,750

Weighted average exercise price per share, Options Exercisable

$ 31.17

Expected to Vest Options , Shares

^[1]

525,275

Expected to Vest Options, Weighted Average Exercise Price Per Share

^[1]

$ 31.14

Range Three

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Range, Low

36.95

Range, High

$ 43.46

Options Outstanding, Shares

2,797,050

Options Outstanding, Weighted Average Exercise Price Per Share

$ 37.03

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

2 years 10 months 24 days

Exercisable Options, Shares

11,250

Weighted average exercise price per share, Options Exercisable

$ 39.09

Expected to Vest Options , Shares

^[1]

2,508,891

Expected to Vest Options, Weighted Average Exercise Price Per Share

^[1]

$ 37.02

Range Four

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Range, Low

43.67

Range, High

$ 54.79

Options Outstanding, Shares

2,437,188

Options Outstanding, Weighted Average Exercise Price Per Share

$ 43.75

Options Outstanding, Weighted Average Remaining Contractual Life (in Years)

3 years 1 month 6 days

Exercisable Options, Shares

555,312

Weighted average exercise price per share, Options Exercisable

$ 43.75

Expected to Vest Options , Shares

^[1]

1,694,818

Expected to Vest Options, Weighted Average Exercise Price Per Share

^[1]

$ 43.75

[1]	Assumes a weighted average forfeiture rate of 9.94%.

Schedule Of Weighted Average Remaining Contractual Life For Options Outstanding And Weighted Average Exercise Price Per Share For Exercisable Options (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2012
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average forfeiture rate	9.94%

Schedule Of Components Of Income Tax Expense and Benefit (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Components Of Income Tax Expense Benefit [Line Items]
Current, Federal	$ 254,021	$ 165,409	$ 105,077
Current, Foreign	9,084	300	2,555
Current, State	39,076	22,901	16,547
Current, Total	302,181	188,610	124,179
Deferred, Federal and foreign	(21,408)	53,056	26,419
Deferred, State	(6,157)	5,800	1,704
Deferred, Total	(27,565)	58,856	28,123
Provision for income taxes	$ 274,616	$ 247,466	$ 152,302

- Definition

The component of income tax expense for the period representing amounts paid or payable (or refundable) as determined by applying the provisions of enacted federal tax law to the domestic taxable Income or Loss from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Paragraph Question 1-7

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 45
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 289
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

+ Details

- Definition

The component of income tax expense for the period representing amounts of income taxes paid or payable (or refundable) for the period for all income tax obligations as determined by applying the provisions of relevant enacted tax laws to relevant amounts of taxable Income or Loss from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 45
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 289
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The component of income tax expense for the period representing amounts paid or payable (or refundable) as determined by applying the provisions of enacted state and local tax law to relevant amounts of taxable Income or Loss from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 45
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 289
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6510177

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 289
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 45
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 95
-Paragraph 28
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The component of total income tax expense for the period comprised of the increase (decrease) in the entity's state and local deferred tax assets and liabilities attributable to continuing operations as determined by applying the provisions of the applicable enacted tax laws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6510177

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 45
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 8, 16, 17, 289
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

+ Details

Schedule Of Components Of Deferred Taxes (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Schedule of Components of Deferred Tax Provision [Line Items]
Self-insurance reserves	$ 112,587	$ 115,201
Compensation accruals	47,571	49,717
State and foreign net operating loss carryforwards and other state and foreign deferred tax assets	54,874	52,506
Other currently non-deductible accrued liabilities	29,934	19,699
Net pension liability-OCI only	12,061	13,959
Doubtful accounts and other reserves	17,562	17,345
Other combined items-OCI only	15,282	17,684
Deferred income tax assets, Gross	289,871	286,111
Less: Valuation Allowance	(44,511)	(42,143)
Net deferred income tax assets:	245,360	243,968
Depreciable and amortizable assets	(322,317)	(342,655)
Other deferred tax liabilities	(2,329)	(2,581)
Net deferred income tax liabilities	$ (79,286)	$ (101,268)

Schedule Of Effective Tax Rates Calculation (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Schedule Of Effective Tax Rates Line Items
Provision for income taxes	$ 274,616	$ 247,466	$ 152,302
Income before income taxes	$ 763,663	$ 696,336	$ 428,097
Effective tax rate	36.00%	35.50%	35.60%

Income Taxes - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2012 USD ($) yr	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($)
Income Taxes [Line Items]
Favorable discrete tax items	$ 1,000	$ 1,000	$ 4,000
Unfavorable discrete tax items			4,000
Charge incurred from life insurance agreements			9,000
Deferred federal and state tax benefit	7,000	25,000
Future taxable income, amount	959,000
Deferred state tax benefit (net of the federal benefit)	(6,157)	5,800	1,704
Net operating losses	54,874	52,506
Valuation allowances	41,000	39,000
Increase in estimated liabilities for uncertain tax positions	1,000	1,000
Decrease in estimated liabilities for uncertain tax positions due to the lapse of the statute of limitations		1,000
Impact of unrecognized tax benefits, if recognized	4,000	5,000
Accrued interest and penalties	$ 1,000	1,000
Jurisdictions statutes of limitations expiration period	12 months
Period of expiration of the statute of limitations for certain jurisdictions	Within the next twelve months
State and Local Jurisdiction
Income Taxes [Line Items]
Deferred state tax benefit (net of the federal benefit)	$ 48,000
Minimum
Income Taxes [Line Items]
Foreign and U.S. state and local jurisdictions have statutes of limitations, in years \| yr	3
Maximum
Income Taxes [Line Items]
Foreign and U.S. state and local jurisdictions have statutes of limitations, in years \| yr	4
Net Operating Losses
Income Taxes [Line Items]
Increase in valuation allowance	$ 2,000
Foreign Net Operating Losses
Income Taxes [Line Items]
Increase in valuation allowance	3,000	$ 3,000
Psychiatric Solutions Inc
Income Taxes [Line Items]
Unfavorable discrete tax items			$ 5,000
Deferred federal tax benefits	400
Deferred foreign tax benefit	3,000
Psychiatric Solutions Inc \| Federal
Income Taxes [Line Items]
Net operating losses	1,000
Psychiatric Solutions Inc \| Foreign Tax Authority
Income Taxes [Line Items]
Net operating losses	$ 9,000

Schedule of Reconciliation Between Federal Statutory Rate and Effective Tax Rate (Detail)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Reconciliation of Statutory Federal Tax Rate [Line Items]
Federal statutory rate	35.00%	35.00%	35.00%
State taxes, net of federal income tax benefit	3.00%	2.90%	3.10%
Nondeductible transaction costs	0.20%		1.30%
Other items	0.10%	0.40%	0.40%
Impact of income attributable to noncontrolling interests	(2.30%)	(2.80%)	(4.20%)
Effective tax rate	36.00%	35.50%	35.60%

Schedule of Net Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Deferred Tax Assets And Liabilities [Line Items]
Current deferred taxes, Assets	$ 105,639	$ 109,297
Current deferred taxes, Liabilities	(1,178)	(973)
Total deferred taxes-current	104,461	108,324
Noncurrent deferred taxes, Assets	142,065	135,189
Noncurrent deferred taxes, Liabilities	(325,812)	(344,781)
Total deferred taxes-noncurrent	(183,747)	(209,592)
Net deferred income tax liabilities	$ (79,286)	$ (101,268)

- Definition

Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed within one year or operating cycle, if longer.

+ References + Details

- Definition

Amount after allocation of valuation allowances of noncurrent deferred tax asset attributable to deductible temporary differences and carryforwards. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).

+ References + Details

- Definition

Amount of deferred tax liability attributable to taxable temporary differences, net of deferred tax asset attributable to deductible temporary differences and carryforwards net of valuation allowances expected to be realized or consumed within one year or operating cycle, if longer.

+ References + Details

Schedule of Reconciliation of Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Reconciliation of Unrecognized Tax Benefits [Line Items]
Balance at January 1,	$ 7,403	$ 7,923	$ 5,754
Additions based on tax positions related to the current year	200	750	1,219
Additions for tax positions of prior years	386	419	2,076
Reductions for tax positions of prior years	(1,165)	(1,628)	(907)
Settlements		(61)	(219)
Balance at December 31,	$ 6,824	$ 7,403	$ 7,923

Lease Commitments - Additional Information (Detail)	12 Months Ended
Lease Commitments - Additional Information (Detail)	Dec. 31, 2011 Facility
Leases Disclosure [Line Items]
Number of hospital facilities	4

Summary of Property Under Capital Lease (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Schedule of Capital Lease Obligations [Line Items]
Land, buildings and equipment	$ 27,836	$ 37,037
Less: accumulated amortization	(26,540)	(35,264)
Property under capital lease, Total	$ 1,296	$ 1,773

Future Minimum Renal Payments Under Lease Commitments (Detail) $ in Thousands	Dec. 31, 2012 USD ($)
Future Minimum Payments Under Non-Cancelable Operating Leases With Initial Terms Of One-Year Or More [Line Items]
Capital Leases, 2012	$ 2,162
Capital Leases, 2013	1,369
Capital Leases, 2014	1,158
Capital Leases, 2015	1,068
Capital Leases, 2016	1,077
Capital Leases, Later years	5,117
Capital Leases, Total minimum rental	11,951
Less: Amount representing interest	(3,684)
Present value of minimum rental commitments	8,267
Less: Current portion of capital lease obligations	(1,585)
Long-term portion of capital lease obligations	6,682
Operating Leases, 2012	58,638
Operating Leases, 2013	50,973
Operating Leases, 2014	43,496
Operating Leases, 2015	36,952
Operating Leases, 2016	21,906
Operating Leases, Later years	102,722
Operating Leases, Total minimum rental	$ 314,687

Commitments and Contingencies - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Sep. 30, 2012	Nov. 15, 2010	Nov. 14, 2010	Jan. 01, 2008
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability	$ 279,000,000	$ 292,000,000
Percentage of liability for claims paid under commercially insured coverage					10.00%
Commercial insurance coverage catastrophic loss deductible per occurrence	10,000,000
Self-insured for professional and general liability, current	48,000,000	60,000,000
Compensation liability claims	66,000,000	65,000,000
Compensation and related benefits	35,000,000	34,000,000
Reduction to reserve for work compensation claim	4,000,000
Combined estimated future purchase obligations	290,000,000
Combined estimated future payments related to non contributory	225,000,000
Defined benefit pension plan estimated payments through 2088	208,000,000
Other retirement plan liabilities	17,000,000
Letters Of Credit And Surety Bonds
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet contingent obligation	80,000,000
Revenue Cycle Data Processing Services
Commitments and Contingencies Disclosure [Line Items]
Combined estimated future purchase obligations	106,000,000
Electronic Health Records Application
Commitments and Contingencies Disclosure [Line Items]
Combined estimated future purchase obligations	181,000,000
Estimated Minimum Liabilities For Physician Commitments
Commitments and Contingencies Disclosure [Line Items]
Combined estimated future purchase obligations	3,000,000
Professional And General Liability
Commitments and Contingencies Disclosure [Line Items]
The amount of commercial insurance aggregate coverage	20,000,000
Professional And General Liability \| Psi Subsidiaries
Commitments and Contingencies Disclosure [Line Items]
Reduction in professional and general liability self-insurance reserves relating to prior years	27,000,000	$ 11,000,000	$ 49,000,000
Weighting given to company-specific metrics		75.00%	50.00%
General industry metrics		25.00%	50.00%
Self Insurance Programs \| Letters Of Credit And Surety Bonds
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet contingent obligation	66,000,000
Other Debt Guarantees \| Letters Of Credit And Surety Bonds
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet contingent obligation	14,000,000
Earthquake
Commitments and Contingencies Disclosure [Line Items]
Commercial property insurance policies covering catastrophic losses	250,000,000
United States \| Earthquake
Commitments and Contingencies Disclosure [Line Items]
Commercial property insurance policies covering catastrophic losses	100,000,000
Puerto Rico
Commitments and Contingencies Disclosure [Line Items]
Commercial property insurance policies covering catastrophic losses	$ 25,000,000
Minimum
Commitments and Contingencies Disclosure [Line Items]
Liability for claims paid under commercially insured coverage					$ 10,000,000
Minimum \| Wind Storms
Commitments and Contingencies Disclosure [Line Items]
Percentage of insurance deductible	3.00%
Minimum \| Location 2
Commitments and Contingencies Disclosure [Line Items]
Minimum Insurance Deductible				$ 250,000
Minimum \| United States \| Earthquake
Commitments and Contingencies Disclosure [Line Items]
Percentage of insurance deductible	1.00%
Maximum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability					10,000,000
Liability for claims paid under commercially insured coverage					60,000,000
Maximum \| Wind Storms
Commitments and Contingencies Disclosure [Line Items]
Commercial property insurance policies covering catastrophic losses				$ 1,000,000,000
Percentage of insurance deductible				5.00%
Maximum \| Location 2 \| Flood
Commitments and Contingencies Disclosure [Line Items]
Maximum insurance deductible	$ 500,000
Maximum \| Location 1 \| Flood
Commitments and Contingencies Disclosure [Line Items]
Maximum insurance deductible	$ 250,000
Maximum \| United States \| Earthquake
Commitments and Contingencies Disclosure [Line Items]
Percentage of insurance deductible	5.00%
Subsidiaries \| Minimum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability							$ 10,000,000
Subsidiaries \| Maximum
Commitments and Contingencies Disclosure [Line Items]
Purchased several excess policies through commercial insurance carriers per occurrence					200,000,000
Psychiatric Solutions Inc
Commitments and Contingencies Disclosure [Line Items]
Purchased several excess policies through commercial insurance carriers per occurrence					$ 200,000,000
Psychiatric Solutions Inc \| Minimum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability	$ 3,000,000					$ 3,000,000
Psychiatric Solutions Inc \| Maximum
Commitments and Contingencies Disclosure [Line Items]
Self-insured for professional and general liability	$ 75,000,000

Relationship with Universal Health Realty Income Trust and Related Party Transactions - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2012 USD ($) yr d	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($)
Related Party Transaction [Line Items]
Lease renewal period, years \| yr	5
Notice period on renewal of lease \| d	90
Period of rights of refusal to leased facilities \| d	180
Minimum
Related Party Transaction [Line Items]
Lease initial terms \| yr	13
Maximum
Related Party Transaction [Line Items]
Lease initial terms \| yr	15
Chief Executive Officer
Related Party Transaction [Line Items]
Estimated payments to acquire life insurance policies	$ 25.0
Estimated death benefit proceeds	33.0
Payments to acquire life insurance policies	1.4	$ 1.4	$ 6.0
Net of tax present value of projected premium funding commitment	9.0
Chief Executive Officer \| Trust Owned by Chief Executive Officer
Related Party Transaction [Line Items]
Estimated payments to acquire life insurance policies	$ 8.0
Relationship with Universal Health Realty Income Trust
Related Party Transaction [Line Items]
Trust outstanding shares held, percentage	6.20%
Advisory fee earned	$ 2.1	2.0	1.8
Pre-tax share of income from the Trust	1.2	4.6	1.0
Share of income included in the share of trust		$ 3.7
Current ownership percentage of the trust		100.00%
Carrying value of investment in Trust	9.3	$ 9.9
Market value of investment in Trust	39.9	30.7
Rent expense under operating leases	$ 16.3	$ 16.3	$ 16.2
Non-controlling ownership interests by subsidiaries	100.00%

Renewal Options and Terms for Hospital Facilities Leased from the Trust (Detail)

12 Months Ended

Dec. 31, 2012

USD ($)

McAllen Medical Center

Capital Leased Assets [Line Items]

Acute Care

$ 5,485,000

2016-12

15 years

^[1]

Wellington Regional Medical Center

Capital Leased Assets [Line Items]

Acute Care

$ 3,030,000

2016-12

15 years

^[2]

Southwest Healthcare System, Inland Valley Campus

Capital Leased Assets [Line Items]

Acute Care

$ 2,648,000

2016-12

15 years

^[2]

The Bridgeway

Capital Leased Assets [Line Items]

Behavioral Health

$ 930,000

2014-12

10 years

^[3]

[1]	We have three 5-year renewal options at existing lease rates (through 2031).
[2]	We have one 5-year renewal options at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
[3]	We have two 5-year renewal options at fair market value lease rates (2015 through 2024).

Renewal Options and Terms for Hospital Facilities Leased from the Trust (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2012 Bed
McAllen Medical Center
Capital Leased Assets [Line Items]
Number of renewal options at existing lease rates	3
Renewal options term at existing lease rates	5 years
Wellington Regional Medical Center
Capital Leased Assets [Line Items]
Number of renewal options at existing lease rates	1
Renewal options term at existing lease rates	5 years
Southwest Healthcare System, Inland Valley Campus
Capital Leased Assets [Line Items]
Number of renewal options at existing lease rates	2
Renewal options term at existing lease rates	5 years
The Bridgeway
Capital Leased Assets [Line Items]
Number of renewal options at existing lease rates	2
Renewal options term at existing lease rates	5 years
Maximum \| McAllen Medical Center
Capital Leased Assets [Line Items]
Renewal options at existing lease rates expiration year	2031
Maximum \| Wellington Regional Medical Center
Capital Leased Assets [Line Items]
Renewal options at existing lease rates expiration year	2021
Renewal options at fair market value lease rates expiration year	2031
Maximum \| Southwest Healthcare System, Inland Valley Campus
Capital Leased Assets [Line Items]
Renewal options at existing lease rates expiration year	2021
Renewal options at fair market value lease rates expiration year	2031
Maximum \| The Bridgeway
Capital Leased Assets [Line Items]
Renewal options at fair market value lease rates expiration year	2024
Minimum \| Wellington Regional Medical Center
Capital Leased Assets [Line Items]
Renewal options at fair market value lease rates expiration year	2022
Minimum \| Southwest Healthcare System, Inland Valley Campus
Capital Leased Assets [Line Items]
Renewal options at fair market value lease rates expiration year	2022
Minimum \| The Bridgeway
Capital Leased Assets [Line Items]
Renewal options at fair market value lease rates expiration year	2015

Pension Plan - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Pension And Other Employee Benefit Plans [Line Items]
Amount of contributions to contributory plan	$ 27,300	$ 21,700	$ 20,800
Accumulated benefit obligation	112,675	106,609
Estimated net loss that will be amortized from accumulated other comprehensive income over the next fiscal year	3,305
Fair value of plan assets	$ 104,074	$ 87,940	$ 73,402

- Definition

Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets.

+ References + Details

Schedule of Reconciliation of Defined Benefit Pension Plan (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2012	Dec. 31, 2011
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets at beginning of year	$ 87,940	$ 73,402
Actual return (loss) on plan assets	13,824	5,689
Employer contributions	7,786	14,065
Benefits paid	(4,946)	(4,541)
Administrative expenses	(530)	(675)
Fair value of plan assets at end of year	104,074	87,940	$ 73,402
Benefit obligation at beginning of year	108,446	93,513
Service cost	1,144	1,162	1,140
Interest cost	4,659	5,047	4,958
Benefits paid	(4,946)	(4,541)
Actuarial (gain) loss	5,226	13,265
Benefit obligation at end of year	114,529	108,446	93,513
Other noncurrent liabilities				$ 10,455	$ 20,506
Total liability at end of year				10,455	20,506
Projected benefit obligation				114,529	108,446
Accumulated benefit obligation				112,675	106,609
Fair value of plan assets	$ 87,940	$ 73,402	$ 73,402	$ 104,074	$ 87,940

Schedule of Components of Net Periodic Cost (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Summary of Components of Net Periodic Benefit Cost and Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income [Line Items]
Service cost	$ 1,144	$ 1,162	$ 1,140
Interest cost	4,659	5,047	4,958
Expected return on plan assets	(7,301)	(6,566)	(5,151)
Recognized actuarial loss	4,219	2,427	2,538
Net periodic cost	$ 2,721	$ 2,070	$ 3,485

- Definition

An amount calculated as a basis for determining the extent of delayed recognition of the effects of changes in the fair value of assets. The expected return on plan assets is determined based on the expected long-term rate of return on plan assets and the market-related value of plan assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 30
-Glossary Expected Return on Plan Assets
-URI http://asc.fasb.org/extlink&oid=6512136

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Glossary Expected Return on Plan Assets
-URI http://asc.fasb.org/extlink&oid=6512171

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(3)
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 87
-Paragraph 264
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph h
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 106
-Paragraph 518
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.

+ References + Details

- Definition

The actuarial present value of benefits attributed by the pension benefit formula to services rendered by employees during the period. The portion of the expected postretirement benefit obligation attributed to employee service during the period. The service cost component is a portion of the benefit obligation and is unaffected by the funded status of the plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Service Cost (Component of Net Periodic Pension Cost)
-URI http://asc.fasb.org/extlink&oid=6525008

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 87
-Paragraph 264
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph a, h
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 106
-Paragraph 518
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Schedule of Measurement Dates (Detail)	12 Months Ended
Schedule of Measurement Dates (Detail)	Dec. 31, 2012	Dec. 31, 2011
Benefit Obligation
Defined Benefit Plan Disclosure [Line Items]
Measurement Dates	12/31/2012	12/31/2011
Fair Value Of Plan Assets
Defined Benefit Plan Disclosure [Line Items]
Measurement Dates	12/31/2012	12/31/2011

Schedule of Weighted Average Assumptions (Detail)	12 Months Ended
Schedule of Weighted Average Assumptions (Detail)	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Schedule of Postemployment Benefits Weighted Average Assumptions [Line Items]
Discount rate	4.05%	4.40%
Rate of compensation increase	4.00%	4.00%
Discount rate	4.40%	5.54%	5.96%
Expected long-term rate at return on plan assets	8.00%	8.00%	8.00%
Rate of compensation increase	4.00%	4.00%	4.00%

Schedule of Market Values of Pension Plan Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	$ 104,074	$ 87,940	$ 73,402
Equity Securities \| U.S. Large Cap
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	22,800	18,921
Equity Securities \| U.S. Mid Cap
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	1,566	1,281
Equity Securities \| U.S. Small-Mid Cap
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	7,738	6,332
Equity Securities \| U.S. Small Cap
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	1,583	1,282
Equity Securities \| International Developed
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	10,779	8,692
Equity Securities \| Emerging Markets
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	3,912	3,123
Fixed Income Securities \| Long Duration Fixed Income
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	51,355	44,587
Fixed income securities \| REIT Fund
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	3,904	3,269
Cash \| Cash Equivalents
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	437	453
Fair Value, Inputs, Level 2
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	104,074	87,940
Fair Value, Inputs, Level 2 \| Equity Securities \| U.S. Large Cap
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	22,800	18,921
Fair Value, Inputs, Level 2 \| Equity Securities \| U.S. Mid Cap
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	1,566	1,281
Fair Value, Inputs, Level 2 \| Equity Securities \| U.S. Small-Mid Cap
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	7,738	6,332
Fair Value, Inputs, Level 2 \| Equity Securities \| U.S. Small Cap
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	1,583	1,282
Fair Value, Inputs, Level 2 \| Equity Securities \| International Developed
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	10,779	8,692
Fair Value, Inputs, Level 2 \| Equity Securities \| Emerging Markets
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	3,912	3,123
Fair Value, Inputs, Level 2 \| Fixed Income Securities \| Long Duration Fixed Income
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	51,355	44,587
Fair Value, Inputs, Level 2 \| Fixed income securities \| REIT Fund
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	3,904	3,269
Fair Value, Inputs, Level 2 \| Cash \| Cash Equivalents
Schedule of Pension Plan Assets by Fair Value [Line Items]
Fair value of plan assets	$ 437	$ 453

Schedule of Estimated Future Benefit Payments (Detail) $ in Thousands	Dec. 31, 2012 USD ($)
Schedule of Pension Expected Future Benefit Payments [Line Items]
2013	$ 5,451
2014	5,724
2015	5,692
2016	6,182
2017	6,379
2018-2022	34,251
Total	$ 63,679

Schedule of Plan Assets Category (Detail)	12 Months Ended
Schedule of Plan Assets Category (Detail)	Dec. 31, 2012	Dec. 31, 2011
Fair Value Hierarchy Of Plan Assets By Category [Line Items]
Total	100.00%	100.00%
Equity Securities
Fair Value Hierarchy Of Plan Assets By Category [Line Items]
Asset Allocation	47.00%	45.00%
Fixed income securities
Fair Value Hierarchy Of Plan Assets By Category [Line Items]
Asset Allocation	49.00%	50.00%
Other
Fair Value Hierarchy Of Plan Assets By Category [Line Items]
Asset Allocation	4.00%	5.00%

Schedule of Asset Allocation Policy and Ranges for Overall Risk and Return Objectives of Portfolio (Detail)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Equity Funds
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	47.00%
Permitted Range, minimum	43.00%
Permitted Range, maximum	49.00%
Equity Funds \| Policy
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	46.00%
Fixed Income Funds
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	49.00%
Permitted Range, minimum	45.00%
Permitted Range, maximum	55.00%
Fixed Income Funds \| Policy
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	50.00%
Other
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	4.00%	5.00%
Permitted Range, minimum	0.00%
Permitted Range, maximum	10.00%
Other \| Policy
Defined Benefit Plan Disclosure [Line Items]
Assets allocation	4.00%

Segment Reporting (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
Segment Reporting (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Segment Reporting Information [Line Items]
Gross inpatient revenues									$ 18,170,937	$ 17,277,976	$ 13,187,274
Gross outpatient revenues									6,828,975	6,091,262	4,995,754
Total net revenues	$ 1,764,927	$ 1,680,353	$ 1,723,084	$ 1,793,036	$ 1,662,996	$ 1,662,675	$ 1,711,255	$ 1,723,296	6,961,400	6,760,222	4,900,147
Income (loss) before allocation of corporate overhead and income taxes									763,663	696,336	428,097
Allocation of corporate overhead									0	0	0
Income (loss) after allocation of corporate overhead and before income taxes									763,663	696,336	428,097
Total assets	8,200,843				7,665,245				8,200,843	7,665,245	7,527,936
Acute Care Hospital Services
Segment Reporting Information [Line Items]
Gross inpatient revenues									12,406,567	11,770,248	10,623,407
Gross outpatient revenues									6,134,615	5,431,146	4,596,317
Total net revenues									3,461,416	3,423,957	3,272,488
Income (loss) before allocation of corporate overhead and income taxes									337,385	352,931	352,334
Allocation of corporate overhead									(162,056)	(131,225)	(128,588)
Income (loss) after allocation of corporate overhead and before income taxes									175,329	221,706	223,746
Total assets	2,984,169				2,782,102				2,984,169	2,782,102	2,681,803
Behavioral Health Services
Segment Reporting Information [Line Items]
Gross inpatient revenues									5,764,370	5,507,728	2,563,867
Gross outpatient revenues									646,177	606,876	350,192
Total net revenues									3,460,141	3,308,862	1,597,022
Income (loss) before allocation of corporate overhead and income taxes									838,603	729,142	353,046
Allocation of corporate overhead									(84,597)	(62,710)	(43,362)
Income (loss) after allocation of corporate overhead and before income taxes									754,006	666,432	309,684
Total assets	4,979,965				4,373,379				4,979,965	4,373,379	4,360,262
Other
Segment Reporting Information [Line Items]
Gross outpatient revenues									48,183	53,240	49,245
Total net revenues									39,843	27,403	30,637
Income (loss) before allocation of corporate overhead and income taxes									(412,325)	(385,737)	(277,283)
Allocation of corporate overhead									246,653	193,935	171,950
Income (loss) after allocation of corporate overhead and before income taxes									(165,672)	(191,802)	(105,333)
Total assets	$ 236,709				$ 509,764				$ 236,709	$ 509,764	$ 485,871

Quarterly Results (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Quarterly Financial Data [Line Items]
Net revenues	$ 1,764,927	$ 1,680,353	$ 1,723,084	$ 1,793,036	$ 1,662,996	$ 1,662,675	$ 1,711,255	$ 1,723,296	$ 6,961,400	$ 6,760,222	$ 4,900,147
Net income	147,660	81,373	117,444	142,570	108,007	94,842	116,034	129,987	489,047	448,870	275,795
Less: Net income attributable to noncontrolling interests	12,199	9,556	9,883	13,963	12,736	9,788	12,385	15,794	45,601	50,703	45,612
Net income attributable to UHS	$ 135,461	$ 71,817	$ 107,561	$ 128,607	$ 95,271	$ 85,054	$ 103,649	$ 114,193	$ 443,446	$ 398,167	$ 230,183
Earnings per basic share attributable to UHS:	$ 1.39	$ 0.74	$ 1.11	$ 1.33	$ 0.99	$ 0.87	$ 1.06	$ 1.17	$ 4.57	$ 4.09	$ 2.37
Earnings per diluted share attributable to UHS:	$ 1.39	$ 0.73	$ 1.10	$ 1.31	$ 0.98	$ 0.86	$ 1.04	$ 1.15	$ 4.53	$ 4.04	$ 2.34

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=16381557&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.23)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 36, 37, 38
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 07-4
-Paragraph 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e565-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 10, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A7
-Appendix A

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 87-21
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 95
-Paragraph 28, 29, 30
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9

+ Details

- Definition

Amount of Net Income (Loss) attributable to noncontrolling interest.

+ References + Details

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=18733213&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=18733213&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 29
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(1)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 5
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A1, A4, A5
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Quarterly Results - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011
Quarterly Financial Information [Line Items]
Favorable pre-tax reduction					$ 10.4
Favorable after-tax reduction					$ 6.4
Tax reduction per diluted share					$ 0.07
Resulting from an agreement entered into with the United States Department of Health and Human Services, the Secretary of Health and Human Services, and the Centers for Medicare and Medicaid Services
Quarterly Financial Information [Line Items]
Favorable pre-tax reduction				$ 30.2
Favorable after-tax reduction				$ 18.8
Tax reduction per diluted share				$ 0.19
Oklahoma Supplemental Hospital Offset Payment Program
Quarterly Financial Information [Line Items]
Favorable pre-tax reduction				$ 7.0
Favorable after-tax reduction				$ 4.3
Tax reduction per diluted share				$ 0.04
Implementation of EHR applications
Quarterly Financial Information [Line Items]
Tax reduction per diluted share			$ 0.05	$ 0.05
Unfavorable pre-tax reduction			$ 8.0	$ 8.3
Unfavorable after-tax reduction			5.0	5.1
Unfavorable after tax impact related to actute care hospital construction				2.7
Implementation of EHR applications \| Federal fiscal years 2006 through 2009
Quarterly Financial Information [Line Items]
Unfavorable pre-tax reduction				$ 2.4
EHR applications
Quarterly Financial Information [Line Items]
Favorable pre-tax reduction	$ 8.9	$ 2.2
Favorable after-tax reduction	$ 5.5	$ 1.3
Tax reduction per diluted share	$ 0.06	$ 0.01
Write-off of deferred financing costs
Quarterly Financial Information [Line Items]
Tax reduction per diluted share		$ 0.19
Unfavorable pre-tax reduction		$ 29.2
Unfavorable after-tax reduction		$ 18.1
Sale of an acute care facility
Quarterly Financial Information [Line Items]
Favorable pre-tax reduction	$ 26.4
Favorable after-tax reduction	$ 16.4
Tax reduction per diluted share	$ 0.17
Reimbursements related to prior years
Quarterly Financial Information [Line Items]
Favorable pre-tax reduction			5.5
Favorable after-tax reduction			$ 3.4
Tax reduction per diluted share			$ 0.03
Professional and general liability self-insurance reserves relating to years prior to 2012
Quarterly Financial Information [Line Items]
Favorable pre-tax reduction	$ 27.2
Favorable after-tax reduction	$ 15.5
Tax reduction per diluted share	$ 0.16

Supplemental Condensed Consolidating Financial Information - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2012
Guarantors
Supplementary Information [Line Items]
Percentage of ownership interests			100.00%
Guarantors \| Interest Expense
Supplementary Information [Line Items]
Statement Adjustment	$ (87.2)
Guarantors \| Net Income
Supplementary Information [Line Items]
Statement Adjustment	53.8
Guarantors \| Noncurrent Liabilities
Supplementary Information [Line Items]
Statement Adjustment	(53.8)
Non Guarantors \| Interest Expense
Supplementary Information [Line Items]
Statement Adjustment	87.2
Non Guarantors \| Net Income
Supplementary Information [Line Items]
Statement Adjustment	(53.8)
Non Guarantors \| Noncurrent Assets
Supplementary Information [Line Items]
Statement Adjustment	$ (53.8)
Parent \| Net Revenue
Supplementary Information [Line Items]
Statement Adjustment		$ 0.3
Parent \| Operating Expense
Supplementary Information [Line Items]
Statement Adjustment		$ 0.3

Supplemental Condensed Consolidating Statements of Income (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts									$ 7,688,071	$ 7,356,798	$ 5,429,233
Less: Provision for doubtful accounts									726,671	596,576	529,086
Net revenues	$ 1,764,927	$ 1,680,353	$ 1,723,084	$ 1,793,036	$ 1,662,996	$ 1,662,675	$ 1,711,255	$ 1,723,296	6,961,400	6,760,222	4,900,147
Operating charges:
Salaries, wages and benefits									3,440,917	3,326,378	2,363,383
Other operating expenses									1,376,122	1,353,693	968,612
Supplies expense									799,621	805,489	716,925
Depreciation and amortization									302,426	287,211	216,930
Lease and rental expense									94,885	90,323	75,363
Transaction costs									5,716		53,220
EHR incentive income									(30,038)	0	0
Costs related to extinguishment of debt									29,170	0	0
Operating expenses									6,018,819	5,863,094	4,394,433
Income (loss) from operations									942,581	897,128	505,714
Interest expense									178,918	200,792	77,617
Interest (income) expense, affiliate									0	0	0
Equity in net income of consolidated affiliates									0	0	0
Income before income taxes									763,663	696,336	428,097
Provision (benefit) for income taxes									274,616	247,466	152,302
Net income	147,660	81,373	117,444	142,570	108,007	94,842	116,034	129,987	489,047	448,870	275,795
Less: Income attributable to noncontrolling interests	12,199	9,556	9,883	13,963	12,736	9,788	12,385	15,794	45,601	50,703	45,612
Net income attributable to UHS	$ 135,461	$ 71,817	$ 107,561	$ 128,607	$ 95,271	$ 85,054	$ 103,649	$ 114,193	443,446	398,167	230,183
Parent
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts									0	0	903
Less: Provision for doubtful accounts									0	0	0
Net revenues									0	0	903
Operating charges:
Salaries, wages and benefits									0	0	0
Other operating expenses									0	200	0
Supplies expense									0	0	0
Depreciation and amortization									0	0	0
Lease and rental expense									0	0	0
Transaction costs									0		0
EHR incentive income									0
Costs related to extinguishment of debt									29,170
Operating expenses									29,170	200	0
Income (loss) from operations									(29,170)	(200)	903
Interest expense									172,467	195,404	70,283
Interest (income) expense, affiliate									0	0	0
Equity in net income of consolidated affiliates									(567,906)	(518,797)	(271,944)
Income before income taxes									366,269	323,193	202,564
Provision (benefit) for income taxes									(77,177)	(74,974)	(27,619)
Net income									443,446	398,167	230,183
Less: Income attributable to noncontrolling interests									0	0	0
Net income attributable to UHS									443,446	398,167	230,183
Guarantors
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts									5,152,816	4,917,358	3,494,351
Less: Provision for doubtful accounts									411,538	340,121	272,335
Net revenues									4,741,278	4,577,237	3,222,016
Operating charges:
Salaries, wages and benefits									2,452,187	2,371,961	1,611,394
Other operating expenses									899,274	923,579	633,838
Supplies expense									496,848	499,200	422,877
Depreciation and amortization									210,867	207,981	147,645
Lease and rental expense									59,596	60,768	48,872
Transaction costs									5,716		53,220
EHR incentive income									(14,284)
Costs related to extinguishment of debt									0
Operating expenses									4,110,204	4,063,489	2,917,846
Income (loss) from operations									631,074	513,748	304,170
Interest expense									3,749	3,212	6,729
Interest (income) expense, affiliate									93,363	87,205	60,876
Equity in net income of consolidated affiliates									(141,983)	(157,009)	(134,760)
Income before income taxes									675,945	580,340	371,325
Provision (benefit) for income taxes									237,072	198,091	134,547
Net income									438,873	382,249	236,778
Less: Income attributable to noncontrolling interests									0	0	0
Net income attributable to UHS									438,873	382,249	236,778
Non Guarantors
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts									2,562,781	2,465,916	1,981,571
Less: Provision for doubtful accounts									315,133	256,455	256,751
Net revenues									2,247,648	2,209,461	1,724,820
Operating charges:
Salaries, wages and benefits									988,730	954,417	751,989
Other operating expenses									502,592	454,601	381,218
Supplies expense									302,773	306,289	294,048
Depreciation and amortization									91,559	79,230	69,285
Lease and rental expense									37,071	31,344	27,639
Transaction costs									0		0
EHR incentive income									(15,754)
Costs related to extinguishment of debt									0
Operating expenses									1,906,971	1,825,881	1,524,179
Income (loss) from operations									340,677	383,580	200,641
Interest expense									2,702	2,176	605
Interest (income) expense, affiliate									(93,363)	(87,205)	(60,876)
Equity in net income of consolidated affiliates									0	0	0
Income before income taxes									431,338	468,609	260,912
Provision (benefit) for income taxes									114,721	124,349	45,374
Net income									316,617	344,260	215,538
Less: Income attributable to noncontrolling interests									45,601	50,703	45,612
Net income attributable to UHS									271,016	293,557	169,926
Consolidating Adjustments
Condensed Financial Statements, Captions [Line Items]
Net revenues before provision for doubtful accounts									(27,526)	(26,476)	(47,592)
Less: Provision for doubtful accounts									0	0	0
Net revenues									(27,526)	(26,476)	(47,592)
Operating charges:
Salaries, wages and benefits									0	0	0
Other operating expenses									(25,744)	(24,687)	(46,444)
Supplies expense									0	0	0
Depreciation and amortization									0	0	0
Lease and rental expense									(1,782)	(1,789)	(1,148)
Transaction costs									0		0
EHR incentive income									0
Costs related to extinguishment of debt									0
Operating expenses									(27,526)	(26,476)	(47,592)
Income (loss) from operations									0	0	0
Interest expense									0	0	0
Interest (income) expense, affiliate									0	0	0
Equity in net income of consolidated affiliates									709,889	675,806	406,704
Income before income taxes									(709,889)	(675,806)	(406,704)
Provision (benefit) for income taxes									0	0	0
Net income									(709,889)	(675,806)	(406,704)
Less: Income attributable to noncontrolling interests									0	0	0
Net income attributable to UHS									$ (709,889)	$ (675,806)	$ (406,704)

Supplemental Condensed Consolidating Comprehensive Income (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Comprehensive Income (Loss) [Line Items]
Net income	$ 147,660	$ 81,373	$ 117,444	$ 142,570	$ 108,007	$ 94,842	$ 116,034	$ 129,987	$ 489,047	$ 448,870	$ 275,795
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges									6,677	(37,477)	1,396
Amortization of terminated hedge									(336)	(336)	(336)
Minimum Pension Liability									4,986	(12,397)	743
Other comprehensive income before tax									11,327	(50,210)	1,803
Income tax expense related to items of other comprehensive income									4,306	(19,174)	689
Total other comprehensive income, net of tax									7,021	(31,036)	1,114
Comprehensive income									496,068	417,834	276,909
Less: Comprehensive income attributable to noncontrolling interests									45,601	50,703	45,612
Comprehensive income attributable to UHS									450,467	367,131	231,297
Parent
Comprehensive Income (Loss) [Line Items]
Net income									443,446	398,167	230,183
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges									6,677	(37,477)	1,396
Amortization of terminated hedge									(336)	(336)	(336)
Minimum Pension Liability									0	0	0
Other comprehensive income before tax									6,341	(37,813)	1,060
Income tax expense related to items of other comprehensive income									2,408	(14,483)	408
Total other comprehensive income, net of tax									3,933	(23,330)	652
Comprehensive income									447,379	374,837	230,835
Less: Comprehensive income attributable to noncontrolling interests									0	0	0
Comprehensive income attributable to UHS									447,379	374,837	230,835
Guarantors
Comprehensive Income (Loss) [Line Items]
Net income									438,873	382,249	236,778
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges									0	0	0
Amortization of terminated hedge									0	0	0
Minimum Pension Liability									4,986	(12,397)	743
Other comprehensive income before tax									4,986	(12,397)	743
Income tax expense related to items of other comprehensive income									1,898	(4,691)	281
Total other comprehensive income, net of tax									3,088	(7,706)	462
Comprehensive income									441,961	374,543	237,240
Less: Comprehensive income attributable to noncontrolling interests									0	0	0
Comprehensive income attributable to UHS									441,961	374,543	237,240
Non Guarantors
Comprehensive Income (Loss) [Line Items]
Net income									316,617	344,260	215,538
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges									0	0	0
Amortization of terminated hedge									0	0	0
Minimum Pension Liability									0	0	0
Other comprehensive income before tax									0	0	0
Income tax expense related to items of other comprehensive income									0	0	0
Total other comprehensive income, net of tax									0	0	0
Comprehensive income									316,617	344,260	215,538
Less: Comprehensive income attributable to noncontrolling interests									45,601	50,703	45,612
Comprehensive income attributable to UHS									271,016	293,557	169,926
Consolidating Adjustments
Comprehensive Income (Loss) [Line Items]
Net income									(709,889)	(675,806)	(406,704)
Other comprehensive income (loss):
Unrealized derivative gains on cash flow hedges									0	0	0
Amortization of terminated hedge									0	0	0
Minimum Pension Liability									0	0	0
Other comprehensive income before tax									0	0	0
Income tax expense related to items of other comprehensive income									0	0	0
Total other comprehensive income, net of tax									0	0	0
Comprehensive income									(709,889)	(675,806)	(406,704)
Less: Comprehensive income attributable to noncontrolling interests									0	0	0
Comprehensive income attributable to UHS									$ (709,889)	$ (675,806)	$ (406,704)

Supplemental Condensed Consolidating Balance Sheet (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Current assets:
Cash and cash equivalents	$ 23,471	$ 41,229
Accounts receivable, net	1,067,197	969,802
Supplies	99,000	96,775
Deferred income taxes	104,461	108,324
Other current assets	87,936	99,859
Current assets held for sale	25,431	48,916
Total current assets	1,407,496	1,364,905
Investments in subsidiaries	0	0
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	5,368,345	5,106,160
Less: accumulated depreciation	(1,986,110)	(1,818,180)
Property Equipment, net	3,382,235	3,287,980
Other assets:
Goodwill	3,036,765	2,627,602	$ 2,589,914
Deferred charges	75,888	111,780
Other	298,459	272,978
Total assets	8,200,843	7,665,245	7,527,936
Current liabilities:
Current maturities of long-term debt	2,589	2,479
Accounts payable and accrued liabilities	889,557	832,125
Current liabilities held for sale	850	2,329
Federal and state taxes	1,062	0
Total current liabilities	894,058	836,933
Intercompany payable	0	0
Other noncurrent liabilities	395,355	401,908
Long-term debt	3,727,431	3,651,428
Intercompany note payable	0	0
Deferred income taxes	183,747	209,592
Redeemable noncontrolling interests	234,303	218,266
UHS common stockholders' equity	2,713,345	2,296,352
Noncontrolling interest	52,604	50,766
Total equity	2,765,949	2,347,118	$ 2,023,771	$ 1,792,394
Liabilities and Equity, Total	8,200,843	7,665,245
Parent
Current assets:
Cash and cash equivalents	0	0
Accounts receivable, net	7,154	8,891
Supplies	0	0
Deferred income taxes	61,364	67,189
Other current assets	2,188	33,057
Current assets held for sale	0	0
Total current assets	70,706	109,137
Investments in subsidiaries	5,781,479	5,213,573
Intercompany receivable	644,105	669,112
Intercompany note receivable	0	0
Property and equipment	0	0
Less: accumulated depreciation	0	0
Property Equipment, net	0	0
Other assets:
Goodwill	820	820
Deferred charges	67,831	103,434
Other	9,645	10,412
Total assets	6,574,586	6,106,488
Current liabilities:
Current maturities of long-term debt	0	0
Accounts payable and accrued liabilities	10,985	14,201
Current liabilities held for sale	0	0
Federal and state taxes	0	0
Total current liabilities	10,985	14,201
Intercompany payable	0	0
Other noncurrent liabilities	46,048	49,840
Long-term debt	3,676,940	3,594,182
Intercompany note payable	0	0
Deferred income taxes	127,268	151,913
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	2,713,345	2,296,352
Noncontrolling interest	0	0
Total equity	2,713,345	2,296,352
Liabilities and Equity, Total	6,574,586	6,106,488
Guarantors
Current assets:
Cash and cash equivalents	11,949	33,221
Accounts receivable, net	741,983	663,593
Supplies	61,100	59,467
Deferred income taxes	43,555	41,755
Other current assets	75,117	56,864
Current assets held for sale	0	48,916
Total current assets	933,704	903,816
Investments in subsidiaries	1,323,832	1,181,849
Intercompany receivable	0	0
Intercompany note receivable	0	0
Property and equipment	3,867,471	3,650,025
Less: accumulated depreciation	(1,288,975)	(1,184,283)
Property Equipment, net	2,578,496	2,465,742
Other assets:
Goodwill	2,554,531	2,132,103
Deferred charges	5,839	5,972
Other	209,558	241,107
Total assets	7,605,960	6,930,589
Current liabilities:
Current maturities of long-term debt	990	1,133
Accounts payable and accrued liabilities	740,484	616,026
Current liabilities held for sale	0	2,329
Federal and state taxes	900	0
Total current liabilities	742,374	619,488
Intercompany payable	1,004,643	689,487
Other noncurrent liabilities	243,478	249,033
Long-term debt	5,372	3,616
Intercompany note payable	1,007,453	1,148,839
Deferred income taxes	56,801	58,001
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	4,545,839	4,162,125
Noncontrolling interest	0	0
Total equity	4,545,839	4,162,125
Liabilities and Equity, Total	7,605,960	6,930,589
Non Guarantors
Current assets:
Cash and cash equivalents	11,522	8,008
Accounts receivable, net	318,060	297,318
Supplies	37,900	37,308
Deferred income taxes	322	322
Other current assets	10,631	9,938
Current assets held for sale	25,431	0
Total current assets	403,866	352,894
Investments in subsidiaries	0	0
Intercompany receivable	360,538	20,375
Intercompany note receivable	1,007,453	1,148,839
Property and equipment	1,500,874	1,456,135
Less: accumulated depreciation	(697,135)	(633,897)
Property Equipment, net	803,739	822,238
Other assets:
Goodwill	481,414	494,679
Deferred charges	2,218	2,374
Other	79,256	21,459
Total assets	3,138,484	2,862,858
Current liabilities:
Current maturities of long-term debt	1,599	1,346
Accounts payable and accrued liabilities	138,088	201,898
Current liabilities held for sale	850	0
Federal and state taxes	620	620
Total current liabilities	141,157	203,864
Intercompany payable	0	0
Other noncurrent liabilities	105,829	103,035
Long-term debt	45,119	53,630
Intercompany note payable	0	0
Deferred income taxes	0	0
Redeemable noncontrolling interests	234,303	218,266
UHS common stockholders' equity	2,559,472	2,233,297
Noncontrolling interest	52,604	50,766
Total equity	2,612,076	2,284,063
Liabilities and Equity, Total	3,138,484	2,862,858
Consolidating Adjustments
Current assets:
Cash and cash equivalents	0	0
Accounts receivable, net	0	0
Supplies	0	0
Deferred income taxes	(780)	(942)
Other current assets	0	0
Current assets held for sale	0	0
Total current assets	(780)	(942)
Investments in subsidiaries	(7,105,311)	(6,395,422)
Intercompany receivable	(1,004,643)	(689,487)
Intercompany note receivable	(1,007,453)	(1,148,839)
Property and equipment	0	0
Less: accumulated depreciation	0	0
Property Equipment, net	0	0
Other assets:
Goodwill	0	0
Deferred charges	0	0
Other	0	0
Total assets	(9,118,187)	(8,234,690)
Current liabilities:
Current maturities of long-term debt	0	0
Accounts payable and accrued liabilities	0	0
Current liabilities held for sale	0	0
Federal and state taxes	(458)	(620)
Total current liabilities	(458)	(620)
Intercompany payable	(1,004,643)	(689,487)
Other noncurrent liabilities	0	0
Long-term debt	0	0
Intercompany note payable	(1,007,453)	(1,148,839)
Deferred income taxes	(322)	(322)
Redeemable noncontrolling interests	0	0
UHS common stockholders' equity	(7,105,311)	(6,395,422)
Noncontrolling interest	0	0
Total equity	(7,105,311)	(6,395,422)
Liabilities and Equity, Total	$ (9,118,187)	$ (8,234,690)

Supplemental Condensed Consolidating Statements of Cash flows (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	$ 815,271	$ 718,251	$ 501,344
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(363,192)	(285,682)	(239,274)
Acquisition of property and businesses	(527,847)	(29,466)	(1,958,298)
Proceeds received from sale of assets and businesses	149,311	67,592	21,460
Costs incurred for purchase and development of electronic health records application	(54,362)	(38,249)	(17,971)
Return of deposit on terminated purchase agreement	6,500	0	0
Net cash provided by (used in) investing activities	(789,590)	(285,805)	(2,194,083)
Cash Flows from Financing Activities:
Reduction of long-term debt	(849,647)	(381,517)	(1,392,086)
Additional borrowings	913,500	98,100	3,266,146
Financing costs	(8,283)	(23,608)	(101,815)
Repurchase of common shares	(19,154)	(60,482)	(11,528)
Dividends paid	(58,395)	(19,466)	(19,422)
Issuance of common stock	5,435	4,779	3,594
Profit distributions to noncontrolling interests	(26,895)	(38,497)	(32,456)
Proceeds from sale of noncontrolling interest in majority owned business	0	0	600
Changes in intercompany balances with affiliates, net	0	0	0
Net cash (used in) provided by financing activities	(43,439)	(420,691)	1,713,033
Increase (decrease) in cash and cash equivalents	(17,758)	11,755	20,294
Cash and cash equivalents, beginning of period	41,229	29,474	9,180
Cash and cash equivalents, end of period	23,471	41,229	29,474
Parent
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	(21,608)	(4,990)	(139,226)
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	0	0	0
Acquisition of property and businesses	0	0	0
Proceeds received from sale of assets and businesses	0	0	0
Costs incurred for purchase and development of electronic health records application	0	0	0
Return of deposit on terminated purchase agreement	6,500
Net cash provided by (used in) investing activities	6,500	0	0
Cash Flows from Financing Activities:
Reduction of long-term debt	(843,002)	(382,060)	(1,388,679)
Additional borrowings	913,500	98,100	3,266,146
Financing costs	(8,283)	(23,608)	(101,815)
Repurchase of common shares	(19,154)	(60,482)	(11,528)
Dividends paid	(58,395)	(19,466)	(19,422)
Issuance of common stock	5,435	4,779	3,594
Profit distributions to noncontrolling interests	0	0	0
Proceeds from sale of noncontrolling interest in majority owned business			0
Changes in intercompany balances with affiliates, net	25,007	387,727	(1,609,070)
Net cash (used in) provided by financing activities	15,108	4,990	139,226
Increase (decrease) in cash and cash equivalents	0	0	0
Cash and cash equivalents, beginning of period	0	0	0
Cash and cash equivalents, end of period	0	0	0
Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	594,606	518,462	342,633
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(312,190)	(226,848)	(186,967)
Acquisition of property and businesses	(513,596)	0	(1,958,904)
Proceeds received from sale of assets and businesses	142,667	0	21,460
Costs incurred for purchase and development of electronic health records application	(54,362)	(38,249)	(17,971)
Return of deposit on terminated purchase agreement	0
Net cash provided by (used in) investing activities	(737,481)	(265,097)	(2,142,382)
Cash Flows from Financing Activities:
Reduction of long-term debt	0	(1,442)	(753)
Additional borrowings	1,613	0	0
Financing costs	0	0	0
Repurchase of common shares	0	0	0
Dividends paid	0	0	0
Issuance of common stock	0	0	0
Profit distributions to noncontrolling interests	0	0	0
Proceeds from sale of noncontrolling interest in majority owned business			0
Changes in intercompany balances with affiliates, net	119,990	(240,087)	1,816,520
Net cash (used in) provided by financing activities	121,603	(241,529)	1,815,767
Increase (decrease) in cash and cash equivalents	(21,272)	11,836	16,018
Cash and cash equivalents, beginning of period	33,221	21,385	5,367
Cash and cash equivalents, end of period	11,949	33,221	21,385
Non Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	242,273	204,779	297,937
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	(51,002)	(58,834)	(52,307)
Acquisition of property and businesses	(14,251)	(29,466)	606
Proceeds received from sale of assets and businesses	6,644	67,592	0
Costs incurred for purchase and development of electronic health records application	0	0	0
Return of deposit on terminated purchase agreement	0
Net cash provided by (used in) investing activities	(58,609)	(20,708)	(51,701)
Cash Flows from Financing Activities:
Reduction of long-term debt	(8,258)	0	(2,654)
Additional borrowings	0	1,985	0
Financing costs	0	0	0
Repurchase of common shares	0	0	0
Dividends paid	0	0	0
Issuance of common stock	0	0	0
Profit distributions to noncontrolling interests	(26,895)	(38,497)	(32,456)
Proceeds from sale of noncontrolling interest in majority owned business			600
Changes in intercompany balances with affiliates, net	(144,997)	(147,640)	(207,450)
Net cash (used in) provided by financing activities	(180,150)	(184,152)	(241,960)
Increase (decrease) in cash and cash equivalents	3,514	(81)	4,276
Cash and cash equivalents, beginning of period	8,008	8,089	3,813
Cash and cash equivalents, end of period	11,522	8,008	8,089
Consolidating Adjustments
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	0	0	0
Cash Flows from Investing Activities:
Property and equipment additions, net of disposals	0	0	0
Acquisition of property and businesses	0	0	0
Proceeds received from sale of assets and businesses	0	0	0
Costs incurred for purchase and development of electronic health records application	0	0	0
Return of deposit on terminated purchase agreement	0
Net cash provided by (used in) investing activities	0	0	0
Cash Flows from Financing Activities:
Reduction of long-term debt	1,613	1,985	0
Additional borrowings	(1,613)	(1,985)	0
Financing costs	0	0	0
Repurchase of common shares	0	0	0
Dividends paid	0	0	0
Issuance of common stock	0	0	0
Profit distributions to noncontrolling interests	0	0	0
Proceeds from sale of noncontrolling interest in majority owned business			0
Changes in intercompany balances with affiliates, net	0	0	0
Net cash (used in) provided by financing activities	0	0	0
Increase (decrease) in cash and cash equivalents	0	0	0
Cash and cash equivalents, beginning of period	0	0	0
Cash and cash equivalents, end of period	$ 0	$ 0	$ 0

Valuation and Qualifying Accounts (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at beginning of period	$ 253,405	$ 248,622	$ 168,876
Charges to costs and expenses	726,671	613,619	546,909
Acquisition of business	5,632		56,596
Write-off of uncollectible accounts	(674,321)	(608,836)	(523,759)
Balance at end of period	$ 311,387	$ 253,405	$ 248,622

Valuation and Qualifying Accounts - Additional Information (Detail) - USD ($)	Dec. 31, 2011	Dec. 31, 2010
Valuation and Qualifying Accounts Disclosure [Line Items]
Cost and expenses related to facilities	$ 17,043	$ 17,823